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3ABSTRACT
The area of microfluidic analysis systems is a rapidly developing field and the
hyphenation  of  chip  electrophoresis  to  mass  spectrometry  (MS)  is  a  very
active research area. Microanalytical techniques are particularly attractive for
analysis  of  biological  samples  where  sample  amounts  can  be  extremely  low
and fast analyses are required. In addition, analytical microsystems provide
the prospect of integrating several functional elements on a single platform.
The  aim  of  this  work  was  to  develop  analytical  microsystems  for  fast  and
efficient analysis of biomolecules and small drug molecules. For this purpose,
microchips were fabricated of epoxy photoresist SU-8 using
photolithography and adhesive bonding techniques. The free-standing
microchips incorporated microchannels for separation and injection, as well
as  monolithically  integrated  electrospray  ionization  (ESI)  emitter.  The
analytes were separated by microchip capillary (zone) electrophoresis (MCE),
on-chip capillary isoelectric focusing (cIEF), and cIEF-transient
isotachophoresis (tITP) followed by ESI/MS detection.
Peptide mass fingerprinting and protein sequencing were performed for
standard proteins. After digestion, the characteristic tryptic peptides were
easily separated by MCE and a number of singly or doubly charged peptides
were detected by ESI/MS. Sequence coverages between 50% and 70% were
routinely obtained for all selected proteins. Additionally, peptide structural
characterization and protein identification based on MS/MS fragmentation
data of a single tryptic peptide was achieved. Finally, this rapid (total analysis
time from sampling to detection less than ten minutes)  and reliable protein
identification  allowed  the  use  of  the  microchips  in  the  analysis  of  human
muscle cell lysates.
In  addition  to  MCE,  cIEF  is  an  attractive  technique  for  separation  of
zwitterionic molecules (e.g., peptides and proteins) by their isoelectric points
(pI).  In  order  to  facilitate  online  coupling  of  cIEF  to  on-chip  ESI/MS  a
bilateral sheath flow interface or a two-dimensional separation unit was
integrated on-chip.  Rapid focusing of  peptides based on their pI values was
achieved due to the pH dependent surface charge of the SU-8 polymer. The
inherent  electroosmotic  flow  (EOF)  taking  place  in  SU-8  microchannels  at
high  pH  was  exploited  to  electrokinetic  mobilization  of  the  focused  pH
gradient  so  that  no  external  pumps  were  required.  In  addition,  the  two-
dimensional chip design enables unique separation selectivity for the
peptides based on both their pI values and intrinsic electrophoretic
mobilities by multiplex-cIEF-tITP.
Rapid  microchip  based  metabolic  profiling  was  demonstrated  using
authentic urine samples from healthy volunteers after intake of tramadol or
paracetamol. Six tramadol metabolites and four paracetamol metabolites,
including  both  phase  I-  and  II  products,  were  separated  by  MCE  and
4detected  by  online  ESI/MS  within  35  s.  In  addition  to  metabolic  profiling,
Michaelis-Menten kinetics was successfully determined for the CYP450-
mediated oxidation of bufuralol to 1-hydroxybufuralol.
To  better  take  advantage  of  the  small  sample  volumes  in  MCE  and  to
reach better concentration sensitivity sample preconcentration
(pretreatment)  was  integrated  on-chip  by  solid-phase  extraction  (SPE)  and
liquid-phase microextraction (LPME). For SPE, a methacrylate monolith
zone  was  firmly  anchored  at  the  injection  cross  of  the  MCE-ESI/MS
microchip by laser induced photopolymerization. The high power laser beam
allowed  maskless  patterning  of  a  precisely  defined  monolith  zone  with  fast
exposure time (here, 7 min). The monolith was selective toward hydrophobic
and  hydrophilic  molecules  and  enrichment  factors  as  high  as  23-fold  was
obtained with a loading/injection time as short  as 25 s.  LPME on the other
hand, was relatively easy to downscale to the microchip format and to use for
low volume applications.  In addition,  it  offered selectivity in the analysis  of
less  polar  metabolites  so  that  one  tramadol  phase  I  metabolite  (M9)  was
detected only after LPME and not after SPE when conditions were optimized
for SPE of very polar phase II metabolites.
In all, these results show that on-chip electrokinetic separations coupled
to  online  ESI/MS  are  versatile  and  have  great  potential  of  becoming
alternatives to the more conventional techniques (i.e., high performance
liquid chromatography (HPLC)).
5PREFACE
This work was carried out in the Division of  Pharmaceutical  Chemistry and
Technology,  Faculty  of  Pharmacy,  University  of  Helsinki  during  the  years
2008-2014.
First  and  foremost  I  would  like  to  thank  my  supervisors  Docent  Tiina
Sikanen  and  Professor  Risto  Kostiainen,  for  giving  me  the  opportunity  to
work  on  this  thesis  during  so  many  years.  I  do  not  think  there  are  many
researchers as dedicated and passionate as Tiina! Her endless time,
knowledge, and confidence in all results, also the useless ones, are enviable.
Without  her  help  and  friendship  this  thesis  would  never  have  finished!
Likewise, there are not many professors as enthusiastic as Risto. His positive
attitude and supportive personality has helped me and many others a lot. In
addition, Professor Tapio Kotiaho is irrecoverable in his knowledge in
everything that has ever been published in analytical chemistry.
Warm  thanks  go  to  my  co-authors  for  their  valuable  collaboration  and
contributions:  Susanna  Laurén  and  Pia  Suvanto  at  the  Department  of
Materials  Science and Engineering,  Aalto University who actually  went into
the  clean  room  and  fabricated  the  chips  for  me.  Thanks  also  to  their
Professor  Sami  Franssila.  In  addition,  big  thanks  go  to  Mrs.  Maria-Elisa
Nordberg  for  preparing  the  enzyme  kinetics  samples  and  to  Dr.  Brianda
Barrios-Lopez for fabricating the porous polymer monoliths. A special
acknowledge  goes  to  Dr.  Katariina  Vuorensola  for  introducing  me  to  the
academic  community  in  the  beginning  of  my  research  career  and  especially
for  enormous  help  with  teaching  duties,  I  have  enjoyed  them  a  lot!
Additionally, I want to acknowledge the reviewers, docent Susanne Wiedmer
(University  of  Helsinki)  and  Professor  Pierre  Thibault  (University  of
Montreal) for their careful work and insightful comments that led to
considerable improvement of this manuscript.
Innumerable people at the (former) Division of Pharmaceutical
Chemistry,  both  past  and  present,  have  made  life  at  work  very  joyful.  Even
during  times  when  I  have  felt  as  though  I  will  never  finish  this  thesis  the
atmosphere created by you in the lab, the office, as well as in the coffee room
have  made  me go  happily  both  to  and  from work  every  day.  Thank  you  all,
you know who you are!
My  warmest  gratitude  belongs  to  friends  and  family.  Especially  the
“Rautalampivägen-gang”, Catrin, Viki, Jessica, Stoffe, Anna, and Mikko as
well as the “proviisorit” Suvi, Aki, Jenni, and Iiro. You have all provided me
with  happy  moments,  good  food,  travelling  company,  childcare,  and  lots  of
6laughter.  I  am  immensely  grateful,  too,  to  my  own  wonderful  family  for
always  supporting  me.  Overwhelming  thanks  go  to  Tommi  for  his
encouragement, love, and amazing understanding during so many years.
Finally, Ellen and Agnes, you are the sunshine of my life!
Espoo, February 2015
Nina Nordman
7CONTENTS
Abstract ....................................................................................................................... 3
Preface......................................................................................................................... 5
Contents ...................................................................................................................... 7
List of original publications ...................................................................................... 9
Abbreviations and symbols ...................................................................................... 11
1 Introduction .................................................................................................... 13
2 Review of the literature .................................................................................. 15
2.1 Toward lab-on-a-chip devices ............................................................... 15
2.2 Microchip-based electrospray ionization mass spectrometry ............ 16
2.3 Microchip capillary electrophoresis and capillary isoelectric
focusing ................................................................................................................ 18
2.4 Microchips for multidimensional separations .................................... 23
2.5 On-chip sample pretreatment............................................................... 24
2.5.1 Electrokinetic techniques ................................................................... 25
2.5.2 Extraction techniques ......................................................................... 26
3 Aims of the study ............................................................................................ 30
4 Experimental ................................................................................................... 31
4.1 Chemicals, materials, and samples ...................................................... 31
4.2 Instrumentation ..................................................................................... 33
4.3 Microchip design and fabrication ......................................................... 35
4.4 Integrated sample pretreatment ........................................................... 36
4.4.1 On-chip solid-phase extraction ......................................................... 36
4.4.2 On-chip liquid-phase microextraction .......................................... 37
4.5 Operation of the microchips ................................................................. 38
5 Results and discussion ................................................................................... 40
85.1 MCE-ESI/MS in peptide analysis and proteomics (I, II) .................. 40
5.1.1 Peptide mass fingerprinting and protein sequencing by
MCE-ESI/MS(MS) (I) ..................................................................................... 41
5.1.2 Identification of proteins in a human cell lysate (I) ........................ 43
5.1.3 Interfacing of microchip cIEF with on-chip ESI/MS for
peptide analysis (II) ....................................................................................... 44
5.1.3.1 Direct coupling of microchip cIEF to MS via an on-
chip sheath flow interface ......................................................................45
5.1.3.2 Coupling of cIEF to MS via a transient-ITP unit .................. 47
5.2 MCE-ESI/MS in metabolomics research (III) .................................... 50
5.2.1 Metabolic profiling ............................................................................. 50
5.2.2 Enzyme kinetics................................................................................... 52
5.3 On-chip sample pretreatment and preconcentration (III, IV) ........... 53
5.3.1 On-chip preconcentration by solid-phase extraction (IV) ...............54
5.3.2 On-chip clean-up by liquid-phase microextraction (III) .................56
5.4 Summary and Critical Review of the Results ...................................... 58
6 Conclusions ...................................................................................................... 61
References ................................................................................................................ 63
9LIST OF ORIGINAL PUBLICATIONS
This  doctoral  dissertation  summarizes  the  work  presented  in  the  following
publications:
I Nina Nordman, Tiina Sikanen, Susanna Aura, Santeri Tuomikoski,
Katariina Vuorensola, Tapio Kotiaho, Sami Franssila, Risto
Kostiainen. Feasibility of SU-8-based capillary
electrophoresiselectrospray ionization mass spectrometry
microfluidic  chips  for  the  analysis  of  human  cell  lysates.
Electrophoresis, 2010, 31, 3745-3753.
II Nina Nordman, Susanna Laurén, Tapio Kotiaho, Sami Franssila, Risto
Kostiainen, Tiina Sikanen. Interfacing microchip isoelectric focusing
with on-chip electrospray ionization mass spectrometry. Manuscript
2015.
III Nina Nordman, Tiina Sikanen, Maria-Elisa Moilanen, Susanna Aura,
Tapio Kotiaho, Sami Franssila, Risto Kostiainen. Rapid and sensitive
drug metabolism studies by SU-8 microchip capillary
electrophoresiselectrospray ionization mass spectrometry. Journal of
Chromatography A, 2011, 1218, 739-745.
IV Nina Nordman, Brianda Barrios-Lopez, Susanna Laurén, Pia Suvanto,
Tapio Kotiaho, Sami Franssila, Risto Kostiainen, Tiina Sikanen.
Shape-Anchored Porous Polymer Monoliths for integrated online
solid-phase extraction-microchip electrophoresis-electrospray
ionization mass spectrometry. Electrophoresis, 2015, 36, 428-432.
The  publications  are  referred  to  in  the  text  by  their  Roman  numerals.  The
original  publications  are  reproduced  with  the  permission  of  the  copyright
holders.
10
Author´s contribution to the publications included in the doctoral thesis:
Publication I
The  analytical  research  plan  and  the  experimental  work,  excluding  the
microfabrication,  were  implemented  by  the  author.  The  publication  was
written by the author with contributions from others.
Publication II
The  analytical  research  plan,  planning  of  the  microchip  designs,  and  the
experimental work, excluding the microfabrication, were implemented by the
author.  The  publication  was  written  by  the  author  with  contributions  from
others.
Publication III
The research plan and the microanalytical experimental work, excluding the
microfabrication, were implemented by the author. The enzyme incubations
and the enzyme kinetics experiments carried out with the reference method
(HPLC) were performed by Mrs. Maria-Elisa Nordberg. The publication was
written by the author with contributions from others.
Publication IV
The  analytical  research  plan  and  the  experimental  work,  excluding  the
microfabrication,  were  implemented  by  the  author.  The  preparation  and
optimization of the methacrylate monoliths was done by Dr. Brianda Barrios-
Lopez.  The  publication  was  written  by  the  author  with  contributions  from
others.
11
ABBREVIATIONS AND SYMBOLS
ADME adsorption, distribution, metabolism, excretion
AN anolyte
APCI atmospheric pressure chemical ionization
APPI atmospheric pressure photoionization
BGE background electrolyte
BI buffer inlet
BSA bovine serum albumin
CA catolyte
CE capillary electrophoresis
CGE capillary gel electrophoresis
CYP cytochrome P450
cIEF capillary isoelectric focusing
COC cycloolefin copolymer
COP cyclo-olefin copolymer
EC electrochemical detection
EIE extracted ion electropherogram
EOF electroosmotic flow
ESI electrospray ionization
FAS field amplified stacking
FL fluorescence
flt floating
gnd grounded
GRAVY grand average of hydropathicity index
HF hydrofluoric acid
HLM human liver microsomes
(HP)LC high performance liquid chromatography
HV high voltage
ITP isotachophoresis
Km Michaelis-Menten constant
L effective channel length
Lt total channel length
LE leading electrolyte
LIF laser-induced fluorescence
LLE liquidliquid extraction
LPME liquid-phase microextraction
LOC lab-on-a-chip
M1 O-desmethyltramadol
M1-Glu glucuronide of O-desmethyltramadol
M5 N,O-didesmethyltramadol
M5-Glu glucuronide of N,O-didesmethyltramadol
M7-Glu glucuronide of 4-hydroxy-ciclohexyl-N-desmethyl tramadol
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M9 4-oxocyclohexyltramadol.
MALDI matrix-assisted laser desorption ionization
MCE microchip capillary (zone) electrophoresis
MEKC micellar electrokinetic chromatography
MS mass spectrometry
MS/MS tandem mass spectrometry
(O)CEC (open-) channel capillary electrochromatography
Ormocomp® trademark of a UV-curable hybrid polymer
PC polycarbonate
PDMS poly(dimethylsiloxane)
PMMA poly(methyl methacrylate)
PI polyimide
pI isoelectric point
ppm parts per million
Q-TOF quadrupole time-of-flight
SDS sodium dodecyl sulfate
SI sample inlet
SLI sheath liquid inlet
SPE solid-phase extraction
SRM selected reaction monitoring
SU-8 trademark  of  an  epoxy-based  polymer  (glycidyl  ether  of
bisphenol A)
SW sample waste
TE terminating electrolyte
tr migration time
U voltage
UV ultraviolet
Vmax limiting rate of enzymatic reaction, “maximum velocity”
μapp apparent mobility
μEOF mobility of the electroosmotic flow
μEP electrophoretic mobility
μTAS micro-total analysis systems
2D two-dimensional
2D-PAGE two-dimensional polyacrylamide gel electrophoresis
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1 INTRODUCTION
All analytical procedures follow specific steps in a well-defined sequence.
First, a representative sample is collected from the system or environment to
be  studied.  Usually  the  sample  will  need  to  be  processed  in  some  way  in
order to be compatible with the analytical method. Sample pretreatment may
include  purification,  concentration,  and  derivatization.  The  presence  of  the
analyte or analytes of interest is then ascertained, and often the
concentration is quantified.
Lab automation has been a primary focus of analytical chemists over the
past years to facilitate the integration of experimental steps and increase
throughput of sample analysis while simultaneously providing a cost effective
platform for sample and data analysis. Traditionally, analyses are performed
by mixing relatively large amounts of sample and reagents in test tubes and
analyzing the product(s) with an analytical instrument. The time required to
analyze a single sample (including sample pretreatment, separation, and
detection) is usually relatively long. Additionally, problems arise if the
sample  is  accessible  in  only  very  small  amount  or  it  is  expensive.  Here,
microchip technology has much to offer. Several functional elements may be
integrated onto a single microfluidic platform, enabling the creation of novel
devices  with  unlimited  capabilities.  The  approach  is  often  referred  to  as  a
micro-total analysis system (μTAS) or lab-on-a-chip (LOC). The ultimate
μTAS  or  LOC  platform  is  a  small,  portable  device  that  automatically  and
rapidly processes very small amounts of samples, following this with
relatively fast analysis. Ideally, these compact devices can easily be carried to
nearly  any  site  where  analysis  is  needed  and  can  be  operated  without  the
need for a trained technician.
Capillary electromigration techniques are a group of analytical methods
that have become very popular for microanalytical systems and that are
highly suitable for integration in a chip-based format. Capillary
electromigration techniques can be divided into capillary electrophoretic
techniques, i.e., capillary electrophoresis (CE), capillary gel electrophoresis
(CGE), capillary isoelectric focusing (cIEF), and capillary isotachophoresis
(ITP) and electrically driven capillary chromatographic techniques, i.e.,
capillary electrokinetic chromatography (CEC) and micellar electrokinetic
chromatography  (MEKC).  All  of  these  modes  can  relatively  easily  be
miniaturized and,  in miniaturized form, offer  promising alternatives for the
analysis of a variety of matrices. In principle, a miniaturized on-chip
electrophoretic  separation  can  be  performed on  a  microchip  with  a  T-cross
layout with electrodes set in buffer reservoirs at the end of the channels. Only
a battery is required for generating the required electrical field. Not only are
electrophoretic separations easily miniaturized, but unlike chromatographic
separation techniques they actually benefit from miniaturization. While the
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interactions between the analyte and the stationary phase decrease when
miniaturizing chromatography, in microchip capillary electrophoresis (MCE)
the  advantage  lies  in  the  injection  scheme.  On-chip  sample  injection  is
usually  performed  across  the  separation  channel  (rather  than  directly  into
the  separation  channel  as  in  conventional  CE),  resulting  in  a  very  sharp
sample zone. The length of the separation channel can then be reduced and
less voltage is  required to obtain the desired separation performance.  Thus,
on-chip  electrophoretic  separations  can  be  realized  in  seconds  with  high
efficiency and very low sample consumption.
The high selectivity, low detection limits, and good quantitative capability
make mass spectrometry (MS) the most important detection method in bio-
and pharmaceutical analysis today. Currently, electrospray ionization (ESI)-
MS  is  the  ionization  method  of  choice  for  microfabricated  devices,  mostly
because  lower  flow  rates  can  be  used  without  loss  of  sensitivity  (i.e.,  the
nanospray regime). Modern microfabrication techniques also enable rapid
fabrication of sharp, accurately defined emitters directly integrated with the
separation channel in a reproducible manner.
In  my  work,  free-standing,  specially  constructed  SU-8  microchips  were
tested  for  high  throughput  analysis  of  biomolecules  (I,  II)  and  small  drug
molecules (III, IV). The microchips were equipped for microchip capillary
electrophoresis (MCE) (I, III, IV) and cIEF (II) and ESI/MS detection. The
microchip methods were shown to be efficient in metabolomics (III), enzyme
kinetics (III), and in proteomics research (I, II). In addition, sample
pretreatment by liquid-phase microextraction (LPME, III) or solid-phase
extraction (SPE, IV) was performed on-chip before separation and detection.
Review of the literature
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2 REVIEW OF THE LITERATURE
2.1 Toward lab-on-a-chip devices
In response to the need for faster and more cost-effective analytical devices,
miniaturization  has  emerged  as  a  major  field  of  research,  extending  from
basic research to commercial applications. Even though the first example of a
miniaturized analytical instrument was a gas chromatograph on a silicon
chip demonstrated in the 1970s,[1] it  was only in 1990 with the introduction
of the μTAS concept that liquid-phase separation techniques[2-6] and coupling
to MS[7,8] were  introduced.  Nowadays,  miniaturization  and  integration  of
multiple  analytical  operations  on  a  single  microfluidic  chip  (i.e.,  LOC
technology) is considered to be one of the most promising technologies for
the challenging problems of modern bioanalysis.[9-12] Miniaturized analytical
devices are desired in highly diverse fields of research, and thus several
factors are driving the current interest in miniaturization. In the health care
field,  analyzers  for  point-of-care  testing  need  to  be  small,  lightweight,  and
portable with low power requirements and high batch-to-batch
reproducibility. High throughput drug discovery, on the other hand, requires
high-density  arrays  of  microvolume  reaction  vessels  for  rapid  screening  of
thousands  of  drug  candidates  against  thousands  of  biological  targets.
Likewise,  the  pressing  demands  to  monitor  and  detect  the  release  of
biological  warfare  agents  on-site  drive  research  in  this  field.  Today,
applications of microanalytical systems widely cover clinical diagnostics,[13,14]
bioanalytical and pharmaceutical research,[15,16] environmental research,[17,18]
cell manipulation and analysis,[19] and proteomics.[20]
A key benefit of miniaturization is the prospect of integrating all steps in
an analytical procedure (i.e., sample preparation, concentration,
derivatization, injection, separation, and detection) into a single microfluidic
device.[21] Many  of  these  standard  analytical  operations  have,  in  fact,  been
independently  miniaturized  and  are  available  as  building  blocks  for  fully
integrated analyzers.[22] The  advantages  of  such  multifunctional  devices
would include rapid yet sensitive analyses with low consumption of samples
and  solvents,  easy  operation,  and  portability.  Microfluidic  devices  should
also provide advantages in terms of analytical performance, i.e., plate
numbers,  peak  capacity,  limit  of  detection,  resolution,  and  so  on.  For  the
future,  the  escalating  interest  in  high-throughput  screening  for  drug
discovery,  the  large-scale  analysis  required  for  genetic  studies,  and  the
potential of modern microfabrication techniques for mass production of
rapid  and  cost-effective  highly  integrated  devices  for  parallel  analyses  will
certainly continue to drive and influence further research in miniaturization
in general and μTAS in particular.
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2.2 Microchip-based electrospray ionization mass
spectrometry
The implementation of miniaturized ESI on microchip devices connected
online  to  a  mass  spectrometer  has  attracted  much  interest  in  recent  years.
For this, the development of an efficient on-chip interface that transfers
dissolved  analytes  from  the  microchannel  into  the  gas  phase  is  critical.
Although microfluidic devices have been successfully combined with several
ionization techniques, including atmospheric pressure chemical ionization
(APCI),[23] atmospheric pressure photoionization (APPI),[24] matrix assisted
laser desorption ionization (MALDI),[25] and other desorption ionization
techniques,[26,27] the  predominant  approach  at  present  is  to  exploit  the
electrospray  process.  The  first  step  toward  miniaturization  of  ESI  was  the
discovery  of  the  nanospray  technique  in  the  mid-90s.[28,29] In nanospray,
small  droplets  are  generated  from  emitters  with  an  inner  diameter  of  just
110 μm. This allows reduction in the applicable flow rates (typically down to
about 10 nL/min), improved ionization efficiency,[29] and reduced ion
suppression.[29,30] The  first  coupling  of  electrospray  to  a  microfluidic  device
was  also  reported  in  the  1990s  and  comprised  a  glass  chip  with  a  channel
opening at the edge (Figure 1A).[7,8] Problems were associated with this blunt
end  approach,  however,  because  of  the  large  dead  volumes  produced  when
the  droplet  spread  on  the  flat  surface  around  the  channel  exit  port.  An
alternative approach involved attaching external capillaries[31] (Figure 1B) or
emitters[32] (Figure 1C) to the microchannel outlet. Despite issues associated
with dead volumes in the junction between the (separation) microchannel
and  the  inserted  capillary  tip  and  with  the  poor  reproducibility  of  the
fabrication process, combinations including on-chip separations have been
successfully achieved with this approach.[33-37] Still, realization of adequate
on-chip separations ahead of  ESI/MS detection requires fully  dead-volume-
free interfacing between the separation column or microchannel and the
emitter. For this purpose, patterning of the emitter monolithically at the end
of the separation microchannel (Figure 1D) is by far the best choice. Current
progress in microfabrication techniques has also allowed the development of
such sharp-pointed, on-chip emitters for sophisticated microfluidic
separation devices in combination with ESI/MS detection.
Review of the literature
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Figure 1 (A-D) Overview of different approaches to combine microfluidic channels with mass
spectrometry (MS). Picture adapted from Ref. [38].
Since the microfluidic community has adopted most of their
microfabrication processes from the semiconductor industry, silicon was the
first  material  to  be  used.[3,39] However,  the  popularity  of  silicon  as  the
fabrication  material  rapidly  declined,  mainly  because  silicon,  as  a
semiconductor, is not as such compatible with the use of high electric fields
for the generation of electroosmotic flow (EOF). The same photolithographic
techniques were,  however easily  adapted to glass and quartz substrates and
the interest in these materials grew rapidly.[5,40] Glass  is  a  chemically  inert
material, has well defined surface characteristics, and can be used to generate
EOF. Later on, polymers have gained in popularity as substrate material for
microfluidic devices. Especially polymer microfabrication technology offers
great opportunities in comparison to silicon and glass.[41] Patterning  of
polymer substrates is relatively rapid, easy, and inexpensive while accurately
defined  structures  can  easily  be  fabricated  as  integral  parts  of  these
microdevices. Lithographically defined polymer materials, in particular,
enable mass production of very complex yet accurately defined
microstructures.[42] A  wide  variety  of  polymers  have  thus  been  used,
including poly(methyl methacrylate) (PMMA),[43] polycarbonate (PC),[44]
cycloolefin copolymer (COC),[45] polyimide (PI),[46] poly(dimethylsiloxane)
(PDMS),[47] SU-8,[48,49] and Ormocer®.[50]
So  far,  the  main  effort  has  been  to  miniaturize  the  MS  ion  source,  and
microfluidic devices are typically coupled to conventional MS instruments.
For truly portable devices,  however,  focus in the future must also be on the
development of miniaturized mass spectrometers. Several research groups
are  working  toward  this  end  and,  today,  nearly  all  types  of  mass  analyzers
have  been  miniaturized  for  the  purpose  of  developing  portable  MS
instruments.[51]
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2.3 Microchip capillary electrophoresis and capillary
isoelectric focusing
With the electrokinetic liquid handling, relatively easy setup, and no need for
pumps  or  valves,  CE  has  been  the  separation  method  of  choice  for
microfluidic separation devices. The chip-based technique is more commonly
known  as  microchip  electrophoresis  (MCE),  though  the  separation
mechanism  is  basically  the  same  as  that  in  conventional  CE.  In  cathodic
mode CE and MCE, positively charged molecules move from the anode to the
cathode where they are detected by a suitable detector. The rate of movement
of the ionic species is determined by their characteristic electrophoretic
mobilities (μEP), which depend on charge and size of the molecules. The μEP
can be determined experimentally from the migration time and field
strengths
where L is the effective capillary/microchannel length (i.e., the distance from
the inlet to the detection point), tr is the migration time of the analyte, U is
the applied voltage, and Lt is the total length of the capillary or microchannel.
However,  because  of  the  EOF  caused  by  the  charged  substrate  surface  and
the applied electric field, the whole solution (including anions) moves toward
the  cathode.  Hence,  the  migration  of  species  (apparent  mobility, μapp) is
determined by the sum of the μEP and the electroosmotic mobility (μEOF).
MCE  separation  channels  are  often  significantly  shorter  (usually  only  a
few centimeters) than conventional CE capillaries. In addition, the greater
surface/volume ratio and larger thermal mass of the microchip substrate lead
to  better  heat  dissipation  and  the  possibility  to  apply  higher  separation
voltages. This means that improvements in the analytical performance can be
obtained  not  only  in  faster  separations  (~10  s  to  a  few  minutes)  due  to
shorter channels but also in higher plate numbers (105106 m-1) due to higher
separation voltages.[52] The setup and functioning principle of a typical LOC
system used for MCE is pictured in Figure 2.
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Figure 2 Setup and functioning principle of a typical MCE system. (A) Schematic view of a
typical MCE setup with separation and injection channels, liquid reservoirs and detection
window, (B) voltage setup during injection, and (C) voltage setup during separation.
Sample injection in microfluidic systems is usually performed
electrokinetically  through  the  separation  channel  (Figure  2B)  so  that  the
amount  of  sample  injected  (typically  in  pL  range)  is  determined  by  the
volume of the intersection of the injection and separation channels. Figure 2
shows  a  microchip  with  a  simple  cross-injection  structure,  but  other
configurations, e.g., T or double-T injectors, are also common.[53] To avoid
broadening  of  the  injected  sample  plug,  “pinched  injection”  is  often
implemented. Here, small pushback voltages are applied to the buffer
reservoirs  so  that  the  sample  cannot  diffuse  into  the  separation  channel
during injection. Compared with conventional CE, where injections are
directly  into  the  separation  capillary  (hydrodynamically  or
electrokinetically), the microchip approach provides very short sample plugs
and  results  in  sharp  analyte  bands  and  excellent  resolution  during  the
following separation. At the same time, the minute sample volumes injected
into  a  microchip  electrophoretic  system  place  great  demands  on  the
detection sensitivity. Both electrochemical detection (EC)[54] and laser-
induced fluorescence (LIF)[55] are  widely  used  with  MCE  devices.  LIF  is  a
powerful  technique  with  sensitivity  down  to  the  single-molecule  level.  A
drawback  is,  however,  the  need  to  derivatize  most  analytes  prior  to
analysis.[55] The ease of miniaturization and integration of EC elements offers
a high potential for the development of portable analytical devices. However,
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problems of interference of the separation voltage with the detection system,
long-term stability of the response, and restrictions regarding the buffer
composition still remain a challenge.[54] As MS offers structural information
about the analytes and high selectivity, it has become an attractive detection
techniques  in  MCE.  In  combination  with  ESI,  MS is  also  a  rather  universal
detection  technique  allowing  label  free  detection  of  various  ionic  and  polar
compounds.  Nevertheless,  hyphenation  of  microfluidics  with  MS  is  not  an
easy  task  and  often  means  coupling  tiny  microfluidic  chips  with  huge  MS
instruments.  Figure  1  gives  an  overview of  different  approaches  to  combine
microfluidic  channels  with  MS.  In  terms  of  minimizing  detrimental  dead
volumes, the preferred approaches (monolithically) integrate the ESI emitter
with the separation microchannel (Figure 1D), ideally with the emitter area
as small as possible. Table 1 lists MCE separation devices with monolithically
integrated  ESI  emitters  developed  for  the  analysis  of  small  molecules  and
biomolecules.
Table 1. Selected designs in which ESI-MS tips are monolithically integrated with MCE
separation chips.
Chip material ESI interface Analytes Reference
PDMS Graphite coated tip Peptides [56]
PDMS Graphite coated tip Peptides [57]
SU-8
Sheath flow
interface
Drug molecules,
peptides, proteins
[48]
SU-8
Sheath flow
interface
Peptides, protein
digest
I
SU-8
Sheath flow
interface
Pharmaceuticals III
SU-8
Sheath flow
interface
Pharmaceuticals IV
Glass Sheathless Pharmaceuticals [59]
Glass
Sheath flow
interface
Peptides, proteins,
protein digest
[60]
Glass
Sheath flow
interface
Cell lysate [61]
Glass
Sheath flow
interface
Small molecules,
proteins
[62]
Cyclo-olefin polymer Gold coating
Small molecules,
amino acids
[58]
Ormocomp polymer
Sheath flow
interface
Proteins [50]
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As  evident  from  Table  1,  different  polymers  as  substrate  material  are
popular for monolithic integration of MCE separation units with ESI
tips.[48,50,56-58] Polymer materials enable rapid and simple chip fabrication at
relatively  low  cost.  However,  polymers  are  not  always  the  best  substrate
material  in  bioanalysis  due  to  unspecific  interactions  between  the
hydrophobic polymer surface and biomolecules (e.g., proteins and peptides).
Therefore, alternative ways of fabricating fully microfabricated emitters have
been realized also with glass as the substrate material.[59-62] Even  though  a
fully microfabricated glass ESI tip monolithically integrated with a MCE
separation unit was presented recently,[62] manual processing steps are often
required  when  fabricating  microchips  of  glass.[59-61] In  terms  of  analytical
performance, Thorslund et al.[56] and Dahlin et al.[57] used PDMS chips with a
graphite-coated tip for the separation of peptides, accomplishing separations
within 2 min on 6-cm[56] and 17-cm-long[57] separation channels, respectively.
Plate numbers were of the order of 104 m-1. Even higher plate numbers were
obtained for the separation of standard peptides by Mellors et al.[60] (105106
m-1) using a 4.7-cm-long or 20.5-cm-long serpentine separation channel.
Similar  high  plate  numbers  and  efficient  separation  were  achieved  by
Sikanen et al.[48] and Sainiemi et al.[62] in their separation of small molecules
and peptide standards in 12  min  on  SU-8  and  glass  MCE-ESI/MS
microchips, respectively.
cIEF is an established separation technique for zwitterionic biomolecules
(e.g., peptides and proteins), exploiting a unique separation principle based
on  their  isoelectric  points  (pI).[63] In cIEF, carrier ampholytes form a pH
gradient under the influence of an electric field, and ampholytic sample ions
are  separated  in  sharp  bands  according  to  their pI values  (Figure  3).  Like
other electrokinetic separation techniques, cIEF is rapid, requires only a
small amount of sample, can be automated, and has high separation
efficiency. In terms of sensitivity, cIEF is also attractive as the first-
dimension separation of a multi-dimensional microchip-based separation
device. The focusing nature of cIEF can increase sample concentration up to
100-fold[64] and  significantly  improve  the  detection  limits  for  analyses  on
miniaturized devices.
Figure 3 Functioning principle of cIEF. When an electric field is applied between the cathode
and the anode (A) ampholytic analytes (e.g., proteins and peptides) move to their isoelectric
point where each individual analyte posseses a neutral charge (B).
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In cIEF, analyte separation is complete after focusing, but if detection is
to be performed with a single-point detector, the focused zones must first be
mobilized. The two most common mobilization techniques are hydrodynamic
flow and electrophoretic mobilization. Hydrodynamic flow mobilization is
usually  generated  under  pressure  or  gravity,  and  an  electric  field  is
maintained to suppress defocusing of the bands during mobilization.[65]
Electrophoretic mobilization can be separated into salt mobilization[66] and
EOF-driven mobilization.[67]  In  salt  mobilization,  ions  are  added  to  one  of
the electrolytes (cations to the anolyte or anions to the catolyte). The addition
of  ions  induces  a  pH  shift  at  one  end  of  the  cIEF  channel,  and  as  this
gradually progresses deeper into the separation channel it causes the whole
pH  gradient/sample  solution  to  migrate  toward  the  anode  or  cathode.  In
EOF-driven  mobilization,  in  turn,  the  whole  volume  of  solution  within  the
channel is driven toward the detector by the EOF inherent in the separation
channel.
Microfabricated  separation  devices  for  cIEF  have  primarily  relied  on
ultraviolet (UV) or fluorescence (FL) detection[68-71] in  addition  to  whole
column imaging.[72] Although  MS  detection  is  often  desired,  coupling  with
cIEF is somewhat troublesome because the carrier ampholytes required for
successful cIEF tend effectively to suppress the ionization efficiency of the
analytes.[73,74] In  spite  of  this,  Wen  et  al.[75] fabricated a polycarbonate
microchip for direct  coupling of  cIEF to ESI/MS and successfully  separated
and detected standard proteins (Figure 4). Still, the cIEF step (before
mobilization) is relatively long (10 min) and a shorter cIEF step would better
meet the demands for fast(er) analysis on microfabricated devices.
Figure 4  (A) Photograph of the cIEF chip with ESI emitter and expanded view showing the
fabrication of a cIEF-ESI/MS microchip. (B) Electropherogram of carbonic anhydrase (pI 5.9
and 6.8) and myoglobin (pI 7.2) separated by microchip cIEF and detected by ESI/MS.[75]
Reproduced with the permission of John Wiley and Sons.
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2.4 Microchips for multidimensional separations
In most situations,  separation is  achieved by a single mechanism where the
resolution and peak capacity are limited. Multidimensional separation
systems are attracting much interest mainly because of the increased peak
capacity that they offer over one-dimensional separations.[76,77] Here,
microchip technology offers advantages such as high speed of analysis, high
throughput,  and  low  sample  volume  requirements.  Sequential  coupling  of
different electrokinetic separations on-chip also does not require carefully
designed  capillary  connectors  but  is  accomplished  by  proper  design  of  the
channel layout. All functional elements are then easily integrated with near-
zero dead-volumes on a single monolithically fabricated platform.
The most common multidimensional separation method for protein and
peptide analysis is two-dimensional polyacrylamide gel electrophoresis (2D-
PAGE).[78] In  2D-PAGE,  sample  molecules  (e.g.,  proteins)  are  separated  by
their pI value  in  the  first  dimension  and  molar  mass  in  the  second.  MS
detection  (offline)  of  the  spots  on  the  2D  gel  enables  identification  of  the
separated species. The technique has several limitations, however. It is time-
consuming, labor-intensive, and difficult to automate, and throughput is
low.[79]  2D-PAGE has also been successfully miniaturized.[80-82] On the other
hand, liquid-phase separations are more convenient for online MS coupling.
Table 2 lists microchip-based 2D separation devices with in-solution
separations, including both chromatographic and electrophoretic
approaches.
One  of  the  first  in-solution  2D  separation  microchip  was  introduced  by
the  Ramsey  group  in  2000  (Table  2).[83] They separated peptides by first-
dimensional  MEKC,  using  sodium  dodecyl  sulfate  (SDS)  as  the  micellar
dispersed phase, and second-dimensional MCE in less than 10 min, following
this  with  FL  detection.  Both  the  resolving  power  and  peak  capacity  were
greatly increased over values obtained by either dimension alone. In terms of
sample throughput, analysis with the MEKC-MCE microchip is the fastest
thus far reported for 2D microchip separation systems (Table 2).
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Table 2. Summary of selected in-solution-based 2-dimensional microfluidic separation
devices.
Separation
technique
Analysis time Detection
method
Peak capacity Reference
MEKC × MCE
Peptides 8-10 min FL 500-1000 [83]
Tryptic peptides 10-15 min FL 4200 [84]
Tryptic peptides 10-35 min FL >4000 [85]
OCEC × MCE
Tryptic peptides 10-15 min FL 150 [86]
cIEF × MCE
Proteins n × 45 s FL 1300 [87]
Proteins 20 min FL not reported [88]
Tryptic peptides 50 min FL 540 [89]
LC × MCE
Tryptic peptides >30 min ESI/MS 30-fold
compared to 1D
[90]
cIEF × LC
Tryptic peptides 60 min FL
MALDI/MS
215 [91]
cIEF × tITP
Peptides <10 min ESI/MS not reported II
2.5 On-chip sample pretreatment
A well-known problem today, particularly in on-chip electrophoretic
separations, is the relatively poor concentration sensitivity, due to the short
optical path length in UV and FL detection and the extremely small amount
of  sample  injected.  For  ESI/MS,  detection  analysis  from  subattomole
amounts of sample has been demonstrated,[31,92] but the very small injection
volumes  (typically  in  pL  range)  often  force  the  use  of  micromolar
concentrations if there is no preconcentration step. Additionally, sample
pretreatment (and simultaneous preconcentration) is usually considered to
be  the  most  time-consuming  step  in  bioanalyses.  Thus,  extensive  work  has
been  carried  out  with  a  view  to  integrating  this  step  with  microchip
electrophoresis systems.[93]
In general, chip-based sample pretreatment methods are analogues of
their conventional counterparts and fall into one of four major categories, as
indicated  in  Figure  5.  In  this  overview,  I  consider  only  on-chip  sample
preconcentration, and thus, only the electrokinetic techniques (field
amplified stacking and isotachophoresis) and extraction-based techniques
(SPE and liquidliquid extraction (LLE)). Additionally, concentration
enhancement  factors  up  to  30  and  100  have  been  reported  for  on-chip
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sample preconcentration by surface affinity reactions[94] and various
membrane-based techniques,[95] respectively.
Figure 5 Classification of chip-based sample pretreatment techniques. Picture adapted from
Ref. [96].
2.5.1 Electrokinetic techniques
One  of  the  most  common  techniques  for  increasing  the  concentration  of
desired compounds is field amplified stacking (FAS). FAS was first used on a
microfluidic device in 1995,[97] when  amino  acids  were  separated  by
electrophoresis.  In  a  typical  sample  stacking  approach,  the  analyte  in  a  low
conductivity  buffer  is  injected  into  the  separation  channel  (capillary  or
microchannel) between higher ionic strength running buffers. After applying
voltage, analytes accelerate toward the cathode/anode due to the faster
migration  in  the  lower  ionic  strength  sample  solution  (high  field  strength).
When they reach the sample zone/BGE boundary they are slowed down (low
field  strength)  and  become  stacked  into  narrow  bands.  The  sample  ions
become stacked at the interface between the low and high conductivity
buffers owing to the higher electric field strength in the low conductivity
buffer. FAS has also been applied for the concentration and MCE separation
of  fluorescently  labeled  amino  acids[98] and  for  MCE  and  MS  detection  of
trace level digests of gel-isolated proteins.[99] Here, the concentration
enhancements were 95-[98] and  50-fold,[99] respectively. The simplicity, easy
applicability, and compatibility with different buffers make FAS widely
applicable to many different detection systems, including MS.[99]
ITP  is  another  well-established  technique  that  can  be  used  both  for
sample preconcentration and as an individual separation technique. In ITP
the sample is injected between a leading electrolyte (LE) and a terminating
electrolyte  (TE)  so  that  the  electrophoretic  mobility  of  the  LE  (μEP(LE)) is
greater than the maximum μEP in  the  sample  and,  reversely,  the μEP(TE) is
lower than the minimum μEP of the sample. When an electric field is applied,
the sample ions are separated in very sharp bands between the LE and the TE
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in the order of their μEP values, and the zones migrate with uniform velocity
toward the detection point (Figure 6).
Figure 6 Functioning principle of ITP. The sample solution (A and B) is introduced between a
leading electrolyte (LE) possessing higher electrophoretic mobility (μEP) than A and B and a
terminating electrolyte (TE) possessing slower μEP than A and B. Upon application of an
electric field between the anode and the cathode A and B separate in sharp bands between
the LE and the TE.
ITP  provides  a  simple  and  powerful  method  of  concentration  that  can
easily  be  integrated  to  the  microchip  format  ahead  of  other  on-chip
operations.  It  can  provide  an  increase  in  sensitivity  of  several  orders  of
magnitude  for  dilute  samples,  while  also  being  suitable  for  highly  saline
samples. ITP has already been extensively used as a preconcentration
method  in  MCE,[100] and  sample  enhancement  factors  as  high  as  800  have
been achieved.[101] One  drawback  of  ITP  is  that  it  is  usually  necessary  to
determine the μEP of  sample  ions  before  the  analysis.  This  may  be  time-
consuming  and  troublesome  especially  for  complex  samples  with  many
analytes of interest.
2.5.2 Extraction techniques
Common  to  all  electrokinetic  techniques  is  that  one  must  fill  the
microchannel with two or more different buffer solutions to create
appropriate electric field gradients for sample stacking and concentration.
Furthermore, electrokinetic stacking methods are not very suitable for
sample clean up (e.g., removing salts from the matrix) and additional off-line
sample pretreatment is often required for very complex samples. Moreover,
electrokinetic approaches typically deliver enrichment factors an order of
magnitude lower than those of the more effective extraction-based
techniques.[96]
Chip-based  extractions  have  been  performed  by  both  SPE  and  LLE.[96]
SPE  relies  on  interactions  between  analytes  (in  mobile  phase)  and  a  solid-
phase packing (stationary phase), which under the appropriate conditions,
result in retention of analytes onto the stationary phase. The choice of
stationary  phase  material  allows  the  SPE  device  to  be  tailored  between  the
Review of the literature
27
great selectivity achievable with an immunoaffinity ligand and the completely
generic result achieved with the octadecyl carbon chain (C18)-bonded silica.
SPE  is  not  only  a  preconcentration  technique,  but  can  at  the  same  time  be
used  as  a  precleaning  process  for  the  separation  of  hydrophobic  analytes
from hydrophilic impurities, or vice versa.
Accomplishing SPE on a microchip requires that, solid support structures
are incorporated into the microchannel.[102,103] Beads  have  been  used  in
analytical devices (e.g., chromatography columns) for several decades and
the  use  of  beads  in  microchannels  is  also  widespread.[104] Trapping beads
inside a microchannel for SPE purposes, however, requires some form of
immobilization within the device. A number of immobilization methods have
been reported, some relying on mechanical barriers, such as microfabricated
frits,[47,105] to  retain  the  beads,  others  on  surface  immobilization[106] or
magnetic fields to manipulate and trap the (magnetic) beads.[107] Precisely
ordered microfabricated structures (micropillars), mimicking a perfectly
ordered packed bed, have been investigated as alternative stationary
phases.[108-110] Ordered pillar arrays are only support structures, however,
and surface chemical reactions often must be employed to put the stationary
phase  material  onto  the  pillars.  As  an  alternative  to  packed  beads,  porous
polymer  monoliths  offer  attractive  features  for  on-chip  SPE.  Monoliths  are
easily formed by in situ polymerization  of  monomers,  in  the  presence  of  a
porogen, by heat or UV. The porosity and surface chemistry of the monolith
can be tuned simply by changing the polymerization time and/or monomer
composition. Additionally, UV-initiated polymerization methods allow
monoliths  to  be  fabricated  in  specific  areas  of  a  microchannel  without  the
need for frits and with no risk of beads leaking out of the microchannel and
into the MS instrument. Monoliths are typically silica- or polymer-based and
have higher permeability and better mass transfer than comparable
particulate materials. This means that they can be run under lower pressure
and operated fully electrokinetically. Even if polymerization conditions might
be difficult to keep constant during fabrication of monolithic stationary
phases, studies have demonstrated that column-to-column reproducibility is
not  poorer  for  monolithic  stationary  phases  than  for  their  packed
counterparts.[111] Table 3 lists selected microchips with integrated SPE phases
for sample pretreatment and/or preconcentration prior to analysis. Table 3 is
not  comprehensive  and  does  not  list  packed  chips  used  for  e.g.,  enzyme
immobilization.
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Another extraction technique that has been used extensively for
preconcentration in analytical  processes is  LLE. In microfluidic systems the
laminar  flow  regime  can  be  exploited  in  order  to  incorporate  LLE  on-chip.
The possibility of creating large interfacial contact regions relative to the
small  volumes  being  manipulated  and,  short  diffusion  distances  is
advantageous in LLE. This straightforward approach of forming a multi-
phase  parallel  laminar  flow  has  been  exploited  by  many  groups.[131-133] In
these  continuous  systems,  however,  enrichment  factors  higher  than  10  are
difficult to achieve because of limitations in applicable organic/aqueous
phase ratios.
In droplet-based extraction, on the other hand, the volume of the acceptor
phase (droplet) can be minimized so that the enrichment from a continuous
phase can effectively be achieved.[134,135] At best, enrichment factors higher
than 1000 have been achieved with droplet-based microextraction.[134,136]
Although the above-mentioned two-phase techniques are relatively easy
to implement even on microchip devices, LLE as such is not easily coupled to
MCE separations, primarily due to the often incompatible nature of solvents
when extraction  is  from a  water-based  solution  into  an  organic  phase.  This
difficulty can be overcome by performing a three-phase extraction in which
analytes  pass  from  the  sample  (donor  solution)  through  an  organic  phase
into  an  acceptor  solution.  The  organic  phase  can  be  held  in  a  membrane
(LPME), as has been shown by Pedersen-Bjergaard and co-workers[137-145] for
off-line cleanup before conventional CE separations. The setup was further
introduced  to  an  MCE glass  microchip  for  LPME before  separation  and  FL
detection of pharmaceuticals.[146] LPME is an equilibrium extraction
technique where recovery is determined by the partition coefficients of the
analytes, the sample volume, the volume of the supported liquid membrane,
and the volume of  the acceptor phase.  At  a  certain point,  the system enters
equilibrium and the  analyte  concentration  in  the  acceptor  solution  remains
constant.  Typically,  LPME  recoveries  range  between  10  and  90%.[142,146] In
another three-phase approach, microdroplets with designer geometries were
used in an LLE system.[147] Here, a multiphase droplet with an organic phase
sandwiched between two aqueous phases was applied. Fluorescein was then
extracted from the aqueous donor droplet solution through the organic phase
(octanol) into the aqueous acceptor solution.
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3 AIMS OF THE STUDY
The primary aim of  the study was to develop fast  and efficient analytical
microsystems for the analysis of biomolecules and small drug molecules. The
various analytes were to be separated on-chip by different electrokinetic
separation  methods,  ionized  by  on-chip  ESI  and  detected  by  MS.  For  this
purpose, two microchip designs were reproduced from SU-8 polymer, with
all  structures  simultaneously  patterned  by  photolithography.  A  further  aim
was to incorporate sample pretreatment (preconcentration) as an integral
part  of  the  analytical  microsystem.  This  was  pursued  by  on-chip  SPE  and
LPME.
The more detailed aims of the research were
 To confirm the applicability of SU-8-based MCE/cIEF-ESI/MS
microchips to the very fast characterization of standard proteins
and protein mixtures (I, II)
 To  solve  the  challenges  related  to  online  coupling  of  cIEF  to
ESI/MS by exploiting SU-8 photolithography for chip fabrication
(II)
 To  take  advantage  of  the  pH  dependent  surface  charge  of  SU-8
polymer  in  order  to  perform on-chip  cIEF without  EOF reductive
coating (II)
 To address the need of increased analysis speed in drug
development by developing a fast microchip based separation
method  for  analyzing  metabolites  in  human  urine  samples  and
determining kinetic parameters (III)
 To  couple  LPME  online  to  a  separation  microchip  for  the
precleaning and preconcentration of drug metabolites from human
urine (III)
 To  perform  fast  on-chip  SPE  before  MCE-ESI/MS  without
substantially increasing the total analysis time (IV)
Experimental
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4 EXPERIMENTAL
This section briefly describes the chemicals, materials, samples,
instrumentation, and experimental setups used in the work. Details of the
experimental  conditions  and  chemicals  can  be  found  in  the  original
publications I-IV.
4.1 Chemicals, materials, and samples
Chemicals used in the work are listed in Table 4. Notes indicate their use. All
chemicals and solvents were of analytical grade or higher.
Table 4. Chemicals used in the work
Reagent/Solvent/Standard Manufacturer/Supplier Note Publication
Acetic acid
Mallinckrodt Baker, Deventer, The
Netherlands
Reagent I-IV
Acetonitrile (ACN)
Rathburn Chemicals, Walkerburn,
Scotland
Solvent I, III
Ammonium acetate Sigma-Aldrich, Steinheim, Germany Reagent I-IV
Ammonium formate Sigma-Aldrich, Steinheim, Germany Reagent I, III
Ampholyte pH 3-10 Sigma-Aldrich, Steinheim, Germany Reagent II
Angiotensin I Sigma-Aldrich, Steinheim, Germany Standard I, II
Angiotensin II Sigma-Aldrich, Steinheim, Germany Standard I, II
Angiotensin III Sigma-Aldrich, Steinheim, Germany Standard II
Benzoin methyl ether (BME) Sigma-Aldrich, Steinheim, Germany Photoinitiator IV
Bovine serum albumin (BSA) Sigma-Aldrich, Steinheim, Germany Standard I
Bradykinin (fragment 1-5) Sigma-Aldrich, Steinheim, Germany Standard I, II
Bufuralol Roche, Basel, Switzerland Standard III
Cotinine Sigma-Aldrich, Steinheim, Germany Standard IV
Cytochrome c Sigma-Aldrich, Steinheim, Germany Standard I, II
2,3-Epoxypropyl methacrylate
(GMA)
Sigma-Aldrich, Steinheim, Germany Monomer IV
Fluorescein-polyethyleneglycol
(PEG-NHS- 5k)
Creative PEGWorks, Winston Salem,
NC, USA
Porogen IV
Formic acid Sigma-Aldrich, Steinheim, Germany Reagent I, III
Histidine Sigma-Aldrich, Steinheim, Germany Standard II
Human liver microsomes (HLM) BD Gentest, Erembodegem, Belgium Reagent III
Human muscle cell lysate
Protein Chemistry Core Facility,
University of Helsinki, Finland
Biological
sample
I
Hydrochloric acid Riedel-de Haën, Seelze, Germany Solvent III
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Reagent/Solvent/Standard Manufacturer/Supplier Note Publication
Hydrogen fluoride (HF) Merck, Darmstadt, Germany Solvent I-IV
1-Hydroxy bufuralol
Ultrafine Chemicals, Manchester,
England
Standard III
ß-Lactoglobulin Sigma-Aldrich, Steinheim, Germany Standard I
Methanol J.T. Baker, Deventer, Holland Solvent I-IV
1-Methoxy-2-propyl acetate (PMA) Sigma-Aldrich, Steinheim, Germany Solvent III
2-Methoxyethanol (2ME) Sigma-Aldrich, Steinheim, Germany Solvent IV
1-Methyl-2-pyrrolidone (NMP) Sigma-Aldrich, Steinheim, Germany Co-porogen IV
Milli-Q water, deionized Milli-Q water purification system Solvent I-IV
Nicotinamide adenine dinucleotide
phosphate oxidase (NADPH)
Sigma-Aldrich, Steinheim, Germany Cosubstrate III
N,N,N,N´,N´-
Tetramethylethylenediamine
(TEMED)
Sigma-Aldrich, Steinheim, Germany Solvent II
N,O-Didesmethyltramadol
Department of Forensic Medicine,
University of Helsinki, Finland
Standard III
1-Octanol Fluka, Buchs, Switzerland Solvent III
Ovalbumin Sigma-Aldrich, Steinheim, Germany Standard I
O-Desmethyltramadol
Department of Forensic Medicine,
University of Helsinki, Finland
Standard III
Paracetamol Orion Pharma, Espoo, Finland Standard III
Polyethyleneglycol 6000 (PEG
(6k))
Applichem, Darmstadt, Germany Porogen IV
Paracetamol glucuronide Sigma-Aldrich, Steinheim, Germany Standard III
Propranolol Sigma-Aldrich, Steinheim, Germany Standard IV
Sodium hydroxide J.T. Baker, Deventer, Holland Reagent III
Sodium phosphate Riedel-de Haën, Seelze, Germany Reagent III
Substance P (fragments 6-11) Sigma-Aldrich, Steinheim, Germany Standard II
Tramadol
Department of Forensic Medicine,
University of Helsinki, Finland
Standard III
Triethylene glycol dimethacrylate
(TEGDMA)
Sigma-Aldrich, Steinheim, Germany Crosslinker IV
Trimethylolpropane trimethacrylate
(TRIM)
Sigma-Aldrich, Steinheim, Germany Crosslinker IV
Trizma base Sigma-Aldrich, Steinheim, Germany Reagent I, II
Trypsin (porcine) Promega, Madison, WI, USA Enzyme I, II
Verapamil hydrochloride Sigma-Aldrich, Steinheim, Germany Standard III, IV
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Table 5 lists the commercially available materials and products that were
used. Notes indicate their use.
Table 5. Commercially available materials and products used in the study.
Materials/Products Manufacturer/Supplier Note Publication
Celgard 2500
microporous
polypropylene membrane
        Celgard, Charlotte, NC, USA For LPME III
Isolute MF C18, 100 mg
reversed-phase cartridge
Int. Sorbent Technology, Mid
Glamorgan, U.K.
For SPE III
Oasis HBL, 30 mg cartridge Waters, Milford, MA, ÙSA For SPE III
Platinum (999, 0.5 mm)
Kultakeskus, Hämeenlinna,
Finland
Electrode material I-IV
Poly(dimethylsiloxane),
Sylgard 184 PDMS
Dow Corning, Midland, MI,
USA
Supporting structures for
microchips
I-IV
SU-8 photoresist
Microchem, Newton, MA,
USA
Fabrication of microchips I-IV
The drug molecules, proteins, and peptides were dissolved in methanol,
water,  or  water/methanol  and  further  diluted  as  stated  in  the  original
publications (I-IV). Protein digests and human muscle cell lysates (I, II) were
prepared according to standard protocols and analyzed without further
pretreatment.
The urine samples (III) were pretreated by SPE using ODS reversed phase
cartridges  (Isolute  MF  C18,  urine  containing  paracetamol  metabolites)  or
polymeric reversed phase cartridges (Oasis HBL, urine containing tramadol
metabolites). In addition to SPE, the urine samples were pretreated by
LPME, as described in publication III and in Ref. [146].
4.2 Instrumentation
Table  6  lists  the  commercial  instruments  used  in  the  work.  Notes  indicate
their  use.  In  addition  to  the  commercial  instruments,  some  in-house  built
and standard laboratory equipment was employed (i.e., chip holders, electric
resistors, vacuum pumps, microscopes, and multimeters).
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Table 6. Commercial instruments used in the study
Instrumentation Manufacturer/Supplier Note Publication
For microchip electrophoresis
Microfluidic ToolKit, computer-
controlled (Labview)
Micralyne, Edmonton,
Canada
High voltage power supply I-IV
For monolith preparation
Zeiss Axioscope Carl Zeiss, Espoo, Finland UV laser IV
For mass spectrometry
Agilent 6330 MS ion trap
Agilent Technologies, Santa
Clara, CA, USA
Mass spectrometer I, II
Compressed air
Atlas Copco air dryer, Wilrijk,
Belgium
Nebulizer gas I, II
Nitrogen
Nitrogen generator system,
Parker, Cleveland, OH, USA
Nitrogen generator I, II
Nitrogen
Whatman 75-72 nitrogen
generator, Haverhill, MA,
USA
Nitrogen generator I, II
Nitrogen
Peak Scientific,
Renfrewshire, Scotland
Nitrogen generator I, II
PE Sciex API 365
Perkin Elmer Sciex,
Concord, Canada
Mass spectrometer II
PE Sciex API 3000
Perkin Elmer Sciex,
Concord, Canada
Mass spectrometer I, III, IV
Q-TOF Micro MS
Waters/Micromass,
Manchester, U.K.
Mass spectrometer I
For reference methods
Agilent HP 1100 HPLC system
Agilent Technologies,
Waldbronn, Germany
Liquid chromatograph III
AtlantisTM dC18 column
Waters Corporation, Milford,
MA, USA
Reversed-phase column III
Fused silica capillary
Composite Metal Services,
Worchester, UK
For capillary electrophoresis II
P/ACE MDQ CE equipment
Beckman Instruments, CA,
USA
Capillary electrophores II
Zorbax Eclipse Plus C18
column
Agilent Technologies, Palo
Alto, CA, USA
Reversed-phase column III
Software etc.
Analyst 1.4 Software for Sciex QqQ I-IV
Data Analysis Software for ion trap I, II
Mass Lynx 4.0 Software for Q-TOF I
Swiss Prot database
MASCOT® online search
engine
(www.matrixscience.com)
Online protein search engine I, II
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4.3 Microchip design and fabrication
The  microchip  designs  are  schematically  presented  in  Figure  7.  The
dimensions  of  the  microchannels  varied,  as  reported  in  the  original
publications  (I-IV),  but  the  fabrication  process  was  similar  for  all  designs,
comprising standard photolithographic and adhesive bonding
techniques.[48,148]
Figure 7 Schematic pictures of the microchips used for (A) MCE and cIEF (for cIEF the
microchip had two sheath flow channels) and for (B) cIEF-transient ITP-ESI/MS. AN anolyte,
BI buffer inlet, CA catolyte, SI sample inlet, SLI sheath liquid inlet, and SW sample.
Dimensions not to scale.
Figure 8 shows the three structural SU-8 layers used in fabrication of the
MCE-ESI/MS microchip (Figure 7A). The first SU-8 layer (70-μm-thick) was
spin  coated  on  a  silicon  wafer,  and  sample  inlets  were  patterned  on  it.  A
second (50-μm-thick) SU-8 layer was then spin coated on top of the first and
patterned with the microchannels. After post-exposure bake the first two
layers  were  simultaneously  developed.  The  third  SU-8  layer  (70-μm-thick)
was  individually  spin  coated  on  a  polymer  substrate,  post-baked,  and  then
bonded with the previously patterned SU-8 layers. Exposure of the third SU-
8  layer  was  done  through  the  transparent  substrate,  and  a  post-exposure
bake followed. Finally, the three-layered microchips were released from the
silicon  substrate  by  sacrificial  wet  etching  in  50%  HF  in  water.  Before  use,
poly(dimethylsiloxane) (PDMS) sheets with 2 mm inlet holes were attached
on top of the SU-8 chips to increase the inlet volumes.
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Figure 8 Schematic picture of the patterning order of the three structural SU-8 layers (left)
and the prepared MCE-ESI/MS microchip released from the silicon wafer and flipped over
(right).[48] Reproduced with permission of the American Chemical Society.
4.4 Integrated sample pretreatment
4.4.1 On-chip solid-phase extraction
A porous  polymer  monolith  was  fabricated  within  the  injection  cross  of  the
microchip  shown  in  Figure  7A.  The  methacrylate  monolith  was  prepared
according to a protocol slightly modified from that previously
presented.[149,150] The monomer mixture, thoroughly described in publication
IV, was loaded into the microchannel and photopolymerized with a UV laser
through the SU-8 cover layer (70-μm-thick) at  the injection cross for 7 min
(Figure 9).
Figure 9 Schematic view of the photopolymerization setup used for preparing the monolith by
beaming a UV laser at the injection cross of the SU-8 MCE-ESI/MS microchip.
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Rinsing of the porogens and unpolymerized methacrylate monomers from
the monolith was found to be crucial in minimizing background disturbance
and suppressing ionization in ESI/MS. For this,  the washing procedure was
optimized with the aid of fluorescent-labeled porogens (fluorescein-PEG, 5k).
Now  the  washing  efficiency  could  be  monitored  as  the  weakening
fluorescence  of  the  monolith  pattern,  in  addition  to  the  quality  of  the  mass
spectra  (Figure  10).  The  optimized  washing  procedure  included  rinsing  the
monolith  with  a  water/methanol  1:1  solution  by  vacuum  suction  for  10
minutes before and after keeping the microchips in the same solution for one
hour. This procedure was found adequate to ensure high quality MS analysis
(Figure  10B).  As  is  evident  from  Figure  10A,  unless  they  are  carefully
removed  from  the  monolith  before  use,  the  PEG  residues  will  reduce  the
quality of the mass spectra.
Figure 10 ESI/MS spectra of a background electrolyte (BGE) run obtained with an SU-8 MCE-
ESI/MS chip with porous methacrylate pattern at the injection cross: (A) after inadequate
washing, showing the characteristic PEG pattern and (B) after a one-hour water/methanol
1:1 wash (60°C) and additional rinsing by vacuum suction for 10 min, showing a negligible
number of different background ions.
4.4.2 On-chip liquid-phase microextraction
On-chip  LPME  was  performed  as  previously  described[146] and  is
illustrated in Figure 11. An aliquot of 2 μL of 0.1% formic acid (pH 2.7) with
100 μM verapamil as an internal standard (acceptor solution) was applied to
the sample inlet (SI) of the SU-8 MCE-ESI/MS microchip (Figure 7A). A 5x5
mm piece  of  Celgard  2500 microporous  polypropylene  membrane  with  25-
μm-thick, 55% porosity, and 0.21 x 0.05 μm pores was wetted with 1-octanol
and  placed  on  top  of  the  acceptor  solution.  Finally,  4  μL  of  alkaline  urine
sample (30 mM sodium hydroxide, pH 11.4, donor solution) was applied on
top  of  the  membrane  to  initiate  extraction.  After  5  min  the  sample  (donor)
droplet was pipetted away, the polypropylene membrane was removed, and a
platinum  electrode  was  placed  in  the  acceptor  solution  in  the  sample  inlet
(SI).  The injection voltages were immediately applied and the injection was
performed  in  pinched  mode  for  60  s  before  application  of  the  MCE
separation voltages.
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Figure 11 Schematic illustration of the on-chip LPME system on top of an SU-8 MCE-ESI/MS
microchip. The sample solution was alkaline (30 mM NaOH, pH 11.4) urine. The acidic (0.1%
formic acid, pH 2.7) acceptor solution contained 100 μM verapamil as internal standard.
4.5 Operation of the microchips
The  microchips  were  placed  on  an xyz-aligning  stage  in  front  of  a  triple
quadrupole MS (II-IV), an ion trap MS (I, II), or a quadrupole time-of-flight
(Q-TOF) MS (I). The liquid reservoirs were filled with appropriate solutions
as explained in the original publications I-IV. An external power supply was
used  for  application  of  the  injection  and  separation  voltages  through
platinum wires placed in the liquid filled inlets. In MCE the sample injection
was performed in pinched injection mode by applying a voltage difference
between  the  sample  inlet  (SI)  and  the  sample  waste  (SW),  while  a  small
focusing potential  was applied to the buffer  inlet  (BI).  During injection,  the
sheath  liquid  inlet  (SLI)  was  floating,  so  that  no  spray  was  produced.  The
MCE separations were performed in cathodic mode with electric field
strengths  of  375-800  V/cm  between  the  BI  and  SLI  with  small  pushback
voltages applied to the SI and SW. The effective separation length of the MCE
channel was 2 or 4 cm.
In cIEF (II) the separation microchannel (Figure 7A, bilateral sheath flow
interface)  was  first  loaded  with  the  sample  solution  (0.2  mg/mL  of
angiotensin  I  and  II  in  2%  ampholyte  solution  pH  3-10)  by  capillary  force.
After loading, reservoirs BI and SLI were filled with catolyte (1% ammonium
hydroxide) and anolyte (80:20 methanol/water with 1% acetic acid),
respectively,  and  focusing  potentials  (BI  grounded  and  SLI  3.0  kV)  were
applied. Focusing was performed for 60-120 s, after which the solutions in BI
and  SLI  were  changed  to  BGE  and  fresh  sheath  liquid,  respectively.  The
focused  analytes  were  then  mobilized  toward  the  MS  by  applying  a  voltage
difference between the BI (3.6 kV) and the SLI (2.0 kV).  The voltage in SLI
simultaneously served as the electrospray voltage. A schematic view of typical
voltage setups during MCE-injection, cIEF-focusing, MCE-separation, and
cIEF-mobilization is shown in Figure 12.
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Figure 12 Schematic view of the voltage setup during MCE-injection, cIEF-focusing, MCE-
separation, and cIEF-mobilization followed by ESI/MS detection.
For the cIEF-transient ITP (tITP) separations (II), the cIEF channel was
first loaded with the sample solution (100 μM peptides in 2% ampholyte with
0.33%  TEMED)  by  applying  a  voltage  difference  (1.5-3.0  kV)  between
reservoirs SI and BGE (Figure 7B) for 100-150 s. Then, reservoirs AN and CA
were  filled  with  anolyte  (1%  formic  acid)  and  catolyte  (0.5%  ammonium
hydroxide), respectively. cIEF-tITP separations were performed in steps as
follows:  After  loading,  the  cIEF  focusing  voltage  (1.5-6.0  kV)  was
immediately  applied  between  the  catolyte  (CA)  and  the  anolyte  (AN)
solutions for 200-270 s.  In a final  step the focused analytes were mobilized
and further separated by applying a positive voltage difference between
reservoirs  BGE  (6  kV)  and  SLI  (3.5  kV).  The  counter  voltage  applied  to
reservoir  SLI  simultaneously  served  as  the  electrospray  voltage  and  was
typically  2.5  kV  relative  to  MS.  In  both  microchip  designs,  the  separation
current (typically 20-40 μA) was divided at the sheath flow intersection so
that the electrospray current was 50-300 nA and the excess current was led
to ground through a 50 MΩ (ion trap and QqQ) or 100 MΩ (Q-TOF) resistor
coupled in parallel with the ES voltage power supply.
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5 RESULTS AND DISCUSSION
The main results of the research are shortly described in this chapter.  Details
can be found in the original publications I-IV.
The SU-8 microchips were first used in the identification of standard and
tryptic  peptides  (I,  II)  and  peptides  from  a  human  cell  lysate  (I),  and  for
screening of human urine for drug metabolites (III). Peptide separations
were performed by both on-chip MCE (I) and on-chip cIEF (II) and followed
by online ESI/MS detection, whereas the urine samples were analyzed by
MCE-ESI/MS after off-chip SPE (III).
The applicability of the SU-8 microchips to quantitative experiments was
preliminarily tested. Human urine samples were precleaned and
concentrated  on-chip  by  LPME  (III),  and  a  porous  polymer  monolith  was
fabricated in situ at  the  microchip  injection  cross  for  SPE  and
preconcentration  of  drug  molecules  before  MCE-ESI/MS  (IV).  In  addition,
Michaelis-Menten kinetics was successfully determined for a CYP450-
mediated  probe  reaction  (phase  I  oxidation  of  bufuralol  to  1-
hydroxybufuralol) (III).
5.1 MCE-ESI/MS in peptide analysis and proteomics (I,
II)
Typically, the preparation and analysis of a proteome sample begins with cell
cultivation and subsequent lysis to separate the proteins from the cell debris.
For identification and quantification of the proteins in the mixture, the
sample is enzymatically digested (usually with trypsin), the peptides are
separated (usually chromatographically), and finally the peptides are
analyzed by ESI or MALDI MS/MS. The MS/MS spectra are then studied for
protein identification and quantification.[151] A  LOC  device  potentially
integrates  all  these  operations  and,  additionally,  can  be  tailored  for  specific
analytical needs for instance, by coupling microchip LC to MS.[46,152,153] Such
LC-ESI/MS  microchips  have  also  been  demonstrated,  and  separation  of
tryptic  peptides of  bovine serum albumin (BSA) has been performed at  low
fmol levels.[46] However, the speed of analysis has not much exceeded that of
conventional analysis systems. The expected rapidity of microchip analysis
has not been achieved, and there is no significant improvement in sample
throughput as compared with conventional instrumentation. Integrated
MCE-ESI/MS,  in  turn,  provides  improved  performance  in  terms  of  sample
throughput.[60,61]
In  this  work,  SU-8  microfabrication  technology  was  utilized  for  the
fabrication of microchip systems for proteomics research. The microfluidic
platform  (Figure  7A),  comprising  a  sample  introduction  unit  and  an
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electrophoretic separation channel with a monolithically integrated ESI
emitter, as well as an auxiliary channel for the introduction of sheath liquid
and internal mass calibrant, was used for peptide mass fingerprinting and
identification  of  proteins  in  a  human  muscle  cell  lysate  sample  and  for
protein identification by MS/MS (I). In addition, microchip cIEF was directly
coupled to ESI/MS detection via a bilateral sheath flow interface (Figure 7A)
and mobilization unit (Figure 7B) (II).
5.1.1 Peptide mass fingerprinting and protein sequencing by MCE-
ESI/MS(MS) (I)
Peptide mass fingerprinting followed by protein identification was performed
for four proteins (cytochrome c, β-lactoglobulin,  ovalbumin,  and  BSA)  with
molar  masses  ranging  from  12  to  69  kDa.  Typically,  a  number  of  singly  or
doubly charged tryptic peptides were identified, and sequence coverages
between 50% and 70% were routinely obtained for all proteins (Table 7).
Table 7. Summary of the MCE-ESI/MS analysis of the tryptic digests of cytochrome c, β-
lactoglobulin, ovalbumin, and BSA.
Protein
Mr
(kDa)
pI
Amino
acids
GRAVYa)
Observed
peptides b)
Sequence
coverage (%)b)
Probability
scoreb)
Expectation
valueb)
Cytochrome c
(CYC_BOVIN)
12 9.52 104 -0.866 10 67 87 2.0×10-4
β-Lactoglobulin
(LACB_BOVIN)
18 4.76 162 -0.167 17 68 97 1.8×10-5
Ovalbumin
(OVAL_CHICK)
43 5.20 386 -0.006 19 59 93 5.4×10-5
BSA
(ALBU_BOVIN)
69 5.78 583 -0.476 46 54 177 2.0×10-13
a)Grand average of hydropathicity index, b)Based on Swiss-Prot database search by MASCOT
online search engine.
Accurate mass measurements greatly facilitate detailed analysis and are
particularly  important  in  the  analysis  of  intact  proteins  whose  masses  may
differ by only small amounts. For example, the mass difference between the
amino  acid  residues  lysine  and  methionine  is  2.94553  Da,  which  means  a
245, 29, and 15 ppm difference for 12 000, 100 000, and 200 000 Da
proteins,  respectively.  When coupling a separation microchip to e.g.,  a  high
resolution Q-TOF instrument it is necessary to replace the original ion source
with  a  tailor-made  chip  stage.  However,  the  layout  of  the  SU-8  microchip
(Figure  7A)  is  also  convenient  for  the  introduction  of  an  internal  mass
calibrant  together  with  the  sheath  liquid  and  thus  allow  as  good  mass
accuracy for chip-based experiments as for conventional counterparts on Q-
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TOF or related instruments. Here, bradykinin fragment 1-5 (m/z=573.3149)
was chosen as internal mass calibrant and was applied along with the sheath
liquid. In this manner, it did not interfere with the analytes of interest during
separation, but enabled identical online mass calibration for all separated
analytes.  Figure  13  shows  the  extracted  ion  electropherograms  (EIE)  and
mass spectra of selected peptides from the β-lactoglobulin tryptic digest
analyzed  by  MCE-ESI  coupled  to  a  high  resolution  Q-TOF  MS  instrument.
Both the EIEs and mass spectra show good signal-to-noise ratios and allow
clear identification of the peptide fragments, with a typical mass error of only
about 10 ppm (Figure 13).
Figure 13 Selected EIEs and corresponding high resolution mass spectra from the MCE-
ESI/MS analysis of β-lactoglobulin tryptic digest. The BGE was 30 mM ammonium acetate
with 50% methanol and the sheath liquid was 80:20 (v/v) methanol/water with 1% acetic acid
including 5 μM bradykinin fragment 1-5 as an internal mass calibrant. Electric field strengths
during injection and separation were 1250 V/cm and 400 V/cm, respectively, and the
effective separation length was 4 cm.
The power of  MS lies  not only in the accuracy of  the mass measurement
(ppm  for  TOF-MS),  but  in  the  capacity  for  tandem  MS  (MS/MS)
measurements, which provide additional information specific for the peptide
amino  acid  sequence  and,  ideally,  protein  identification  based  on  a  single
peptide MS/MS spectrum. Here, MS/MS characterization of selected tryptic
peptides from cytochrome c and β-lactoglobulin was performed in addition
to  peptide  mass  fingerprinting.  The  product  ion  spectra  of  the  selected
precursor tryptic peptides are characterized by the easily identifiable y and b
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series fragment ions (Figure 14). Both cytochrome c and ß-lactoglobulin
could  be  reliably  identified  by  the  Mascot® online search engine[154] on  the
basis  of  MS/MS fragmentation data of  a   single tryptic  peptide of  each,  i.e.,
m/z=1456.7 for cytochrome c and m/z=934.2 for ß-lactoglobulin. The Mascot
scores, indicating identity or extensive homology to the proteins in question,
were 67 (expectation value 8.3×10-5) for cytochrome c and 42 (expectation
value 0.028) for ß-lactoglobulin.
Figure 14 MS/MS spectra of selected singly-charged tryptic peptides of (A) β-lactoglobulin
(m/z=934.2) and (B) cytochrome c (m/z=1456.7) as precursor ions from the MCE-
ESI/MS/MS analysis. The BGE was 30 mM ammonium acetate with 50% methanol and the
sheath liquid was 80:20 (v/v) methanol/water with 1% acetic acid. Electric field strengths
during injection and separation were 1000 V/cm and 375 V/cm, respectively, the effective
separation length was 4 cm, and the fragmentation amplitude was 2.0 V.
5.1.2 Identification of proteins in a human cell lysate (I)
The  applicability  of  the  SU-8  MCE-ESI/MS  chip  to  the  analysis  of
authentic biological samples was shown by the analysis of a tryptic digest of a
human muscle cell lysate. Despite the complexity of the cellular matrix, seven
proteins of different size, pI value, and hydrophilicity were identified in the
sample (Table 8). The Mascot® probability-based scores[154] ranged from 102
to 211, indicating significant homology between detected and theoretical
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tryptic peptides, and sequence coverages as good as 93% were obtained. In
addition  to  rigorous  screening  against  blank  samples  in  order  to  eliminate
potential false positives, all proteins listed in Table 8 were also identified by
in-house HPLC-ESI/MS analysis of the same sample.
Table 8. Proteins identified in digested human muscle cell lysate by MCE-ESI/MS
analysis. The separation BGE was 30 mM ammonium acetate with 50% methanol and the
sheath liquid was 80:20 (v/v) methanol/water with 1% acetic acid. Electric field strengths
during injection and separation were 1000 V/cm and 650 V/cm, respectively, and the
effective separation length was 2 cm.
Protein Mr,
kDa
pI Amino
acids
GRAVYa) Number
of peptidesb)
Sequence
coverage, %
Q70VV1; rhesus
blood group D antigen
5.6 6.51 48 0.085 5 85
Q6PCD6; GLS2
protein
6.6 11.35 61 -1.075 8 93
Q8N9L7; CDNA
FLJ36925 fis, clone
BRACE2005169
13.5 9.8 120 -0.756 8 70
CAF00094; DNAJ
(Hsp40) homolog,
subfamily C member 11
14.4 5.22 119 -1.071 10 65
Q96HG5; actin beta,
(fragment)
41.0 5.56 368 -0.202 17 48
JC4775; interferon
induced double-stranded
RNA activated protein
57.5 5.83 504 -0.679 23 32
Q6PIC7; MAP7
domain-containing protein
74.1 8.68 660 -1.115 21 19
a) Grand average of hydropathicity index. b) Based on SwissProt database search by Mascot online
search engine.
5.1.3 Interfacing of microchip cIEF with on-chip ESI/MS for peptide
analysis (II)
cIEF is an established technique based on separation of zwitterionic
compounds (e.g., peptides and proteins) according to their pI values and
followed by electrokinetic or hydrodynamic mobilization of the focused pH
gradient toward the detector.[63] Microchip cIEF has also been implemented
for rapid separations of  proteins,  though usually  in combination with linear
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(optical)  imaging  of  the  cIEF  gradient  through  the  cover  layer,  without  the
mobilization step.[68,70,72] The  coupling  to  MS  detection  is  rare  because  the
carrier  ampholytes  required  for  successful  cIEF  tend  to  suppress  the
ionization efficiency of the target compounds.[73,74] As a result, the potential
of microchip cIEF-MS in proteomics research is often overlooked. Here, two
different  chip  designs  were  introduced  to  facilitate  the  online  coupling  of
cIEF to on-chip ESI/MS detection. The first design (Figure 7A) was used for
direct  EOF-driven mobilization (of  peptides focused by cIEF) to the MS via
an integrated (two-sided) sheath flow interface. The second design (Figure
7B) incorporated two subsequent, intersecting separation channels where
peptide focusing by cIEF was performed in the first dimension and then tITP
separation during mobilization through the second dimension. Also in this
case, an integrated (one-sided) ESI sheath flow interface was used.
5.1.3.1 Direct coupling of microchip cIEF to MS via an on-chip sheath
flow interface
The feasibility of direct coupling of microchip cIEF to ESI/MS detection was
examined  by  using  a  separation  microchip  with  a  bilateral  on-chip  sheath
flow interface. With the symmetrical interface (Figure 7A) sheath liquid
could  be  fed  to  the  ESI  tip  from  both  sides  of  the  separation  channel.  The
organic sheath flow enhances the ESI process, especially when running
buffers/samples contain high amounts of  water.  Here the sheath liquid also
minimized major background interferences due to the carrier ampholytes
and  as  a  result,  the  carrier  ampholytes  were  not  observed  when  the  cIEF
pattern  was  mobilized  to  the  MS  (Figure  15).  The  acidic  sheath  liquid  also
served  as  the  anolyte  during  cIEF so  that  the  pH gradient  (pH 3-10),  along
with  the  focused  peptides,  could  be  directly  run  to  the  MS  after  focusing.
Microchip cIEF-ESI/MS was demonstrated with the model compounds,
angiotensin I (pI 7.70)  and  angiotensin  II  (pI 7.54).[155] The two peptides,
having very similar pI values,  migrated  at  about  23  s  (Figure  15).  Although
the two peptides did not separate from each other because of their similar pI
values, they migrated as sharp, focused bands with peak capacity of about 86,
indicating that efficient focusing takes place during the cIEF step.
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Figure 15 Schematic illustration of the theoretical position of angiotensin I and II after cIEF
separation and extracted ion electropherograms (EIE) of the same peptides (both 0.2
mg/mL) following cIEF separation, mobilization, and ESI/MS detection. The size of the circles
in the schematic illustration assimilates the molar masses of the peptides. Time t=0 s in the
EIE corresponds to the end of the focusing step and start of the mobilization step. The
focusing was performed in 2% ampholyte solution (pH 3-10) including 25% methanol at 2400
V/cm for 60 s. The mobilization was done by feeding BGE (20 mM ammonium acetate with
25% methanol) from the SI at a field strength of 800 V/cm. The mass spectrum recorded at
23 s (insert on the right, no background substraction) shows abundant protonated ions of
angiotensins I and II and negligible background interference due to the carrier ampholytes.
This  setup  is  somewhat  similar  to  that  described  by  Wen  et  al.  (Figure
5)[75] except that, in this work, actuation of the cIEF chip was based purely on
electrokinetic flow instead of the pressure-driven flow used previously. This
was possible owing to the fact that the microchip was made of SU-8. Namely,
the surface charge of SU-8 is inherently pH-dependent; basic and acidic
buffers maintain cathodic and anodic EOF, respectively.[156] Thus,  the  flow
direction  close  to  the  anode  (low pH)  is  opposing  that  at  the  cathode  (high
pH)  so  that  the  net  velocity  in  the  SU-8-based  channel  during  cIEF
approaches  zero.  With  most  other  microchip  materials  the  cIEF  separation
channels need to be coated in order to eliminate or significantly reduce the
EOF  to  allow  for  complete  focusing  of  the  analytes.[67] The  advantage  of
having uncoated (charged) surfaces arise from the fact that, after focusing,
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EOF can be used for mobilization instead of pressure-driven flow. Thanks to
the  relatively  short  separation  channel,  the  cIEF focusing  time  in  this  work
was  also  significantly  shorter  (60  s)  compared  to  that  applied  (~10  min)  in
the previous work in which a 16-cm-long cIEF channel was used.[75]
5.1.3.2 Coupling of cIEF to MS via a transient-ITP unit
In  addition  to  direct  coupling  of  cIEF  to  ESI/MS  another  microchip
design,  with  multiple  intersecting  channels  for  isolation  of  the  cIEF
separation unit from the ESI interface, was also developed (Figure 7B). This
design  permitted  cIEF  separation  in  the  first  part  of  the  channel,  fully
isolated  from  the  ESI  interface  by  a  second  separation  channel  for  tITP.
Before  operation,  the  separation  microchannels  and  the  sheath  liquid
channel  were  filled  with  BGE  and  sheath  liquid,  respectively,  by  capillary
force.  After  this  the operation of  the microchip was monitored via electrical
currents during electrokinetic loading (with 2% ampholyte solution),
focusing,  and  mobilization  (Figure  16).  Some  interesting  observations  were
made.  As can be seen from Figure 16,  the total  amount of  charges decrease
during the first 25 s when the cIEF channel is filled with ampholyte solution.
Simultaneously  the  pH gradient  is  formed by  the  carrier  ampholytes  in  the
sample plug entering the cIEF channel. As a result, the sample components
and  the  carrier  ampholytes  start  to  arrange  according  to  their pI values
already during the loading step. However, a subsequent increase in current
occurs between 45 and 55 s (Figure 16), suggesting progressive migration of
the acetate counterions (from the BI into the cIEF channel) and thus drift in
the pH gradient and slow fluctuation of the electrical current between 50 and
100 s (Figure 16), similar to earlier work with conventional CE capillaries.[157]
The  sample  components  (or  the  carrier  ampholytes)  do  not  readily  reach
their isoelectric points during the loading step. Thus, the cIEF focusing must
be finalized during the second cIEF step (Figure 16) by switching to potential
difference between the anolyte (AN) and the catolyte (CA). However, due to
the  arrangement  of  species  during  the  beginning  of  the  loading  step,  a
relatively  short  focusing  time  is  required  here.  The  current  drop  during  the
focusing  step  (Figure  16)  indicates  the  formation  of  a  more  stable  pH
gradient, within about 60 s, with the steady-state current leveling off at about
15 μA (8.9% RSD, n=6 repeated runs).
Finally,  the  pH  gradient  is  electrokinetically  mobilized  toward  the  MS
(Figure 16). However, the pH gradient is preceded by a relatively long plug of
the  running  buffer  which  acts  as  a  leading  electrolyte  (LE).  The  ampholyte
solution  also  acts  as  the  terminating  electrolyte  (TE)  and  instead  of  just
mobilizing  a  cIEF  gradient,  the  separation  mode  is  more  likely  tITP  as
described.[157] This  means  that  the  observed  migration  order  is  affected  by
both pI- and μEP values of the sample components. The pI mainly determines
the  position  of  the  sample  component  in  the  cIEF  channel,  and  thus  its
(individual) effective separation length from the cIEF channel to the ESI tip.
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The intrinsic μEP,  in  turn,  determine  the  speed  at  which  each  sample
component  is  migrating  toward  the  MS.  This  is  illustrated  with  the
separation of histidine (pI 7.55)[155] and angiotensin I (pI 7.70)[155] in Figure
16. Despite the fact that the pI values are very close to each other (ΔpI 0.15),
these two compounds are baseline-resolved (RS=1.9) thanks to their very
different size and thus, different intrinsic μEP values.
Figure 16 The electrical current profiles (average of six repeated runs) during sample loading
(SI→BI), focusing (AN→CA), and mobilization (BI→SLI) along with the EIEs of histidine
([M+H]+=156.0) and angiotensin I ([M+2H]2+=649.8) separated by cIEF-tITP-ESI/MS. The
anolyte (AN) was 1% acetic acid, the catolyte (CA) 1% ammonium hydroxide, the BGE (BI)
30 mM ammonium acetate with 30% methanol, and the sheath liquid (SLI) methanol:water
80:20 (v/v) with 1% acetic acid.
Figure 17 shows the use of this setup in the separation of a mixture of five
peptides (bradykinin (fragment 1-5, pI 10.55), angiotensin III (pI 9.35),
substance P (fragment 6-11, pI 7.81), angiotensin I (pI 7.70), and angiotensin
II (pI 7.54)),[155] with different pI values. The most basic peptides were
prevented from focusing in a distal  region of  the microchannel  (i.e.,  beyond
the  Y  intersection  close  to  inlet  CA)  by  adding  0.33%  (v/v)  TEMED  to  the
ampholyte solution[158,159] and thereby shift the theoretical position of pH 10
3.3  mm  downstream  from  the  Y  intersection  (Figure  17).  Under  these
conditions, the most basic peptide, bradykinin (pI 10.55), migrates and
focuses to the interface of TEMED and the ampholyte solution (pH 10) after
which  it  is  diffused  into  the  TEMED  zone  (Figure  17).  The  theoretical
position  of  the  other  peptides  after  the  focusing  step  is  given  according  to
their pI values.
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Figure 17 Schematic illustration of the theoretical positions of bradykinin fragment 1-5 (BK1-
5), angiotensin III (AngIII), substance P fragment 6-11 (SP6-11), angiotensin I (AngI), and
angiotensin II (AngII) following cIEF. The size of the circles assimilates the molar masses of
the peptides. The theoretical ITP migration order is given based on the intrinsic
electrophoretic mobilities (μEP) measured in conventional silica capillaries by injecting
peptides in the running buffer or in the 2% ampholyte solution. The EIEs of the same
peptides from cIEF-tITP analysis show both the focusing (200 s at 1333 V/cm) and
mobilization (417 V/cm) steps. Loading of the cIEF channel with the sample solution was
performed at 1000 V/cm for 100 s. The sample solution contained peptides (each 100 μM),
2% ampholyte (pH 3-10), and 0.33% TEMED. The anolyte was 1% formic acid, the catolyte
was 0.5% ammonium hydroxide, the BGE was 30 mM ammonium acetate with 30%
methanol, and the sheath liquid was methanol:water 80:20 (v/v) with 1% acetic acid. Time
t=0 s in the electropherograms corresponds to the end of the focusing step (also indicated
with dashed line).
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As is evident from Figure 17, the migration order of the peptides does not
follow pure cIEF,  but is  largely affected by their  intrinsic μEP values.  This is
particularly evident for angiotensin III and substance P fragment 6-11, both
of  which  show  relatively  high  cathodic  mobilities  and  thus  overtake
angiotensins  I  and  II  (featuring  slow  anodic  mobilities  in  the  ampholyte
solutions) during the mobilization step (Figure 17). Instead, bradykinin,
which also shows high cathodic mobility, but is trapped in the TEMED zone
based  on  its pI value,  will  not  catch  the  angiotensins  I  and  II  and  migrates
the last. Comparison of the peptides’ intrinsic μEP:s in the plain BGE and in
the 2% ampholyte solution also reveals that addition of ampholytes into the
running  buffer  has  a  clear  impact.  This  is  particularly  the  case  of
angiotensins  I  and  II,  which  shift  from  cathodic  to  anodic  mobility.  As  a
result, three peptides with nearly identical pI values (i.e., angiotensin II, pI
7.54; angiotensin I, pI 7.70; substance P, fragment 6-11, pI 7.81[155]) are
efficiently  resolved  in  cIEF-tITP  mode  (Figure  17).  The  repeatability  of  the
migration  times  (after  focusing  and  mobilization)  was  also  relatively  good
(3.1-6.8% RSD, n=3).
5.2 MCE-ESI/MS in metabolomics research (III)
The development of potential drug candidates frequently is terminated when
adsorption, distribution, metabolism, and excretion (ADME) properties are
found  to  be  poor.  Expensive  terminations  in  late  clinical  stages  could  be
avoided if these properties were clarified much earlier in the drug discovery
process.[160] Metabolic  profiling  of  new  drug  candidates  is  particularly
important and includes not only the identification of metabolites but also
screening of their properties.[161] Equally  important  are  screening  of
drugdrug  interactions  and  determining  the  kinetic  parameters  of  the  drug
metabolism. In these types of analyses, the key issue is high throughput, i.e.,
analyzing as many samples as possible in a short time.
Here,  the  applicability  of  the  microchips  to  metabolics  research  was
demonstrated  by  screening  for  metabolites  of  tramadol  and  paracetamol  in
authentic human urine samples and by determining the kinetic parameters of
the CYP450 mediated bufuralol 1-hydroxylation.
5.2.1 Metabolic profiling
The MCE-ESI/MS microchips were used for metabolic profiling of human
urine  samples  after  off-chip  SPE.  As  presented  in  Figure  18,  six  tramadol
metabolites,  including  phase  I  and  phase  II  products,  as  well  as  tramadol
itself were detected and separated from each other by MCE-ESI/MS.
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Figure 18 EIEs of tramadol and its metabolites detected in a human urine sample and
separated by MCE-ESI/MS after off-chip SPE (5-fold preconcentration). The BGE was 30
mM ammonium acetate with 50% methanol and the sheath liquid was 80:20 (v/v)
methanol/water with 1% acetic acid. The electric field strengths during injection (20 s) and
separation were 1000 and 800 V/cm, respectively. M1, O-desmethyltramadol; M5, N,O-
didesmethyltramadol; M1-Glu, glucuronide of O-desmethyltramadol; M5-Glu, glucuronide of
N,O-didesmethyltramadol; M7-Glu, glucuronide of 4-hydroxy-ciclohexyl-N-desmethyl
tramadol.
In  the  case  of  paracetamol  (Figure  19),  mostly  phase  II  conjugation
products (glucuronide, glutathione, and cysteine) were detected, in addition
to paracetamol itself. With use of tramadol and paracetamol as reference
compounds, the feasibility of the MCE-ESI/MS system could be tested for a
broad range of metabolites with diverse chemical and physical properties.
According to the literature, tramadol is extensively converted to several
phase I oxidation products,[162,163] while  the  main  urinary  metabolites  of
paracetamol are phase II conjugation products, such as glucuronides.[164,165]
Thus, the metabolite findings for both tramadol (Figure 18) and paracetamol
(Figure 19) are in good accordance with previous results.
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Figure 19 EIEs of paracetamol and its metabolites separated from a human urine sample by
MCE (effective separation length 2 cm) and detected by ESI/MS after off-chip SPE (5-fold
preconcentration). The BGE was 30 mM ammonium acetate with 50% methanol and the
sheath liquid was 80:20 (v/v) methanol/water with 1% acetic acid. The electric field strengths
during injection (20 s) and separation were 1000 and 500 V/cm, respectively.
5.2.2 Enzyme kinetics
Enzyme  kinetics  is  a  discipline  that  focuses  on  the  reaction  rates  of
enzymatically catalyzed chemical reactions. In a typical enzyme-catalyzed
reaction  the  substrate  is  bound  to  the  enzyme,  converted  to  a  product  and
released. The Michaelis-Menten constant (Km) describes the substrate
concentration at which the reaction velocity is half of the maximal reaction
rate (Vmax). In this work, the kinetic parameters (Km and Vmax) for bufuralol
1-hydroxylation  in  human  liver  microsomes  (HLM)  were  determined  to
demonstrate the applicability of the SU-8 microchips to quantitative enzyme
kinetics  studies.  The  CYP450-mediated  metabolism  was  shown  to  follow
Michaelis-Menten kinetics with Km and  Vmax values  of  55  μM  and  147
pmol/min/mg protein, respectively (Figure 20). These kinetic parameters
compare well with the values determined by in-house HPLC-UV (Km= 31 μM,
Vmax=  185  pmol/min/mg  protein)  as  well  as  with  literature  values  (Km
50250 μM[166] and Vmax 60240 pmol/min/mg protein).[167]
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Figure 20 Michaelis-Menten kinetics of the CYP450-mediated conversion of bufuralol to 1-
hydroxybufuralol in human liver microsomes (HLM) determined by MCE-ESI/MS in selected
reaction monitoring (SRM) mode. The separation was performed under electric field strength
of 750 V/cm in 30 mM ammonium acetate with 50% methanol as BGE and 80:20 (v/v)
methanol/water with 1% acetic acid as sheath liquid. The substrate concentration ranged
from 12.5 to 400 μM and all incubations were done in duplicate at each substrate
concentration.
An obvious advantage of performing MCE-ESI/MS analyses as compared
to traditional HPLC-UV is the speed of analysis. Here the migration times of
1-hydroxybufuralol  and  bufuralol  were  24.6  s  and  27.0  s,  respectively  with
the  MCE-ESI/MS method as  compared  to  5.1  min  and  6.6  min  required  in
the  in-house  HPLC-UV  method.  In  addition,  the  sample  consumption  in
MCE is much less than that in HPLC. First of all, in MCE the volume pipetted
to the sample inlet is approximately 3 μL (as compared to 20 μL injected in
HPLC). In addition, as a result of miniaturization, multiple repeated analyses
can  be  performed  out  of  the  3  μL  sample  volume,  since  only  a  few  tens  of
picoliter is effectively used (here 75 pL, determined by the volume at the
intersection of the injection and separation channels).
5.3 On-chip sample pretreatment and preconcentration
(III, IV)
As  stated  in  the  previous  chapter,  very  small  amounts  of  sample  is
required  in  order  to  perform  multiple  repeated  analyses  on  a  microchip
platform. However, in order to improve the efficiency of sample consumption
(injected vs. total sample volume required) and to reach better concentration
sensitivity  there  is  a  need  for  coupling  online  sample  pretreatment  as  an
integral part of separation microchips.[96] In this work, sample pretreatment
by  SPE  (IV)  and  LPME  (III)  was  integrated  directly  on  the  SU-8  MCE-
ESI/MS microchips for preconcentration of drug standards (IV) and clean-up
and analysis of authentic urine samples (III).
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5.3.1 On-chip preconcentration by solid-phase extraction (IV)
SPE  is  one  of  the  most  useful  techniques  for  sample  purification  and
preconcentration.  In  this  study,  a  porous  methacrylate  monolith  was
integrated in the injection cross of an SU-8-based MCE-ESI/MS microchip to
perform on-chip sample precleaning and preconcentration during the
injection step before MCE-ESI/MS. The use of a high-power laser allowed for
maskless  photopolymerization  of  a  precisely  defined,  cross  shaped  porous
polymer zone in situ at  the  injection  cross  of  the  SU-8  separation  chip
(Figure 7A and Figure 9). In addition, the high intensity of the laser beam (15
μJ  at  1  kHz,  355  nm)  enabled  very  fast  curing  (here,  best  performance  at  7
min)  and  initiation  of  the  photopolymerization  reaction  even  through  a  70
μm-thick  SU-8  cover  layer,  which  itself  absorbs  the  near  UV  light  to  some
degree.[168] The  layout  of  the  injection  cross  also  allowed  firm  anchoring  of
the  monolith  based  on  its  shape  and  no  prefunctionalization  of  the  SU-8
surface  was  needed.  With  a  view  to  performing  rapid  online
preconcentration,  the  porosity  of  the  monolith  was  compromised  with
relatively  high  through-flow  (i.e.,  large  pores  for  low  back  pressure)  over
flawless retention in order to allow for fully electrokinetic actuation and thus
avoid the need for coupling to external pumps. The operation principle of the
SPE-MCE-ESI microchip is presented in Figure 21 and illustrated with a four
step protocol:  (1)  sample loading (in 2% ammonium hydroxide,  pH 12),  (2)
rinsing (of unretained, hydrophilic analytes), (3) injection (in BGE, release of
retained  hydrophobic  analytes),  and  (4)  elution  followed  by  simultaneous
MCE separation (of released hydrophobic analytes).
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Figure 21 The operation principle of the SPE-MCE-ESI microchip is illustrated with squares
(grey) and circles (black) representing hydrophilic and hydrophobic sample components,
respectively. EIE of the [M+H]+ ions of cotinine (grey line, 50 μM) and verapamil (black line,
20 μM) show that the hydrophilic, unretained cotinine is washed away in step 2, whereas
hydrophobic verapamil is selectively retained (steps 1–2), released (step 3), and eluted to
MS (step 4). The blank injection (~4.5–5 min) and elution (~5–6.5 min) in the end of the
electropherogram show no memory effect, that is, all sample components are efficiently
released from the monolith in steps 3–4. The sample components were loaded in 2%
ammonium hydroxide solution (pH 12, 1000 V/cm, step 1) and injected in BGE (30 mM
ammonium acetate with 50% methanol, 1000 V/cm, step 3). Rinsing and elution was
performed in BGE (800 V/cm, step 2 and 3).
During sample loading (30 s), the hydrophilic compound cotinine
(logPo/w=0.21)  was not adsorbed on the porous monolith,  but rather spread
throughout  the  monolith  and  gave  a  broad  and  tailing  peak  when rinsed  to
the  MS  (step  2).  Instead,  verapamil,  which  is  more  hydrophobic
(logPo/w=5.04) was concentrated at the monolith border (step 1) and released
only  after  elution  with  organic  solvent  (50%  methanol  with  30  mM
ammonium acetate,  step 3 and 4).  The repeatabilities  of  the migration time
(RSD=3.1%, n=3) and peak height (RSD=11.5%, n=3) of the preconcentrated
verapamil  indicate  robust  performance  from  run  to  run.  These  values  are
comparable  to  those  previously  reported  for  similar  MCE-ESI/MS  analyses
without  SPE  concentration  in  this  work  (III)  and  in  the  literature,[48,125,169]
which  clearly  indicates  that  addition  of  on-chip  SPE  did  not  significantly
interfere with the MCE separation. Furthermore, correlation was established
between the loading time (10–25 s) and the peak area obtained using two test
compounds with somewhat similar hydrophobicity, namely tramadol with
logPo/w=2.45 and propranolol with logPo/w=2.58.  For  both  compounds,  the
enrichment factors were directly proportional to the loading times and were
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calculated to be approximately 15-fold (R2=0.950, tramadol) and 23-fold
(R2=0.999,  propranolol)  at  a  loading  time  of  just  25  s  (Figure  22A).  The
availability of such short loading times (comparable to normal MCE injection
times)  means  that  our  chip  design  enables  efficient  SPE  without
compromising the inherent high speed of MCE as illustrated with rapid SPE-
MCE-ESI/MS analysis of preconcentrated pharmaceuticals in Figure 22B.
With our SPE-MCE-ESI chip,  the total  analysis  cycle time was typically  less
than four minutes (including loading, rinsing, elution/injection, and MCE-
ESI/MS).
Figure 22 (A) Effect of the sample loading time (step 1) on the area of the released peaks as
illustrated with propranolol (logPo/w = 2.58) and tramadol (logPo/w = 2.45). (B) Separation of
preconcentrated bufuralol (logPo/w = 2.99; black line) and verapamil (logPo/w = 5.04; grey line)
after simultaneous loading into the monolith (step 1, 15 s), release (step 3), and separation
by MCE (step 4). Sample loading (each 25 μM) and rinsing (steps 1–3) was according to
Figure 21, but the electric field strength during separation (step 4) was 900 V/cm.
5.3.2 On-chip clean-up by liquid-phase microextraction (III)
In LPME, target analytes are extracted from a biological or other matrix (pH
adjusted  to  obtain  analytes  in  neutral  form),  through  a  hollow fiber  wetted
with an organic solvent, into a suitable acceptor solution (pH adjusted to give
analytes  in  ionic  form).[137] The  acceptor  solution  is  then  injected  into  a
chromatographic  or  electrophoretic  separation  system.  LPME  is  easily
downscaled  to  low  μL  volumes  by  replacing  the  hollow  fiber  with  a  flat
polypropylene  membrane,  which  also  facilitates  its  implementation  to  LOC
systems.[146]
The experimental setup used in this work is shown in Figure 11. Here, the
pH  gradient  between  the  donor  (pH  11.4)  and  acceptor  (pH  2.7)  solutions
served as the only driving force for extraction since no stirring was applied to
promote  mass  transfer  in  the  system.  Figure  23  lists  the  metabolites  of
tramadol  in  addition  to  tramadol  itself  detected  with  the  LPME-MCE-
ESI/MS(MS) setup. All compounds except N,O-didesmethyltramadol (M5)
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were easily  detected even in full-scan MS mode.  In contrast,  metabolite  M5
was  only  observed  with  the  more  specific  and  sensitive  detection  in  SRM
mode, probably because of its poorer extraction efficiency (i.e., zwitterionic
nature and relatively low logD value at pH 11), which reduces its theoretical
mass transfer from the donor solution to the octanol-wetted membrane.
Figure 23 EIEs (M9, M1, and tramadol) and SRM electropherogram (M5) of tramadol and its
metabolites separated from a human urine sample by MCE and detected by ESI/MS(/MS)
after on-chip LPME (2-fold preconcentration). The LPME was performed from alkaline urine
(NaOH 30 mM, pH 11.4) into acidic acceptor solution (0.1% formic acid, pH 2.7) for 5 min,
then injected (60 s, 1000 V/cm) and separated (750 V/cm) in 30 mM ammonium formate with
50% methanol. The sheath liquid consisted of 80:20 (v/v) methanol/water with 1% formic
acid. LogD and pKa values were derived from the online MarvinSketch chemical editor at
www.chemaxon.com. M1, O-desmethyltramadol; M5, N,O-didesmethyltramadol; M9, 4-
oxocyclohexyltramadol.
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5.4 Summary and Critical Review of the Results
In  this  work,  microchip  based  tools  for  various  bioanalytical  tasks  were
developed  and  tested.  The  microchips,  made  of  SU-8  epoxy  polymer,  were
used in the analysis of proteins and peptides (I, II) and metabolites in human
urine samples (III). In addition sample pretreatment (preconcentration)
steps  (III,  IV)  were  integrated  into  the  microchips  and  exploited  in  the
concentration and precleaning of drug molecules prior to online separation
and detection. The polymer microchips incorporated separation channel(s), a
sheath flow interface, and a monolithically integrated ESI emitter for online
MS detection. Separations were performed by MCE (I, III, IV), cIEF (II), and
cIEF-tITP  (II)  with  detection  by  ESI/MS  or  MS/MS.  Integration  of  sample
pretreatment (preconcentration) was achieved by LPME (III) and SPE (IV).
The  SU-8  microchips  performed  well  in  the  MCE-ESI/MS  analysis  of
tryptic  peptides (I)  and metabolites of  tramadol and paracetamol in human
urine  (III).  The  experiments  demonstrated  the  possibility  of  analyzing  both
proteomics and metabolomics samples fast and efficiently. A full validation
of  the  performance  of  the  MCE-ESI/MS  microchips  was  not  undertaken
here. However, the reproducibility of the chip fabrication (batch-to-batch)
has been reported,[170] and the repeatabilities in this work and previously[170]
have routinely been below 5% for the migration time and below 11% for the
peak area.
    A  great  advantage  of  CE,  and  of  its  counterpart  MCE in  particular,  is  the
very  narrow  peak  widths,  which  often  indicate  good  separation  efficiency.
Here, the short injection plug (determined by the intersection of the
separation and injection channels) resulted in peak widths as narrow as 0.6 s
at half height and plate numbers approaching 106 for tryptic peptides (I). In
addition, the straightforward integration of the separation channel with the
ESI emitter (through a monolithically integrated sheath flow interface)
provided dead-volume-free junctions and negligible peak broadening.
Furthermore,  the  sheath  liquid  is  also  advantageous  if  the  sample  contains
high  amounts  of  ES  signal  suppressing  agents.  This  was  shown  for  cIEF
separation of peptides in carrier ampholyte solution (II). The carrier
ampholytes  easily  suppress  the  ionization  of  the  sample  compounds,  but
here, due to the organic sheath liquid, carrier ampholytes were not observed
in the mass spectra of a cIEF separation of angiotensins I and II (II).
Even  though it  is  often  claimed that  the  very  small  injection  volumes  in
MCE is a great advantage it also sets limitations especially if quantitative
experiments are to be performed.  Namely,  if  quantitative analyses are to be
reliable, the repeatability of the injection volume needs to be very good. With
such small volumes as those characteristic of MCE, the effect of hydrostatic
pressure between the open-to-air microchannel inlets becomes critical. The
pressure difference induces hydrodynamic flow in the channels  (in addition
to the electrokinetic flow) and consequently, variations in the actual injected
sample volume between injections. However, the experiments on Michaelis-
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Menten  kinetics  for  the  CYP450-mediated  conversion  of  bufuralol  to  1-
hydroxybufuralol  (III)  suggested  the  possibility  of  applying  the  developed
method for quantitative purposes as well.  The successful  and reliable use of
the microchips for quantitative purposes would nevertheless require a more
automated setup, a rigorous microchip validation and, most importantly, an
optimization of the sample injection performance.
Besides analysis, sample pretreatment (and preconcentration) by LPME
(III)  and  SPE  (IV)  was  integrated  on-chip.  LPME  was  found  suitable  for
precleaning and preconcentration of urine samples before MCE-ESI/MS and
was  relatively  easy  to  integrate  on  chip.  In  particular,  LPME  offered
selectivity in the analysis of less polar phase I metabolites, which tend to be
hard  to  detect  in  SPE  if  the  conditions  are  optimized  for  the  extraction  of
highly  polar  phase  II  metabolites.  In  this  work,  a  relatively  low
preconcentration  factor  of  two  was  applied.  The  low  value  was  due  to  the
volume  of  the  on-chip  inlets  (~2  μL),  but  depending  on  the  applied  chip
material  and  the  fabrication  method,  the  depth  of  the  sample  inlet  could
easily  be  reduced  to  a  few tens  of  micrometers,  which  would  correspond to
acceptor volumes in the nL range. Thus, multifold sample preconcentration
could be achieved with on-chip LPME in the same way as with off-chip LLE
or SPE.
For on-chip SPE, a porous methacrylate monolith was prepared by laser-
induced photopolymerization at the intersection of the injection and
separation microchannels of an enclosed SU-8 microchannel (IV). Sample
pretreatment (preconcentration) of selected drug molecules was performed
during  the  injection  step  and  followed  by  MCE  separation  and  ESI/MS
detection. Although similar on-chip SPE systems have been reported earlier
(Table 3), the setup described here provides several unique features. The use
of  high  power  laser  instead  of  the  more  common  UV  lamps  enables  fast
curing  (best  performance  here  at  7  min)  and  initiation  of  the
photopolymerization reaction through the 70-μm-thick SU-8 structures.
When  using  UV  lamps,  relatively  long  exposure  times  (typically  20  to  40
min)  and  UV-transparent  substrates  are  usually  required.  In  addition,  the
high  intensity  of  the  laser  beam  allows  precise  definition  of  the  UV
irradiation and thus polymerization of a relatively small area (here, Ø~500
μm) with no need for masking. Thus, laser exposure significantly reduces the
complexity of the monolith fabrication, while providing sufficient structural
uniformity for SPE applications. What also distinguishes the present from
previous designs exploiting electrokinetic flow[107,116,118,119,122] is that, here, the
SPE material  was  shape  anchored  at  the  injection  cross  of  a  standard  MCE
chip  so  that  sample  loading  and  elution  were  part  of  the  injection  and
separation steps, respectively. This, most of all, allowed very fast SPE, so that
the  rapidity  of  analysis  characteristic  of  MCE  was  not  sacrificed.  A  loading
time  of  just  25  s,  a  time-scale  comparable  to  a  normal  microchip  injection
time,  resulted  in  up  to  23-fold  enrichment  for  the  test  compounds.  To  our
knowledge, this loading/SPE time is by far the fastest reported for an on-chip
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SPE-MCE-ESI/MS  analysis  (see  also  Table  3).  A  further  application  might
also be to immobilize trypsin into the monolith and perform online digestion
of proteins during the injection step. The on-chip integration of sample
pretreatment (preconcentration) demonstrated that this normally time-
consuming step can be performed with significant speed (III, IV).
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6 CONCLUSIONS
Chip-based separation devices are gaining more and more interest as
analytical tools. Microfluidics is superior to conventional instrumentation
when it comes to speed, high throughput, reduced sample consumption, and
the  integration  of  multiple  analytical  functions  with  minimal  or  zero  dead
volume between elements. Recent years have seen great advances in LOC
technology,  such  as  separations  with  MS  detection  in  seconds,
multidimensional analysis, and devices integrating chemical synthesis and
analysis. Although most publications thus far have reported only one or two
integrated tasks, new platforms offering multiple integrated functions and
rapid  analysis  of  highly  complex  biological  samples  can  be  expected  in  the
near future.
In  this  work,  microchips  made  of  epoxy  photoresist  SU-8  with  a
monolithically integrated ESI/MS interface were used for the electrokinetic
(MCE,  cIEF)  separation  of  biomolecules  and  drug  molecules  before  online
ESI/MS  detection.  The  SU-8  microchips  are  ready  for  use  directly  after
fabrication  with  no  need  for  further  surface  treatment.  The  pH  dependent
surface  charge  of  SU-8  allows  for  both  zero  net  charge  in  the  separation
channel during cIEF focusing (between an acidic anolyte and a basic catolyte)
and inherent (cathodic) EOF when using high pH buffers in MCE separations
or cIEF mobilizations. Furthermore, the possibility to implement
monolithically  an on-chip ESI emitter  at  the microchannel  outlet  allows for
rapid  and  low-cost  mass  production  of  identical  chips  and  reproducible
performance from chip to chip.
The  microchip  methods  developed  in  this  study  were  exploited  to  both
proteomics  and  metabolomics  research.  For  both  of  these,  short  analysis
times are key. Here, the SU-8 microchip provided MCE separations of tryptic
peptides  or  drug  metabolites  in  less  than  10  min  or  corresponding  cIEF
separations, including loading, focusing, and mobilization, in 1 to 10 min.
Separation was followed by MS or MS/MS detection.
A  challenge  often  encountered  in  bioanalysis  is  the  limited  amount  of
sample available, but analytical microsystems provide advantages here too.
In a typical T-cross microchip, the sample volume injected is determined by
the volume of the intersection of the separation and injection channels, and
here it was just 75 pL. A problem in MCE that remains to be tackled is that,
even  though  the  amount  of  sample  actually  analyzed  is  very  small,  the
amount that must be pipetted to the sample inlet is many times greater (here,
approximately  3  μL).  Furthermore,  although  the  small  injection  volumes  in
MCE provide advantages in terms of low sample consumption, relatively high
sample concentrations will usually be needed to meet the requirements of the
detector. While relatively good LOD (S/N=3) and LOQ (S/N=10) values (9.3
nM  and  31.2  nM  for  LOD  and  LOQ,  respectively)  for  1-hydroxy  bufuralol
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were achieved in this study, very small injection volumes will often force the
use of micromolar concentrations if a preconcentration step is not included.
Both on-chip LPME (for pretreatment and preconcentration of metabolites
from human urine samples) and on-chip SPE (for preconcentration of small
drug molecules) were thus integrated on the SU-8 microchips prior to MCE-
ESI/MS.
The  small  sample  volumes  required  in  LPME  together  with  the  direct
integration  on-chip  offer  advantages  in  terms  of  speed  of  analysis  and  the
facility  to  perform  sample  concentration  before  the  analysis  simply  by
adjusting  the  extraction  volumes.  On  the  other  hand,  SPE  is  the  more
commonly used method of sample pretreatment. Here, a methacrylate-based
porous  polymer  monolith  was  fabricated  via laser-induced
photopolymerization in situ at  the  injection  cross  of  the  separation
microchip. The use of photopolymerized monoliths in combination with MS
detection  is  superior  to  packing  with  beads  or  particles  because  of  the
simplicity of fabrication and elimination of the risk of the beads or particles
leaking toward the MS instrument. It is also possible to tune the porosity of
the monolith (by optimizing the exposure time and porogen content) and so
reduce the back pressure, while maintaining efficient retention of analytes.
Thus,  the  microchip  can  be  fully  operated  by  electrokinetic  flow,  a  feature
that  also  favors  precise  flow  control  and  easy  valving  with  negligible  dead
volume (time lag) as complex interfacing to external pumps is not required.
In addition,  the surface chemistry of  the monolith can be modified to allow
selectivity simply by changing the monomer composition.
All in all, this study offers further proof that microchip systems have great
potential  in  modern  (bio)analytical  chemistry.  The  future  success  of  these
systems in routine analysis would nevertheless require a clear demonstration
of the superiority of the technology and robustness as well as sufficiently low
cost  in  daily  operation.  However,  the  potential  of  microanalysis  systems
might also lay in the possibility of performing fast on-chip extractions
followed  by  very  fast,  rough  separations  before  or  in  addition  to  standard
techniques.  For this  purpose,  it  is  not even necessary to achieve as accurate
and robust results as with e.g., standard HPLC-MS systems.
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Research Article
Feasibility of SU-8-based capillary
electrophoresis-electrospray ionization
mass spectrometry microﬂuidic chips
for the analysis of human cell lysates
Monolithically integrated, polymer (SU-8) microchips comprising an electrophoretic
separation unit, a sheath ﬂow interface and an ESI emitter were developed to improve the
speed and throughput of proteomics analyses. Validation of the microchip method was
performed based on peptide mass ﬁngerprinting and single peptide sequencing of
selected protein standards. Rapid, yet reliable identiﬁcation of four biologically important
proteins (cytochrome C, b-lactoglobulin, ovalbumin and BSA) conﬁrmed the applicability
of the SU-8 microchips to ambitious proteomic applications and allowed their use in the
analysis of human muscle cell lysates. The characteristic tryptic peptides were easily
separated with plate numbers approaching 106, and with peak widths at half height as
low as 0.6 s. The on-chip sheath ﬂow interface was also exploited to the introduction of an
internal mass calibrant along with the sheath liquid which enabled accurate mass
measurements by high-resolution Q-TOF MS. Additionally, peptide structural char-
acterization and protein identiﬁcation based on MS/MS fragmentation data of a single
tryptic peptide was obtained using an ion trap instrument. Protein sequence coverages
exceeding 50% were routinely obtained without any pretreatment of the proteolytic
samples and a typical total analysis time from sampling to detection was well below ten
minutes. In conclusion, monolithically integrated, dead-volume-free, SU-8 microchips
proved to be a promising platform for fast and reliable analysis of complex proteomic
samples. Good analytical performance of the microchips was shown by performing both
peptide mass ﬁngerprinting of complex cell lysates and protein identiﬁcation based on
single peptide sequencing.
Keywords:
Epoxy photoresist SU-8 / Mass spectrometry / Microﬂuidics / Proteomics
DOI 10.1002/elps.201000373
1 Introduction
Microﬂuidic devices have recently emerged as a powerful
analytical platform to execute liquid-phase analyses [1]. The
miniature format and the capability of handling minute
sample amounts result in rapid analyses and signiﬁcantly
reduced costs without compromising the analytical perfor-
mance [2, 3]. The surface chemistry of microﬂuidic channels
can also be altered in a similar manner to that of
conventional silica capillaries in order to implement various
electrophoretic separation techniques on chips [4, 5] or to
anchor solid phase supports for on-chip chromatographic
separations [6, 7]. Especially polymer microdevices have
recently become a convenient bioanalytical platform as they
provide all these advantages and can be regarded as
disposable, low-cost devices.
Thanks to its high sensitivity and selectivity, ESI/MS is
presently one of the main techniques in bioanalysis and lays
the foundation for proteomics research [8]. ESI/MS also
greatly beneﬁts from miniaturization and interfacing
microﬂuidic devices with ESI/MS is thus of growing interest
[9]. Downscaling ESI to a nanospray regime allows a
reduction in the applied ﬂow rates and consequently, an
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increase in detection sensitivity compared to conventional
ESI. In addition, parallel production of sharp, accurately
deﬁned emitters by microfabrication means ensures
improved reproducibility compared to that of individually
prepared nanospray needles. Much effort has gone into
implementation of miniaturized ESI emitters on silicon,
glass and polymers and these are comprehensively covered
by many recent reviews [1, 10–13]. However, realization of
on-chip separation before ESI/MS detection requires
sophisticated microfabrication techniques to enable
dead-volume-free interfacing of the separation column with
the emitter. Apart from some recent designs [14–19],
most on-chip electrophoretic or liquid chromatographic
separation devices have been combined with MS
through external nanospray capillaries manually inserted at
the end of the separation channel [20–24]. The more
reproducible approach, however, is to pattern the emitter
directly at the end of the separation column by micro-
fabrication means [14–19] and thereby avoid the dead
volumes in ﬂuidic junctions, which may drastically reduce
the separation efﬁciency. Here, polymer microfabrication
technology offers great opportunities. In comparison to
silicon and glass processing, patterning of polymer
substrates is relatively rapid and inexpensive and sharp ESI
emitter structures can be easily patterned as integral
parts of separation microdevices [25, 26]. Lithographically
deﬁned polymer materials (e.g. negative photoresist SU-8),
in particular, enable mass production of very complex yet
accurately deﬁned microstructures [26]. As a full-wafer
process, photolithography also enables fabrication of
highly integrated microdevices during a single photo-
exposure step [26].
The potential of microﬂuidic chips in proteomics
research has been shown, for instance, by coupling LC
microchips to MS [14, 15, 27]. These LC-ESI/MS microchips
have been capable of separating tryptic peptides of BSA at
low femtomole detection levels, but the speed of analysis has
remained similar to that of conventional analysis systems,
i.e. in the range of tens of minutes to one hour per sample.
This clearly compares unfavorably to the expected rapidity of
microchip analysis and does not provide signiﬁcant
improvement with respect to the sample throughput as
compared to conventional instrumentation. Integrated CZE-
ESI/MS microchips, in turn, have been shown to provide
better performance in terms of sample throughput.
Mellors et al. [18] recently reported a fully integrated CZE-
ESI/MS microchip made of glass and capable of analyzing
complex protein digests with a fairly high throughput
(approximately 3 min per sample on a 20.5-cm-long separa-
tion channel). Later the same microchip was also utilized for
single cell lysis followed by ESI/MS detection of hemoglobin
originating from the lysed cells [28]. In another work, direct
ESI/MS analysis of a BSA tryptic digest, without prior
separation, was demonstrated using an integrated glass
CZE-ESI/MS microchip [17]. However, chromatographic or
electrophoretic separation prior to MS detection adds in
speciﬁcity of the analysis because of the possibility to use the
migration time data as an additional identiﬁcation para-
meter, along with m/z for individual analytes. In addition,
fabrication of glass microchips often involves certain
manual and serial processing steps, which limit their mass
production and batch-to-batch reproducibility. For example,
cutting of the emitter by a dicing saw [18, 28] or manual
pulling of the emitter to a tip shape [17] was required to
implement ESI emitters on the above-mentioned separation
microchips.
In this work, integrated CZE-ESI/MS microchips were
fabricated from SU-8 polymer so that all critical structures
were simultaneously patterned by photolithography [29, 30].
SU-8 microfabrication technology relies on high-accuracy
full-wafer photolithography, an approach that enables
parallel production of tens of chips with identical features at
the same time and thus very good reproducibility from
batch-to-batch, similar to SU-8-based direct spray ESI
emitters [31]. The applicability of the microchips to protein
identiﬁcation based on peptide mass ﬁngerprinting and
peptide sequencing was demonstrated by combining
microchip CZE separation with online ESI/MS or MS/MS
detection of tryptic peptides. Eventually, the SU-8 CZE-ESI/
MS microchip was utilized in the analysis of human muscle
cell lysates.
2 Materials and methods
2.1 Chemicals
BSA, cytochrome C from bovine heart, ovalbumin from hen
egg white, and b-lactoglobulin from bovine milk, as well as
angiotensin I, angiotensin II and bradykinin fragment 1–5
were all purchased from Sigma-Aldrich (Steinheim,
Germany). Sequencing grade modiﬁed porcine trypsin
(Promega, Madison, WI, USA) was used as the digestion
enzyme. Methanol and acetic acid were from Mallinckrodt
Baker B.V. (Deventer, The Netherlands). Trizma base,
ammonium acetate, ammonium formate and formic acid
were from Sigma-Aldrich and ACN was from Rathburn
Chemicals (Walkerburn, Scotland). Water was puriﬁed with
a Milli-Q water puriﬁcation system (Millipore, Molsheim,
France). All reagents and solvents were of analytical or
HPLC grade.
Negative photoresist SU-8 50 (Microchem, Newton, MA,
USA) was purchased from Microresist Technologies GmbH
(Berlin, Germany) and PDMS (Sylgard 184, Dow Corning,
Midland, MI, USA) from VWR International Oy (Espoo,
Finland).
2.2 Standard protein digestion
Incubation of the proteins with trypsin was performed
according to a standard protocol. Brieﬂy, 4 mL of enzyme
solution (0.35 mg/mL in 50mM acetic acid) was added to
4 mL of protein solution (10 mg/mL in water). The mixture
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was kept at room temperature for 10 min followed
by addition of 15 mL of 0.1 M Tris (pH 9.2) with 10%
ACN to give a ﬁnal protein concentration of 1.7 mg/mL
and an enzyme:protein ratio of 1:29. Incubation was
performed at 371C for 18 h. Blank control samples
were prepared by replacing the protein or the enzyme
solution with water or 50 mM acetic acid, respectively.
The control blank samples were then incubated in
the same manner as described previously. All samples
were analyzed without further modiﬁcations or prior
pretreatment.
2.3 Preparation of human muscle cell lysates
Human muscle cells were lysed according to standard
protocol in RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl,
1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate,
0.1% SDS, 1 tablet protease inhibitor cocktail). The lysed
cells were stored in a freezer (201C) until used. Before
digestion the cell lysate was vortexed for 2 min followed by
centrifugation at 13 200 rpm for 10 min. The supernatant,
containing only soluble proteins, was digested with
trypsin for 18 h at 371C. The incubation mixture
contained 25.8% cell lysate v/v and 0.09 mg/mL trypsin in
0.1 M Tris buffer (pH 9.2) with 10% ACN. No further
modiﬁcations or pretreatments were performed before
analysis.
2.4 Microchips designs
The microchips (Fig. 1) comprising a monolithically
integrated injection and separation unit, a sheath ﬂow
interface and an ESI emitter were fabricated entirely from
epoxy photoresist SU-8 using photolithography and adhe-
sive bonding techniques as reported earlier. [16, 30] The
effective separation lengths of the CZE-ESI/MS chips were 4
or 2 cm. Other microchannel dimensions are given in detail
in Fig. 1. Before use, PDMS sheets with 2 mm inlet holes
were attached on top of the SU-8 chip to increase the inlet
volumes.
2.5 Microchip CZE
The samples were injected electrokinetically (25 s) in
pinched injection mode. An electric ﬁeld of 1000–1250
V/cm was applied between the sample inlet and the sample
waste, while a small focusing potential was applied
to the buffer inlet (Fig. 1). During injection, the sheath
liquid inlet (SLI) was ﬂoating so that no spray was
produced. The CZE separations were performed in cathodic
mode using electric ﬁeld strengths of 375–650 V/cm
between the buffer inlet and SLI. The BGE was 30 mM
ammonium acetate (pH 7.1) or ammonium formate (pH
6.3) with 50% methanol, while the sheath liquid was a
methanol–water (80:20) solution with 1% acetic or formic
acid, respectively.
2.6 MS
The SU-8 microchips were coupled to two different MS
instruments. An Agilent 6330 MS ion trap MS (Agilent
Technologies, Santa Clara, CA, USA) equipped with an xyz-
aligning stage and a CCD camera was used for rapid
analysis of the protein digests by MS and MS/MS, and a
Q-TOF Micro MS (Waters/Micromass, Manchester, UK)
was used for high-resolution MS measurements. In both
cases, an external power supply (Micralyne, Edmonton,
Canada) was used for application of the separation and
electrospray (ES) voltages through platinum wires placed in
the microchannel inlets. The ES voltage also served as the
counter voltage for the CZE separation.
Typically, an ES voltage of 3.6 kV (relative to MS) was
applied to the SLI. The separation current (typically
20–40 mA) was divided at the sheath ﬂow intersection so that
the ES current was 50–300 nA and the excess current was
led to ground through a 50MO (ion trap) or 100MO
(Q-TOF) resistor coupled in parallel with the ES voltage
power supply.
The ion trap MS was operated in positive ion mode with
a capillary voltage of 1.6 kV, end-plate offset of 500 V,
and a trap drive value of 94.6. Nitrogen (Nitrogen generator
system, Parker, Cleveland, OH, USA) was used as the
drying gas (4.0 L/min, 1701C). In MS mode, the data was
acquired over a mass range of m/z 100–2200 with a maxi-
mum accumulation time of 100 ms. In MS/MS mode,
collision-induced dissociation was performed for the selec-
ted precursor ions using a fragmentation amplitude of
2.00 V and an isolation width of 2.0 Da. Data analysis soft-
ware was used for acquisition and data processing.
Figure 1. Schematic view of the ﬂuidic design (A) and photo-
graph (B) of the SU-8 CZE-ESI/MS microchip (dimensions not to
scale). BI5buffer inlet, SI5 sample inlet, SW5 sample waste,
SLI5 sheath liquid inlet.
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The Q-TOF micro instrument was operated in positive
ion mode with sample cone voltage of 50.0 V and extraction
cone voltage of 2.0 V. The TOF parameters were: 5630 V
ﬂight tube, 842 V pusher, 640 V puller. Nitrogen produced
by a high-purity nitrogen generator (Peak Scientiﬁc,
Renfrewshire, Scotland) was used as the cone gas (40 L/h).
The MS data was acquired over a mass range of m/z
300–1500 in continuum mode with a scan time of 0.2 s
and an inter-scan delay of 0.1 s. For high-resolution MS,
bradykinin fragment 1–5 (m/z 573.3149) dissolved in the
sheath liquid (5 mM) was used as an internal mass calibrant.
The MassLynx 4.0 software was used for data acquisition
and processing.
The theoretical molecular masses (Mr), pI values and
amino acid sequences of the tryptic peptides were derived
from the MASCOTs online search engine (www.ma-
trixscience.com) using the Swiss-Prot database therein.
Peaks observed at m/z within71.0 Da (tryptic peptides
originating from standard proteins) or71.2 Da (tryptic
peptides from the cell lysates) of their theoretical values
were considered as positive matches and maximum one
missed cleavage was allowed.
2.7 Analysis of human muscle cell lysates
Peptide mass ﬁngerprinting was performed in order to
identify the potential proteins from the human muscle cell
lysates. First, the tryptic digests of the cell lysates were
analyzed by traditional HPLC-ESI/MS (for experimental set-
up, see the Supporting Information) to get a list of cellular
proteins potentially present in the cell lysate. Next, the same
samples were analyzed by microchip-CE-ESI/MS on the ion
trap MS (similarly to the tryptic digests of the standard
proteins) and the data was searched for the proteins
identiﬁed by HPLC-ESI/MS. Only proteins that were
identiﬁed by both techniques were considered as positive
matches.
3 Results and discussion
In this work, SU-8 microfabrication technology, including
photolithographic patterning of a microchannel network
(Fig. 1) as well as enclosure of the microstructures by SU-8
adhesive bonding [29], was utilized for fabrication of
microchip analysis systems for proteomics research. A
microﬂuidic platform was developed comprising a sample
introduction unit and an electrophoretic separation channel
with a monolithically integrated ESI emitter as well as an
auxiliary channel for the introduction of sheath liquid and
internal mass calibrant (Fig. 1). The main advantage of the
full-wafer SU-8 microfabrication process is that both
separation and injection microchannels as well as an ESI
emitter tip can be fabricated at the same time during a
single photoexposure step. The chip-to-chip reproducibility
is therefore high and manufacturing costs low, since a
number of microchips can be implemented on the same
wafer [16]. Aligning of the different SU-8 layers also exploits
lithographic accuracy and allows sharp and precisely deﬁned
emitter structures to be patterned in the end of the
separation microchannels without manual postprocessing.
Here, the applicability of the SU-8 microchips to proteomics
research was demonstrated by performing protein identiﬁ-
cation based on rapid CZE separation of tryptic peptides
prior to their online MS identiﬁcation and MS/MS
characterization. The SU-8 microchips were coupled to
two different MS instruments, namely an ion trap and a Q-
TOF MS, both of which record a broad mass range at high
speed and thus provide enough data points for reliable
recording of mass spectra from narrow electrophoretic
peaks. The microchip method was validated with the help of
selected standard proteins (cytochrome C, b-lactoglobulin,
ovalbumin and BSA) that sufﬁciently differed in size, pI
value and hydrophilicity (Table 1) and represented proteins
of different physical and chemical properties. Eventually,
separation of tryptic peptides followed by peptide mass
ﬁngerprinting and identiﬁcation of proteins from human
muscle cell lysate samples was demonstrated using the SU-8
CZE-ESI/MS microchip.
3.1 Protein identiﬁcation by peptide mass
ﬁngerprinting
Before analysis, the CZE separation voltages and the MS
parameters were optimized with the help of selected peptide
standards, i.e. angiotensin I and II. The migration times of
angiotensin I and II were 72.0 and 81.1 s, respectively. The
run-to-run (n5 3) repeatability was determined by utilizing
Table 1. Summary of the microchip CZE-ESI/MS analyses of the tryptic digests of cytochrome C, b-lactoglobulin, ovalbumin and BSA
Protein Mr (kDa) pI Amino acids GRAVY
a) Number of
peptidesb)
Sequence
cov. (%)b)
Probability
scoreb)
Expect. valueb)
Cytochrome C (CYC_BOVIN) 12 9.52 104 0.866 10 67 87 2.0 104
X-Lactoglobulin (LACB_BOVIN) 18 4.76 162 0.167 17 68 97 1.8 105
Ovalbumin (OVAL_CHICK) 43 5.20 386 0.006 19 59 93 5.4 105
BSA (ALBU_BOVIN) 69 5.78 583 0.476 46 54 177 2.0 1013
a) Grand average of hydropathicity index.
b) Based on Swiss-Prot database search by MASCOT online search engine.
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angiotensin II as an internal standard for angiotensin I. The
measured repeatabilities for the migration time and the
peak area were 4.7 and 3.2%, respectively. The BGE
composition was then optimized separately for each
proteolytic sample, with respect to the electrolyte type
(ammonium acetate or ammonium formate) and concentra-
tion as well as the amount of methanol in the BGE. For
most protein digests, a 30 mM ammonium acetate solution
containing 50% methanol was shown to provide the best
resolving power, yet ammonium formate solution of the
same strength allowed the best resolution of ovalbumin
tryptic peptides. Typically, a number of singly or doubly
charged tryptic peptides were identiﬁed and sequence
coverages between 50 and 70% were routinely obtained for
all selected proteins (Table 1). A representative separation of
the tryptic peptides observed for cytochrome C with their
extracted ion electropherograms (EIE) is given in Fig. 2.
Tables S1–S3 in the Supporting Information give detailed
lists of all peptides observed for ovalbumin, X-lactoglobulin
and BSA digests, respectively.
Figure 2. EIEs from the microchip CZE-ESI/
MS analysis of the cytochrome C tryptic
digest on the ion trap MS. The separation
BGE was 30mM ammonium acetate with
50% methanol and the sheath liquid was
80% methanol with 1% acetic acid. Electric
ﬁeld strengths during injection and separa-
tion were 1000 and 375 V/cm, respectively,
and the effective separation length was
4 cm.
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Thanks to the straightforward integration of all unit
operations (i.e. sample introduction, separation and ESI) on
the same microchip, the ﬂuidic junctions were dead volume
free, which resulted in negligible peak broadening and a
high number of theoretical separation plates (N). At the
best, peak widths at half height (wh) down to 0.6 s were
reached for the tryptic peptides, which gave theoretical plate
numbers (N) as high as 6.7 105. Most importantly, such
efﬁcient separation together with reliable identiﬁcation of
the protein in question was achieved within very short
analysis times (2.5–6.3 min on a 4-cm-long separation
channel) and with minimal manual workload. Thanks to the
very small injection volume of only 45 pL (as per volume of
the intersection of the injection and separation channels),
the digestion matrix containing relatively high electrolyte
concentrations could be injected as such, without any need
for sample pretreatment before analysis. The amount of
protein injected per analysis was as low as 1.0–6.3 fmol, as
per initial protein concentration (20–140 mM) in the diges-
tion matrix, showing that the tryptic peptides could be
detected with reasonably high sensitivity regarding proteo-
mics applications.
Although surface contamination through nonspeciﬁc
adsorption of biomolecules is often reported for polymer
microchips, here adsorption of the tryptic peptides to SU-8
was considered negligible since blank runs did not show any
memory effects. The addition of small amounts of organic
solvents, as was done here, or surfactants to the BGE
has also been shown to signiﬁcantly reduce nonspeciﬁc
interactions between the SU-8 surface and the analytes of
interest. [16]
The layout of the SU-8 microchip (Fig. 1) is also well
suited for introduction of an internal mass calibrant toge-
ther with the sheath liquid in order to allow exact mass
measurements on, for instance, Q-TOF instruments. Here,
bradykinin fragment 1–5 (m/z 573.3149) was chosen as an
Figure 3. Selected EIEs and corresponding
high-resolution mass spectra from the
microchip CZE-ESI/MS analysis of b-lacto-
globulin on the Q-TOF MS. The separation
BGE was 30mM ammonium acetate with
50% methanol and the sheath liquid was
80% methanol with 1% acetic acid and 5 mM
bradykinin fragment 1–5 as sheath liquid.
Electric ﬁeld strengths during injection and
separation were 1250 and 400 V/cm, respec-
tively, and the effective separation length
was 4 cm.
Figure 4. ESI-collision-induced dissociation spectra of selected
singly charged tryptic peptides of (A) b-lactoglobulin (m/z 934.2)
and (B) cytochrome C (m/z 1456.7) as precursor ions from the
microchip CZE-ESI/MS/MS on the ion trap MS. The separation
BGE was 30mM ammonium acetate with 50% methanol and the
sheath liquid was 80% methanol with 1% acetic acid. Electric
ﬁeld strengths during injection and separation were 1000 and
375 V/cm, respectively, and the effective separation length was
4 cm. The fragmentation amplitude was 2.0 V.
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internal mass calibrant and was applied along with the
sheath liquid at a concentration of 5 mM. In this manner, it
did not interfere with the analytes of interest during
separation, but enabled identical online mass calibration
between all separated analytes. Figure 3 shows the EIEs and
mass spectra of selected peptides from the b-lactoglobulin
tryptic digest and Table S4 in the Supporting Information
lists the peptides observed from the cytochrome C tryptic
digest analyzed by microchip CZE-ESI coupled to a high-
resolution Q-TOF MS. Both the EIEs and mass spectra show
good S/N and clearly identify the peptide fragments with a
typical mass error around 10 ppm (Fig. 3 and Table S4).
3.2 Protein identiﬁcation by MS/MS
An obvious advantage of the rapid analysis facilitated by the
microchip CZE-ESI/MS is the ability to perform MS/MS on
very small quantities of the protein digest. In addition to
accurate mass determination by high-resolution MS instru-
ments, MS/MS provides detailed structural information on
the peptides to facilitate protein identiﬁcation based on
peptide sequencing. In this work, MS/MS characterization
of tryptic peptides, ﬁrst separated by on-chip CZE, was
done on the ion trap instrument. The MS/MS spectra of
selected tryptic peptides from b-lactoglobulin and cyto-
chrome C digests are given in Fig. 4A and B, respectively.
The product ion spectra of the selected precursor peptides
are characterized by the easily identiﬁable y and b series
fragment ions. Both cytochrome C and X-lactoglobulin could
be accurately identiﬁed by the MASCOTs [32] online search
engine based on MS/MS fragmentation data of only a single
tryptic peptide of each, i.e. m/z 1456.7 for cytochrome C and
m/z 934.2 for X-lactoglobulin. The MASCOT scores,
indicating identity or extensive homology to the proteins
in question, were 67 (expect. value 8.3 105) and 42
(expect. value 0.028) for cytochrome C and X-lactoglobulin,
respectively.
3.3 Analysis of human muscle cell lysates
The applicability of the SU-8 CZE-ESI/MS microchip to the
analysis of authentic biological samples was shown by
analyzing a tryptic digest of human muscle cell lysates.
Regardless of the complexity of the human cellular matrix
seven proteins of different size, pI value and hydrophilicity
were identiﬁed from the cell lysates (Table 2). The
MASCOTs probability-based scores [32] ranged from 102 to
211 indicating signiﬁcant homology between detected and
theoretical tryptic peptides and sequence coverages as good as
93% were received. The EIEs of the tryptic peptides of an
actin related protein Q96HG5, highly expressed in muscle
cells, are shown in Fig. 5 while Tables S5–S10 in the
Supporting Information give detailed lists of the tryptic
peptides observed for all other identiﬁed proteins from the
human muscle cell lysates. All proteins listed in Table 2 were
also identiﬁed by in-house HPLC-MS analysis of the same
sample. A conventional HPLC-MS analysis was carried out
with a view to conﬁrm the positive matches because data-
dependent MS/MS analysis of the cell lysate was not feasible
on microchips. Namely, the acquisition rate of the current
MS instrumentation in MS/MS mode is not high enough for
reliable sampling of the very narrow electrophoretic peaks
(o1 s) characteristic of microchip CE. Therefore, the time
constant of the MS detector often becomes a limiting factor in
microchip CE-ESI/MS analysis [18, 33] with respect to
thorough MS/MS characterization in particular, unless
nonscanning instruments with high acquisition rate (e.g.
TOF-MS) are used. In addition to comparison with HPLC-
MS, rigorous screening against blank samples was carried out
in order to eliminate potential false positives. When
compared to the HPLC-MS method the microchip method
is very fast and requires a much smaller amount of sample
(o3 mL) for analysis. In microchip CZE-ESI/MS analysis all
peptides migrated within 98 s on the 2-cm-long separation
microchannel (Table 2), while the HPLC-MSmethod requires
20 mL of sample and takes tens of minutes per one run.
Table 2. Proteins identiﬁed from the digested human muscle cell lysate by microchip CZE-ESI/MS analysis on the ion trap MS
Protein Mr (kDa) pI Amino
acids
GRAVYa) Number of
peptidesb)
Sequence
coverage (%)
Q70VV1 Rhesus blood group D antigen 5.6 6.51 48 0.085 5 85
Q6PCD6 GLS2 protein 6.6 11.35 61 1.075 8 93
Q8N9L7 CDNA FLJ36925 ﬁs, clone BRACE2005169 13.5 9.8 120 0.756 8 70
CAF00094 DNAJ (Hsp40) homolog, subfamily C member 11 14.4 5.22 119 1.071 10 65
Q96HG5 Actin beta, (fragment) 41.0 5.56 368 0.202 17 48
JC4775 Interferon-induced double-stranded RNA
activated protein
57.5 5.83 504 0.679 23 32
Q6PIC7 MAP7 domain-containing protein 74.1 8.68 660 1.115 21 19
The separation BGE was 30mM ammonium acetate with 50% methanol and the sheath liquid was 80% methanol with 1% acetic acid.
Electric ﬁeld strengths during injection and separation were 1000 and 650 V/cm, respectively, and the effective separation length was
2 cm.
a) Grand average of hydropathicity index.
b) Based on Swiss-Prot database search by MASCOT online search engine.
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4 Concluding remarks
The microchip methods developed in this study were shown
to be efﬁcient tools for proteomics research. The SU-8
microchip CZE-ESI/MS analysis including rapid (o10min)
CZE separation of tryptic peptides and their high-resolution
MS or MS/MS identiﬁcation, was ﬁrst validated with the
help of selected, biologically important proteins. Regardless
of the protein properties (size, hydrophilicity, pI value), the
characteristic peptide fragments were easily separated with
Figure 5. EIEs of the tryptic peptides from the protein Q96HG5 of the human muscle cell lysate analyzed by microchip CZE-ESI/MS on the
ion trap MS. The separation BGE was 30mM ammonium acetate with 50% methanol and the sheath liquid was 80% methanol with 1%
acetic acid. Electric ﬁeld strengths during injection and separation were 1000 and 650 V/cm, respectively, and the effective separation
length was 2 cm.
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reasonably high sensitivity (at the femtomole level) and with
sequence coverages better than 50% and plate numbers
approaching 106. Next, the microchips were applied to the
analysis of authentic biological samples by analyzing tryptic
peptides originating from human cell lysates. Fast and
efﬁcient separation of a number of tryptic peptides facilitated
reliable identiﬁcation of several human proteins from the
complex cellular matrix by microchip CZE-ESI/MS. The
microchips also showed good repeatability as indicated by
low RSD for both the migration time (RSD5 4.7%) and peak
area (RSD5 3.2%). Moreover, the SU-8 microfabrication
technology exploited in the chip fabrication not only enables
production of accurately deﬁned microstructures but also
low-cost mass production of a number of chips with identical
features and thus, highly reproducible performance from
chip-to-chip. This is the main advantage of the fully
integrated SU-8 CZE-ESI/MS microchips over other thus
far published CZE-ESI/MS microchips. Inevitably, the
speed of microchip CZE-ESI/MS analysis is another indis-
putable reward as against both conventional and microchip
LC-ESI/MS systems.
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31. HPLC-MS experiments  
An Agilent HP 1100 HPLC system equipped with an AtlantisTM dC18 column (2.1 x 50 mm, 3 
μm; Waters) was used for the separation of tryptic peptides from a digested human muscle cell 
lysate sample. The injection volume was 20 μL and the eluent flow rate was 450 μL/min. The 
aqueous phase (A) contained 5 mM ammonium acetate and the organic phase (B) was methanol. 
The gradient profile was from 5 to 95% B in 15 min followed by 95% B for 5 min.    
The HPLC system was coupled to an API3000 triple quadrupole (QqQ) mass spectrometer 
(Perkin Elmer Sciex, Concord, ON, Canada) with a commercial turbo electrospray ionization 
(ESI) source. The 450 μL/min flow from the column was split 1:10 prior to MS detection. The 
MS was operated in positive ion mode with an electrospray voltage of 5500 V and scanning a 
mass range of m/z 300-2000 (2.5 s/scan). The main ion optics were: declustering potential (DP) 
30 V, focusing potential (FP) 200 V, entrance potential (EP) 10 V, and collision exit potential 
(CE) 30 V. Nitrogen (Whatman 75-72 nitrogen generator; Haverhill, MA) was used as the 
curtain and turbo gas while compressed air (Atlas Copco air dryer, Wilrijk, Belgium) was used 
as the nebulizer gas. The flow rates of the curtain and nebulizer gases were 1.44 and 1.53 L/min 
respectively and the source temperature was 280°C. Data was processed with Analyst1.4 
software.  
42. Tables 
Table S-1. The peptides observed in the microchip CZE-ESI/MS analysis of the tryptic digest of 
ovalbumin listed as per their migration time together with mass variation between the observed 
and calculated m/z, theoretical molecular mass and position in the amino acid sequence. The 
BGE was 30 mM ammonium formate with 50% methanol and the sheath liquid was 80% 
methanol with 1% formic acid. Electric field strengths during injection and separation were 1000 
V/cm and 375 V/cm, respectively, on the ion trap MS and the effective length of the separation 
microchannel was 4 cm.  
Migration 
time (s) 
Observed ions
?m/z Theoretical mass (Da) 
Position 
in
sequence [M+H]
+ [M+2H]2+
8.9 1688.2 0.4 1686.8 127-142
14.5 1774.3 0.4 1772.9 323-339
31.9 1382.7 0.0 2763.3 59-84
43.6 535.5 -0.7 535.2 287-290
45.1 1209.1 -0.4 1208.5 190-199
54.3 631.6 -0.7 631.3 182-186
55.1 409.4 0.2 408.2 59-61
62.3 1140.8 -0.3 2280.2 85-104
73.3 277.1 -1.0 277.1 227-228
73.3 388.3 0.0 387.3 277-279
73.4 260.1 -0.1 259.2 278-277
76.0 1737.8 0.0 3473.6 190-218
78.1 1544.2 0.0 3086.5 200-226
107.6 1581.5 -0.2 1580.7 264-276
126.8 1646.8 -0.5 3292.6 291-322
148.8 2025.7 -1.0 2026.1 111-126
154.6 1537.4 0.1 3072.6 159-186
191.2 1730.9 -1.0 1730.9 370-385
306.5 1344.9 -0.8 1344.7 370-381
5Table S-2. The peptides observed in the microchip CZE-ESI/MS analysis of the tryptic digest of 
?-lactoglobulin listed as per their migration time together with mass variation between the 
observed and calculated m/z, theoretical molecular mass and position in the amino acid sequence. 
The BGE was 30 mM ammonium formate with 50% methanol and the sheath liquid was 80% 
methanol with 1% acetic acid. Other injection and separation conditions as per Table S1.  
Migration 
time (s) 
Observed ions
?m/z Theoretical mass (Da) 
Position 
in 
sequence [M+H]
+ [M+2H]2+ [M+3H]3+
4.2 247.7 -0.6 247.3 76-77
25.2 1964.9 0.7 1963.2 84-100
64.2 331.4 0.0 330.4 139-141
64.8 837.9 -0.1 837.0 142-148
66.6 674.9 0.1 673.8 78-83
68.4 561.7 -0.4 1122.2 61-69
69.0 933.9 -0.3 933.2 1-8
82.2 673.8 0.0 672.8 9-14
84.6 573.7 0.0 572.7 71-75
88.8 409.4 0.0 408.4 136-138
90.0 826.7 -0.3 2477.9 142-162
95.4 892.1 -0.9 2676.1 102-124
97.8 1065.8 -0.4 1065.2 92-100
99.6 916.2 -0.8 916.0 84-91
103.8 904.9 0.8 903.1 76-83
109.2 1157.8 0.0 2313.6 41-60
148.8 1245.8 -0.5 1245.3 125-135
6Table S-3. The peptides observed in the microchip CZE-ESI/MS analysis of the tryptic digest of 
BSA listed as per their migration time together with mass variation between the observed and 
calculated m/z, theoretical molecular mass and position in the amino acid sequence. The BGE 
was 30 mM ammonium formate with 50% methanol and the sheath liquid was 80% methanol 
with 1% acetic acid. Other injection and separation conditions as per Table S1.  
Migration 
time (s) 
Observed 
ions ?m/z 
Theoretical 
mass (Da) 
Position 
in 
sequence 
Migration 
time (s) 
Observed 
ions ?m/z 
Theoretical 
mass (Da) 
Position 
in 
sequence 
49.2 509.6 (1+) 0.3 508.3 558-561 101.2 500.5 (1+) 0.3 499.2 25-28
52.5 589.6 (2+) 0.3 1176.6 300-309 101.7 517.6 (1+) 0.3 516.3 281-285
59.3 723.7 (2+) 0.3 1444.8 157-167 102.5 789.9 (1+) 0.4 788.5 257-263
88.3 733.8 (2+) 0.4 1464.7 456-468 102.9 649.7 (1+) 0.4 648.3 223-228
88.5 475.6 (1+) 0.3 474.3 242-245 102.9 508.5 (1+) 0.3 507.2 229-232 
88.6 689.8 (1+) 0.4 688.4 236-241 103.2 1002.9 (1+) 0.3 1001.6 598-607
88.7 545.7 (1+) 0.4 544.3 101-105 103.2 1283.9 (1+) 0.2 1282.7 361-371
89.0 432.5 (1+) 0.3 431.2 456-459 103.4 712.8 (1+) 0.4 711.4 29-34
89.1 572.7 (1+) 0.3 571.4 219-222 103.5 946.2 (2+) 0.3 1889.8 101-117
89.4 1640.1 (1+) 0.2 1638.9 437-451 105.5 660.7 (1+) 0.4 659.3 490-495
90.3 388.5 (1+) 0.3 387.2 545-547 105.7 1014.9 (1+) 0.3 1013.6 549-557
90.5 383.4 (1+) 0.2 382.2 264-266 112.0 752.9 (1+) 0.5 751.4 341-346
90.5 331.4 (1+) 0.2 330.2 372-374 140.9 1231.9 (2+) 0.2 2461.4 3-23
90.5 821.2 (1+) 0.7 819.5 483-489 162.9 1351.9 (2+) 0.8 2700.2 460-482
90.6 347.4 (1+) 0.2 346.2 496-498 194.6 1889.4 (1+) 0.5 1887.9 169-183
90.7 404.4 (1+) 0.2 403.2 452-455 201.3 1884.9 (1+) 0.0 1883.9 281-297
90.8 439.5 (1+) 0.3 438.2 434-436 229.6 1039.1 (2+) 0.1 2075.9 267-285
91.0 391.4 (1+) 0.2 390.2 246-248 240.1 979.1 (2+) 0.6 1955.0 319-336
91.1 1143.0 (1+) 0.3 1141.7 548-557 241.5 1386.7 (1+) 0.1 1385.6 286-297
91.6 537.6 (1+) 0.3 536.3 157-160 242.6 886.8 (1+) 0.4 885.4 131-138
99.3 1017.9 (2+) 0.3 2033.1 588-607 374.1 318.4 (2+) 0.7 633.4 20-24
99.4 741.2 (3+) 0.5 2219.1 529-547 374.6 362.4 (3+) 0.5 1082.6 161-168
99.4 1480.0 (1+) 0.2 1478.8 421-433 375.5 333.5 (2+) 0.3 664.4 156-160
101.0 1512.0 (1+) 0.2 1510.8 438-451
7Table S-4. The peptides observed in the microchip CZE-ESI/MS analysis of the tryptic digest of 
cytochrome C listed as per their migration time together with mass variation between the 
observed and calculated m/z, theoretical molecular mass and position in the amino acid sequence. 
The BGE was 30 mM ammonium acetate with 50% methanol and the sheath liquid was 80% 
methanol with 1% acetic acid and 5 μM bradykinin fragment 1-5. Electric field strengths during 
injection and separation were 1000 V/cm and 400 V/cm, respectively, on the Q-TOF MS and the 
effective length of the separation microchannel was 4 cm.  
Migration 
time (s) 
Observed ions Error 
(ppm) 
Theoretical 
mass (Da) 
Position in 
sequence [M+H]+ [M+2H]2+
42.6 584.8216 10.8 1167.6149 28-38
43.2 284.1754 10.9 283.2644 26-27
43.2 489.2704 -16.6 488.2707 88-91
43.2 634.3887 -6.5 633.3850 9-13
43.2 678.3816 -1.6 677.3748 74-79
43.2 779.4363 -16.3 778.4411 80-86
44.4 261.1590 10.3 260.1485 23-25 or 54-55
44.4 728.8521 17.6 1455.6630 40-53
48.0 361.1729 -29.6 360.1757 89-91
48.0 964.5020 -34.7 963.5277 92-99
50.4 434.1909 5.1 433.1809 101-104
8Table S-5. Tryptic peptides of Q70VV1 observed in the microchip CZE-ESI/MS analysis of the 
digested human muscle cell lysate listed as per their migration time together with mass variation 
between the observed and calculated m/z, theoretical molecular mass and position in the amino 
acid sequence. The BGE was 30 mM ammonium acetate with 50% methanol and the sheath 
liquid was 80% methanol with 1% acetic acid. Electric field strengths during injection and 
separation were 1000 V/cm and 650 V/cm, respectively, on the ion trap MS and the effective 
length of the separation microchannel was 2 cm. 
Migration 
time (s) 
Observed ions ?m/z Theoretical mass (Da) 
Position in 
sequence [M+H]+ [M+2H]2+
15.9 175.2 0.1 174.1 11-11
24.3 267.2 0.1 532.3 8-11
44.2 1823.2 0.5 3643.9 12-42
52.0 793.8 0.4 792.4 5-10
90.0 368.6 -1.2 736.4 2-7
9Table S-6. Tryptic peptides of Q6PCD6 observed in the microchip CZE-ESI/MS analysis of the 
digested human muscle cell lysate listed as per their migration time together with mass variation 
between the observed and calculated m/z, theoretical molecular mass and position in the amino 
acid sequence. The BGE was 30 mM ammonium acetate with 50% methanol and the sheath 
liquid was 80% methanol with 1% acetic acid. Injection and separation conditions as per Table 
S5. 
Migration 
time (s) 
Observed ions ?m/z Theoretical mass (Da) 
Position in 
sequence [M+H]+ [M+2H]2+
8.0 1007.0 -0.1 2012.1 29-48
8.1 761.8 0.9 1520.7 14-28
15.9 175.2 0.1 174.1 2-2
21.2 1567.8 -0.9 1567.7 49-61
22.1 459.4 0.1 458.3 6-9
24.3 1364.2 1.2 2725.2 38-61
48.7 326.4 -0.5 651.3 1-5
54.0 855.8 0.3 854.5 29-37
10
Table S-7. Tryptic peptides of Q8N9L7 observed in the microchip CZE-ESI/MS analysis of the 
digested human muscle cell lysate listed as per their migration time together with mass variation 
between the observed and calculated m/z, theoretical molecular mass and position in the amino 
acid sequence. The BGE was 30 mM ammonium acetate with 50% methanol and the sheath 
liquid was 80% methanol with 1% acetic acid. Injection and separation conditions as per Table 
S5. 
Migration 
time (s) 
Observed ions ?m/z Theoretical mass (Da) 
Position in 
sequence [M+H]+ [M+2H]2+
8.0 432.4 -0.6 863.4 58-65
8.6 413.4 -0.7 825.5 9-15
11.2 1763.0 0.2 1761.8 16-29
15.9 175.2 0.1 174.1 57-57
15.9 1125.0 -0.1 2248.1 58-77
18.1 1606.8 -0.1 3211.7 66-94
24.5 1302.0 -0.6 1301.6 2-12
72.0 1860.6 -0.7 3719.9 78-113
11
Table S-8. Tryptic peptides of CAF00094 observed in the microchip CZE-ESI/MS analysis of 
the digested human muscle cell lysate listed as per their migration time together with mass 
variation between the observed and calculated m/z, theoretical molecular mass and position in the 
amino acid sequence. The BGE was 30 mM ammonium acetate with 50% methanol and the 
sheath liquid was 80% methanol with 1% acetic acid. Injection and separation conditions as per 
Table S5. 
Migration 
time (s) 
Observed ions ?m/z Theoretical mass (Da) 
Position in 
sequence [M+H]+ [M+2H]2+
8.2 688.6 -0.5 1375.7 99-109 
14.8 1099.0 0.4 1097.6 76-84 
15.9 175.2 0.1 174.1 many 
19.6 471.4 -0.7 941.5 76-83 
20.1 795.8 0.8 1588.8 84-96 or 85-97
25.2 1353.2 -0.5 1352.7 24-35 
46.6 421.4 -0.7 841.5 98-104 
53.2 447.4 -0.7 893.5 46-52 
56.0 1366.0 -0.3 2730.3 1-23 
68.5 635.6 -0.8 635.4 32-36 
12
Table S-9. Tryptic peptides of JC4775 observed in the microchip CZE-ESI/MS analysis of the 
digested human muscle cell lysate listed as per their migration time together with mass variation 
between the observed and calculated m/z, theoretical molecular mass and position in the amino 
acid sequence. The BGE was 30 mM ammonium acetate with 50% methanol and the sheath 
liquid was 80% methanol with 1% acetic acid. Injection and separation conditions as per Table 
S5. 
Migration 
time (s) 
Observed ions ?m/z Theoretical mass (Da) 
Position in 
sequence [M+H]+ [M+2H]2+
7.4 831.8 -0.2 1661.8 143-156 
7.9 723.6 0.5 1444.7 180-191 
8 679.6 -0.8 679.4 112-117 
8 925.0 0.6 923.4 257-263 
8 557.4 0.3 1112.5 281-290 
8.1 761.8 -0.1 1521.7 284-296 or 118-130
8.3 631.4 1.0 629.4 408-412 
8.7 575.6 0.3 574.3 378-382 
9.2 633.4 0.2 1264.6 297-307 
14.5 486.4 -1.0 486.4 130-133 
14.8 1099.0 0.4 1097.6 394-402 
15.4 911.2 -0.3 910.5 251-257 
15.6 561.6 -0.3 1121.5 310-318 
15.9 175.2 0.1 174.1 many 
19.6 1076.0 0.5 1074.5 447-455 
19.6 1077.0 -0.7 1076.7 109-117 
36.6 715.6 0.2 714.4 201-206 
40.9 811.8 0.4 810.4 102-108 
48.7 697.6 -0.4 1393.6 118-129 
56.9 828.6 0.1 827.5 89-96 
64.5 823.8 -0.7 823.5 40-46 
72.9 839.8 0.4 838.4 499-504 
97.4 489.4 1.1 487.3 403-406 
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Table S-10. Tryptic peptides of Q6PIC7 observed in the microchip CZE-ESI/MS analysis of the 
digested human muscle cell lysate listed as per their migration time together with mass variation 
between the observed and calculated m/z, theoretical molecular mass and position in the amino 
acid sequence. The BGE was 30 mM ammonium acetate with 50% methanol and the sheath 
liquid was 80% methanol with 1% acetic acid. Injection and separation conditions as per Table 
S5. 
Migration 
time (s) 
Observed ions ?m/z Theoretical mass (Da) 
Position in 
sequence [M+H]+ [M+2H]2+
6.9 947.8 0.4 946.4 344-350
8.0 515.2 -1.1 515.3 186-189
8.0 596.6 -0.7 596.3 291-295
8.0 596.6 0.6 1190.6 224-234
8.3 631.6 0.2 630.4 151-155
8.7 575.6 0.6 1148.6 291-300
9.1 469.4 0.4 936.4 206-214
9.2 633.4 0.1 632.3 368-372
11.4 252.2 0.1 502.3 151-154
13.2 570.6 -0.7 570.3 296-300
15.0 618.4 1.2 1233.6 296-308
15.9 175.2 0.1 174.1 629-629
17.2 573.4 0.0 572.4 331-335
18.8 1149.0 -0.6 1148.6 291-300
20.1 795.8 -0.3 1589.9 235-248
23.9 657.4 1.1 1311.7 249-260
41.5 317.2 0.1 632.3 368-372
42.0 1797.4 -0.6 1797.0 134-150
46.6 421.4 1.2 419.2 224-227
56.0 1366.0 -0.7 1365.7 156-170
63.4 1317.2 0.6 1315.6 341-350
II
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Abbreviations: AngI, angiotensin I; AngII, angiotensin II; AngIII, angiotensin III; AN, anolyte; BGE,
background electrolyte; BI, buffer inlet; BK1-5, bradykinin fragment 1-5; CA, catholyte; EIE, extracted
ion electropherogram; μEP, electrophoretic mobility; His, histidine; HV, high voltage; LE, leading
electrolyte; MCE, microchip capillary electrophoresis; SI, sample inlet; SLI, sheath liquid inlet; SP6-
11, substance P fragment 6-11; TE, terminating electrolyte; TEMED, N, N, N´, N´-
tetramethylethylenediamine; tITP, transient isotachophoresis
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2Abstract
In this work, we demonstrate the interfacing of microchip capillary isoelectric focusing (cIEF) with
online mass spectrometric (MS) detection via a fully integrated, on-chip sheath flow electrospray
ionization (ESI) emitter. Thanks to the pH-dependent surface charge of the SU-8 polymer used for the
chip fabrication, cIEF can be successfully run in native SU-8 microchannels without need for any
surface pretreatment prior to analysis. On the other hand, the inherent electroosmotic flow (EOF)
taking place in SU-8 microchannels at high pH can be exploited to electrokinetic mobilization of the
focused pH gradient toward the MS so that no external pumps are required. In addition to direct
coupling of a cIEF separation channel to an ESI emitter, we developed a two-dimensional separation
chip for two-step, multiplex cIEF-transient-isotachophoretic (tITP) separation. In this case, the cIEF is
performed in the first dimension (effective L= 20 mm) and tITP in the second dimension (L=35 mm)
followed by ESI/MS detection. As a result, the migration order is affected by both the pI values (cIEF)
and the intrinsic electrophoretic mobilities (tITP) of the sample components. The selectivity of the
separation system was shown to be different from pure cIEF or pure ITP, which at best allowed for
baseline separation of two compounds with nearly identical pI values. The repeatabilities of the
migration times of the two-step cIEF-tITP separation were as good as 3.1-6.8% RSD (n=3). Thanks to
the short separation channel, relatively short focusing times of 60-270 s (depending on the applied
focusing potential) were sufficient for establishment of the pH gradient and cIEF separation of the
sample components, yielding total analysis times (including loading, focusing, and mobilization) well
below 10 min.
Keywords: microchip electrophoresis; isoelectric focusing; isotachophoresis; mass spectrometry;
microfluidics
1. Introduction
Microchip capillary (zone) electrophoresis (MCE) in combination with microscope-based fluorescence
(FL) detection is the gold standard for microfluidic separations thanks to its high speed of analysis and
good feasibility for proteomics research [1, 2]. In addition to free zone electrophoresis, capillary
isoelectric focusing (cIEF) is another established technique based on separation of zwitter ionic
biomolecules (e.g., peptides and proteins) according to their pI and followed by electrokinetic or
hydrodynamic mobilization of the focused pH gradient toward the detector [3]. Microchip cIEF has
also been implemented for rapid separations of proteins, though usually in combination with linear
(optical) imaging of the cIEF gradient through the cover layer, without the mobilization step [4-6].
However, a major limitation of optical detection (UV or FL) in proteomics applications is the fact that
the ampholytes (required for establishment of the pH gradient) also strongly absorb UV light below
280 nm. This means that only tryptophan and tyrosine containing peptides and proteins can efficiently
be detected. Coupling of cIEF to mass spectrometry (MS) detection is thus of great interest to many
proteomics applications, where more specific identification of peptides and proteins is needed.
However, it is again the ampholytes that challenge the coupling of cIEF to MS because of the
ampholytes’ tendency to suppress the ionization efficiency of the target compounds [7, 8]. As a result,
the potential of microchip cIEF-MS in proteomics research has often been overlooked.
In this study, we demonstrate efficient coupling of microchip cIEF separation to on-chip electrospray
ionization (ESI)/MS detection. Specifically, we exploit the parallel microfabrication technology for
implementation of fully integrated multidimensional separation systems with dead-volume-free on-chip
ESI emitters and sheath flow interfaces out of SU-8 negative photoresist, similar to earlier work [9-15].
3Through SU-8 photolithography and adhesive bonding [10, 16], the construction of complex separation
platforms with multiple intersecting microchannels is relatively straightforward. Furthermore, zero-
dead-volume valving and transfer of samples from one dimension to another is easily achieved through
electroosmotic flow (EOF) supported by SU-8 [17]. In addition to direct coupling of a cIEF channel to
on-chip ESI/MS, we also demonstrate a multiplex cIEF-transient isotachophoretic (tITP) chip design in
which peptides are first separated based on cIEF (pH 3-10) and then isotachophoretically during EOF-
driven mobilization through a subsequent separation channel to ESI/MS. The latter approach not only
allows for effective preconcentration of the sample zones by cIEF, but also additional selectivity for
peptide separations, as the migration order of the peptides is dissimilar from pure cIEF or ITP.
2. Materials and methods
2.1. Chemicals
All peptides (angiotensins I, II, and III, bradykinin (fragments 1-5), and substance P (fragment 6-11)),
the amino acid histidine, ampholyte (pH 3-10), ammonium acetate, formic acid, Trizma base, and N, N,
N ,´ N´-tetramethylethylenediamine (TEMED) were purchased from Sigma-Aldrich (Steinheim,
Germany). Methanol, acetic acid, and ammonium hydroxide were from Mallinckrodt Baker B.V.
(Deventer, The Netherlands) and acetonitrile was from Rathburn Chemicals Ltd. (Walkerburn,
Scotland). Water was purified with a Milli-Q water purification system (Millipore, Molsheim, France)
and all solutions were degassed by sonication for 10-15 min before use.
Negative photoresist SU-8 50 (Microchem, Newton, MA) used for chip fabrication was purchased from
Microresist Technologies GmbH (Berlin, Germany) and poly(dimethyl siloxane) (PDMS, Sylgard 184,
Dow Corning, Midland, MI) from VWR International Oy (Espoo, Finland).
2.2. Microchip Designs
The SU-8 microchips were fabricated by UV photolithography and adhesive bonding as described
earlier [10, 12, 13, 16, 18]. Two types of microchip designs were used in the study. The first design,
has been applied previously for MCE-ESI/MS [10], but was now used for direct coupling of cIEF to
MS and comprised a 25-mm-long separation channel (50×50 μm2, w×h) intersected by two 12-mm-
long auxiliary channels (100×50 μm2, w×h) providing the sheath liquid to an on-chip ESI emitter tip
(Figure 1A). The second microchip design comprised two intersecting separation channels (both 50×50
μm2, w×h), the first of which was used for cIEF (effective L=20 mm) prior to mobilization through the
second channel (L=35 mm). This design was explicitly designed for this purpose. Here, one 12-mm-
long auxiliary channel (150×50 μm2, w×h) intersected with the mobilization channel just before the
ESI emitter tip (Figure 1B). To compensate for potential peak broadening, the microchannel turns of
the second chip design were tapered from the inner perimeter to a width of 30 μm. In addition, both
designs also incorporated dummy side channels that facilitated easier filling. Before use, thin PDMS
sheets with 2 mm inlet holes were attached on top of all chip inlets to delimit liquid spreading on the
chip surface.
2.3. Direct coupling of microchip capillary isoelectric focusing to mass spectrometry
The cIEF-ESI/MS experiments were performed using the microchip design depicted in Figure 1A. The
MS detection was performed on an ion trap 6330 MS (Agilent Technologies, Santa Clara, CA, USA)
equipped with a CCD camera and an xyz-aligning stage for chip mounting. The MS was operated in
positive ion mode with a capillary voltage of -1.6 kV, end-plate offset of -500 V, and a trap drive value
of 94.6. Nitrogen (Nitrogen generator system, Parker, Cleveland, OH) was used as the drying gas (4.0 l
min-1, +70ºC) and data was acquired over a mass range of m/z 100-2200 with a maximum accumulation
time of 100 ms. Data Analysis software was used for acquisition and data processing. An external μTK
4power supply (Micralyne Inc., Edmonton, AB) was used for application of the cIEF, mobilization, and
electrospray (ES) voltages through platinum wires placed in the microchannel inlets. Before analysis,
the separation and sheath liquid channels were filled with sample solution and sheath liquid,
respectively, by capillary flow. The sample solution contained the peptides dissolved in 2% ampholyte
solution (pH 3-10) including 25% methanol and the sheath liquid was methanol:water 80:20
incorporating 1% acetic acid (Figure 1A). After filling, the sample solution in the sample inlet (SI) was
replaced by the catholyte (1% ammonium hydroxide), whereas the sheath liquid also served as the
anolyte during cIEF. Focusing of the peptides was performed at 2400 V cm-1 applied between BI and
SLIs for 60 s, i.e., until an electrical current drop and stable reading was obtained. After focusing, the
catholyte in the SI was replaced by the background electrolyte (BGE, 20 mM ammonium acetate with
25% methanol) and the peptides were mobilized toward the MS by applying electric field strength of
800 V/cm between the SI and the SLIs. During the mobilization step, the excess electrical current was
grounded through a 50 M resistor coupled in parallel with the ES voltage power supply similar to a
previously described protocol [15].
2.4. Microchip capillary isoelectric focusing-transient isotachophoresis-mass spectrometry
The multiplex cIEF-tITP separations were performed using the microchip design depicted in Figure 1B.
The MS experiments were performed on an API365 triple-quadrupole MS (Perkin-Elmer Sciex,
Concord, ON, Canada) instrument equipped with an xyz-aligning stage and a CCD camera and operated
in positive ion mode using nitrogen generated by a Whatman 75-720 nitrogen generator (Haverhill,
MA) as the curtain gas. Data were recorded in full-scan MS mode with a dwell time of 350 ms per scan
and a mass range of m/z 100-950. Analyst 1.4 software was used for acquisition and data processing.
The high voltage (HV) instrumentation used for supplying the focusing, mobilization, and ES voltages
was similar to that used in the cIEF-ESI/MS experiments. Before analysis, the separation channels and
the auxiliary channel were filled with BGE (30 mM ammonium acetate with 30% methanol) and sheath
liquid (methanol:water 80:20 with 1% acetic acid), respectively, by capillary flow and vacuum suction.
After filling, the solution in the BI was replaced by BGE, the solution in the SI with sample solution
(peptides in 2% ampholyte solution with 0.33% TEMED), and the solution in the SLI with sheath
liquid. Inlet CA was filled with the catholyte (0.5-1% ammoniumhydroxide) and inlet AN with the
anolyte (1% formic –or acetic acid) (Figure 1B). Then, the cIEF channel was loaded with the sample
solution using electrokinetic flow at 500-1000 V cm-1 applied between reservoirs SI and BI for 100 s.
Next, cIEF was performed by switching the potential difference (E=500-2000 V/cm) between the CA
and the AN. Typically, a stable current reading was obtained in 200-270 s, which was considered
sufficient for the formation of the pH gradient and subsequent focusing of the peptides based on their
pI values. Last, the focused peptide zones were mobilized toward the MS by applying potential
difference between the BI (6 kV) and the SLI (3.5 kV). The voltage applied to the SLI served not only
as the counter voltage for the mobilization, but also as the ESI voltage (2.5 kV relative to MS). The
electrical currents, recorded by multimeters and the μTK Editor software, were used for monitoring of
the chip performance.
3. Results and discussion
In this study, two different chip designs were introduced to facilitate the online coupling of cIEF to on-
chip ESI/MS detection. The first design (Figure 1A) was used for direct EOF-driven mobilization (of
peptides focused by cIEF) to the MS via an integrated (two-sided) sheath flow interface. The second
design (Figure 1B) incorporated two subsequent, intersecting separation channels which allowed us to
perform peptide focusing by cIEF in the first dimension (effective L=20 mm) and then tITP separation
during mobilization through the second dimension (L=35 mm). Also in this case, EOF-driven
mobilization and an integrated (one-sided) ESI sheath flow interface were used. The performances of
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by monitoring the stability of the electrical currents during sample loading, focusing (cIEF), and
mobilization.
3.1.  Direct coupling of microchip capillary isoelectric focusing to mass spectrometry
The separation chip pictured in Figure 1A was used for direct coupling of cIEF to ESI/MS detection. It
comprised a symmetrical (two-sided) sheath flow interface which allowed us to feed sheath liquid to
the ESI tip from both sides of the separation channel. The organic sheath flow enhances the ES
ionization process, especially when running buffers/samples contain high amounts of water. Here the
sheath liquid also minimized major background interferences due to the carrier ampholytes and as a
result, the carrier ampholytes were not observed when the cIEF pattern was mobilized to the MS
(Figure 2). The acidic sheath liquid also served as the anolyte during cIEF so that the pH gradient (pH
3-10), along with the focused peptides, could be directly run to the MS after focusing. As a result, the
model compounds, angiotensins I (pI=7.70) and II (pI=7.54) [19] migrated at about tmigr=23 s (Figure
2). Although the two angiotensins did not separate from each other because of their very similar pI
values, they migrated as sharp, focused bands with peak capacity of about 86 indicating that efficient
focusing takes place during the cIEF step.
This setup was somewhat similar to that previously published for protein separation by on-chip cIEF
[20]. However, in our work, purely EOF-driven mobilization was used instead of hydrodynamic
(pressure-driven) flow mobilization used in the previous work. Here, the possibility to use EOF-driven
mobilization, and thus avoid the complex coupling to external pumps, was facilitated by the fact that
our microchips were made of SU-8 polymer whose surface charge is inherently pH-dependent; basic
buffers maintain cathodic- and acidic buffers anodic EOF [17]. Thus, the flow direction close to the
anode (low pH) is opposing to that at the cathode (high pH) so that the net velocity in the SU-8-based
channel during cIEF approaches zero. With most other microchip materials (or conventional silica
capillaries), the cIEF separation channels need to be coated in order to eliminate the EOF.
Alternatively, if not fully eliminated, the EOF should be significantly reduced to allow for complete
focusing of the analytes before they migrate to the detector [21]. The advantage of having uncoated
(charged) surfaces arise from the fact that, after focusing, EOF can be used for mobilization instead of
pressure-driven flow. The pH-dependent surface charge of SU-8 was thus an excellent fit for the
purpose so that EOF could be eliminated during cIEF and reverted for EOF-driven mobilization by
simply switching the potential difference (Figure 1A) and replacing the catholyte in the SI with BGE.
Thanks to the relatively short separation channel, the cIEF focusing time in this work was also
significantly shorter (60 s) compared to that applied (~10 min) in the previous work in which a 16-cm-
long cIEF channel was used [20]. Of great importance is also the fact that the cIEF-ESI/MS
experiments could be performed by using the same microchannel configuration as previously used for
MCE-ESI/MS experiments by our group [10, 12, 13, 18]. This enables straightforward switching
between microchip cIEF and MCE separation modes so that the best selectivity and resolving power
are obtained for each type of sample.
3.2. Multiplex capillary isoelectric focusing and transient-isotachophoretic separation
Although feasible, direct coupling of microchip cIEF to ESI/MS is somewhat limited in terms of
suitable solvents. Namely, only volatile acids with high organic content can be used as anolyte solution
with setups similar to that presented in Figure 1A. Obviously, the resolving power of two compounds
with very similar pI values (like angiotensins I and II) is also very challenging. Therefore, we
developed a new two-dimensional separation chip in which cIEF separation (first dimension) was
followed by tITP separation taking place in a subsequent separation channel (second dimension) during
mobilization (Figure 1B). In this design, the anolyte composition is not limited to MS compatible
solvents because this inlet is only active during cIEF focusing and the anolyte solution is never
6mobilized toward ESI/MS detection. Thus, nonvolatile salts and aqueous acids/bases can also be used
as anolytes, which often improves the stability of (the formation of) the pH gradient. However, filling
of such a complex network of intersecting microchannels with multiple different solutions is somewhat
challenging by using capillary flow. Therefore, we developed an electrokinetic sample loading protocol
to facilitate straightforward filling of the chip with the ampholyte solution between the running buffer
prior to cIEF-tITP separations.
Before analysis, all separation microchannels were filled with the same running buffer by capillary
flow and vacuum suction. The sample in 2% ampholyte solution was then loaded only into the cIEF
part (SI↔BI) using electrokinetic flow as described in Figure 1B (i.e., loading step). In order to
understand and monitor the electrokinetic migration taking place, the electrical current was monitored
during the loading process as well as during focusing and mobilization steps (Figure 3). A closer
examination of the current profile during the loading step suggests that, in addition to filling of the
cIEF channel, tIEF takes place already during the loading step. Namely, during the first 25 s, the total
amount of charges decrease indicating filling of the cIEF channel with ampholyte solution and
simultaneous formation of the pH gradient by the carrier ampholytes in the sample plug entering the
cIEF channel. As a result, the sample components and the carrier ampholytes start to arrange according
to their pI already during the loading step which allows for relatively short focusing times in the
following cIEF step. However, a subsequent current increase is observed between 45 and 55 s (Figure
3), which indicates progressive migration of the acetate counter-ions from the BI into the cIEF channel.
This in turn results in drift in the pH gradient and slow fluctuation of the electrical current between 50
and 100 s (Figure 3), similar to earlier work performed with conventional CE capillaries [22].
Therefore, the sample components (or the carrier ampholytes) do not readily reach their true isoelectric
points during the loading step, but are stacked isotachophoretically based on both their pI values and
intrinsic electrophoretic mobilities (μEP) [22, 23]. Thus, the cIEF arrangement must be finalized during
the second focusing step (Figure 3) by switching the potential difference between the anolyte (AN) and
the catholyte (CA). Here, 1% formic acid or acetic acid was used as the anolyte while the catholyte was
0.5-1% ammoniumhydroxide. These solutions provide opposing EOF and thus zero net velocity
between inlets AN and CA similar to that described for the one-dimensional chip design. Further
examination of the current profile during the focusing step (Figure 3) indicates formation of a more
stable pH gradient within about 60 s as evidenced by the continuous current drop with a steady state
current levelling off at around 15 μA (Figure 3). The repeatability of the steady state current between
repeated runs (n=6) was 8.9% RSD.
Once focusing is complete, the pH gradient is mobilized toward the MS using electrokinetic flow
similar to the one-dimensional design, i.e., by switching potential difference between BI and the SLI.
However, in this case, the sample plug (i.e., the pH gradient) is preceded and followed by a relatively
long plug of the running buffer which acts as a leading electrolyte (LE). Accordingly, the ampholyte
solution acts as the terminating electrolyte (TE) sandwitched between two LE zones similar to tITP
[22]. As a result, instead of just mobilizing a pure cIEF gradient toward the MS, the separation mode
during the mobilization step is more likely tITP so that the observed migration order is affected by both
the pI value and the intrinsic electrophoretic mobility of the sample component. After cIEF focusing
the back of the ampholyte (TE) plug starts to dissolve into the running buffer (LE) because the faster
BGE ions overcome the ampholyte ions. As a result, the analyte ions migrate (according to their μEP)
and focus at the front interface between the ampholyte (TE) and the running buffer (LE). Finally, when
all ampholyte ions are dissolved, the analyte ions are separated according to the principles of zone
electrophoresis. The pI values mainly determine the position of the sample components in the cIEF
channel, and thus their (individual) effective separation length from the cIEF channel to the ESI tip.
The intrinsic electrophoretic mobilities (in the ampholyte solution), in turn, determine the speed in
which each sample component is migrating toward the MS and the resulting migration order is
dissimilar from both pure cIEF and pure ITP. This is clearly illustrated with the separation of histidine
7(pI=7.55) [19] and angiotensin I (pI=7.70) [19] in Figure 3. Although the pI values are very close to
each other (pI=0.15), these two compounds are baseline-resolved (RS=1.9)  thanks  to  their  very
different size and thus, different intrinsic electrophoretic mobilities.
In this case, the electrophoretic mobility is not affecting the migration order of histidine and
angiotensin I, which migrate in order of increasing pI, as expected. Instead, the effect of the
electrophoretic mobility on the migration order becomes more prominent, when analyzing a mixture of
five peptides with greater distribution in the pI values, namely bradykinin (fragment 1-5, pI=10.55),
angiotensin III (pI=9.35), substance P (fragment 6-11, pI=7.81), angiotensin I (pI=7.70), and
angiotensin II (pI=7.54) [19]. In order to prevent the most basic pH range from shifting in a distal
region of the microchannel (i.e., beyond the Y intersection close to inlet CA), TEMED was added to a
final concentration of 0.33% (v/v) in the 2% ampholyte solution [24, 25]. As a result, the theoretical
position of pH 10 was 3.3 mm downstream from the Y intersection. Under these conditions, the most
basic peptide, bradykinin (pI=10.55),  migrates  and  focuses  to  the  interface  of  TEMED  and  the
ampholyte solution (pH 10) after which it is diffused into the TEMED zone (Figure 4). The theoretical
position of the other peptides after the focusing step is given according to their pI values in Figure 4.
However, now, the observed migration order of the five model peptides does not follow the order of
increasing pI, but is largely affected by the peptides’ intrinsic electrophoretic mobilities. For instance,
angiotensin III and substance P (fragment 6-11), which both show relatively high cathodic
electrophoretic mobilities, are able to bypass angiotensins I and II (featuring slow anodic mobilities in
the ampholyte solution) during the mobilization step (Figure 4). Instead, bradykinin, which also shows
high cathodic mobility, but is trapped in the TEMED zone based on its pI value, will not catch the
angiotensins I and II and migrates last. Therefore, the coupling of cIEF separation with electrokinetic
mobilization (in tITP mode) as presented in this study provides different kind of selectivity for the
separation than tITP alone. Although the migration order of such multiplex cIEF-tITP separation is
difficult to predict theoretically, it was shown to be very well repeatable in terms of the migration times
that were within 3.1-6.8% RSD (n=3) for all of the peptides.
A closer examination of the bradykinin peak shape also evidences that cIEF arrangement has indeed
taken place during the focusing step: the sharp front of the bradykinin peak indicates focusing to the
borderline of TEMED (based on pI), whereas the tailing peak is due to diffusion into the TEMED zone
(during cIEF once the electrophoretic mobility has ceased). Comparison of the peptides’ intrinsic
electrophoretic mobilities in the plain BGE and in the 2% ampholyte solution also reveals that addition
of ampholytes into the running buffer not only has a clear impact on the resulting EOF (2.510-4 cm2
(Vs)-1  1.410-4 cm2 (Vs)-1), but also on the electrophoretic mobilities. This is particularly the case of
angiotensins I and II, which shift from cathodic to anodic mobility. As a result, three peptides with
nearly identical pI (i.e., angiotensin II, pI=7.54; angiotensin I, pI=7.70; substance P, fragment 6-11,
pI=7.81 [19]) are efficiently resolved in multiplex cIEF-tITP mode (Figure 4).
4. Conclusions
In this work, we have addressed the challenges of the combination of microchip cIEF with online, on-
chip ESI/MS detection by coupling of the two via an immediate on-chip sheath flow ESI interface. The
robustness of the developed setup was shown by coupling the chips to two different types of mass
analyzers, namely an iontrap and a triple quadrupole mass spectrometer. The pH-dependent surface
charge of the SU-8 polymer used for microchip fabrication enabled EOF-driven mobilization (high pH)
on one hand and elimination of EOF (low pH) for successful cIEF in native channels without any
surface pretreatment on the other hand. In all, our results clearly emphasize the potential of microchip-
based cIEF-ESI/MS in peptide analysis. In addition to direct coupling of cIEF separation to on-chip
ESI/MS, parallel microfabrication technology applied herein facilitates construction of relatively
8complex, yet dead-volume-free fluidic networks featuring multiple intersecting microchannels that can
be exploited to multiplex separations not feasible for conventional capillary systems, like the
combination of cIEF-tITP demonstrated in this work. An obvious challenge of the multiplex cIEF-tITP
approach presented is the fact that the theoretical migration order is difficult to predict based on pure
cIEF or pure ITP separation rules. This is, however, not a limiting factor in case the microchip setup is
combined with MS detection capable of identifying the sample components based on their mass-to-
charge ratios. In return, additional selectivity and increased resolving power can be obtained compared
to pure cIEF or pure ITP (or zone electrophoresis) separation modes alone. To our knowledge, there are
very few prior reports on the combination of cIEF and ITP on chip or on the microchip cIEF-MS
coupling in general.
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(A)
(B)
Figure 1. SU-8-based microchips. Schematic views of the SU-8 microchips used (A) for direct
coupling of cIEF to on-chip ESI/MS and (B) for multiplex cIEF-tITP separation coupled to on-chip
ESI/MS together with high voltage sequences used. In (A), filling of the separation channel with the
sample solution was done by capillary flow from the sample inlet (SI), after which the focusing
potential was applied between the sheath liquid inlets (SLI, anolyte/sheath liquid) and the SI
(catholyte). Mobilization of the peptides toward the MS was done by changing the solution in SI to the
background electrolyte (BGE) and switching on the mobilization voltages. In (B), loading, cIEF, and
mobilization were performed electrokinetically with the voltages given in the table. BI=buffer inelt.
SI=sample inlet. CA=catholyte. AN=anolyte. SLI=sheath liquid inlet.
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Figure 2. Microchip cIEF-ESI/MS of angiotensins I and II. Schematic illustration of the theoretical
position of angiotensin I (AngI) and II (AngII) after cIEF separation and extracted ion
electropherograms  (EIE)  of  the  same  peptides  (both  0.2  mg  mL-1) following cIEF separation,
mobilization, and ESI/MS detection performed using the chip design depicted in Figure 1A. The size of
the circles in the schematic illustration assimilates the molecular masses of the peptides. Time t=0 s in
the EIE corresponds to the end of the focusing step and start of the mobilization step. The focusing was
performed in 2% ampholyte solution (pH 3-10) including 25% methanol at 2400 V cm-1 for 60 s. The
mobilization was done by feeding BGE (20 mM ammonium acetate with 25% methanol) from the SI at
E=800 V cm-1. The mass spectrum recorded at t=23 s (insert on the right, no background subtraktion)
shows abundant protonated ions of AngI and AngII and negligible background interference due to the
carrier ampholytes.
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Figure 3. Electrical current profiles. The electrical current profiles (average from six repeated runs)
during sample loading (SI→BI), focusing (AN→CA), and mobilization (BI→SLI) along with the EIEs
of histidine (His, 100 μM, [M+H]+=156.0) and angiotensin I (AngI, 100 μM, [M+2H]2+=649.8)
separated by cIEF-tITP-ESI/MS. The anolyte (AN) was 1% acetic acid, the catholyte (CA) 1%
ammoniumhydroxide, the BGE (BI) 30 mM ammonium acetate with 30% methanol, and the sheath
liquid (SLI) methanol:water 80:20 with 1% acetic acid.
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Figure 4. Multiplex cIEF-tITP-ESI/MS of peptide standards. Schematic illustration of the
theoretical position of bradykinin fragment 1-5 (BK1-5), angiotensin III (AngIII), substance P fragment
6-11 (SP6-11), angiotensin I (AngI), and angiotensin II (AngII) following cIEF. The size of the circles
assimilates the molecular masses of the peptides. The theoretical ITP migration order is given based on
the intrinsic electrophoretic mobilities (μEP) measured in conventional silica capillaries by injecting
peptides in the running buffer or in the 2% ampholyte solution (see Supplementary data). The extracted
ion electropherograms (EIE) of the same peptides from multiplex cIEF-tITP analysis, performed with
the two-dimensional chip, design show both the focusing (200 s at 1333 V cm-1) and mobilization (417
V cm-1) steps. Loading of the cIEF channel with the sample solution was performed at 1000 V cm-1 for
100 s. The sample solution contained peptides (each 100 μM), 2% ampholyte (pH 3-10), and 0.33%
TEMED. The anolyte was 1% formic acid, the catholyte was 0.5% ammoniumhydroxide while the
running buffer and the sheath liquid were according to Figure 3. The EIE of angiotensin I has been
background subtracted with respect to the background ions m/z=648.0 and m/z=650.2. Time t=0 s in the
electropherograms corresponds to the end of the focusing step (also indicated with dashed line).
1Supplementary data
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2Determination of electrophoretic mobilities (μEP)
Materials and methods
Chemicals
Coumarin used as an electroosmotic flow (EOF) marker was purchased from Sigma Aldrich
(Steinheim, Germany). All other chemicals were the same as those reported in the Materials and
methods section in the main paper.
Instrumentation
The capillary electrophoresis (CE) instrumentation used for determination of the electrophoretic
mobilities (μEP) of the peptides was a P/ACE MDQ CE equipment (Beckman Instruments, CA, USA)
equipped with a UV detector (λabs= 214 nm) and temperature control units for the capillary and
samples. The fused silica capillary (I.D. 50 μm, O.D. 375 μm, length 47 cm) was purchased from
Composite Metal Services (Werchester, UK). Hydrodynamic injections (15 s, 0.5 psi (3.4 kPa)) were
performed in duplicate. The effective separation length was 40 cm and the separation voltage applied
was 25 kV (532 V cm-1). The background electrolyte (BGE) was 30 mM ammonium acetate with 30%
methanol. Before use the capillary was conditioned sequentially with 0.1 M NaOH containing 30%
methanol, water:methanol 70:30 (v/v), and BGE by flushing at 20 psi (137.9 kPa) for 15 min each.
Between analyses the capillary was flushed with BGE at 20 psi for 2 min.
Calculation of the electrophoretic mobilities (μEP)
The μEP of a component, i, in an electric field can be expressed by Equation (S1):
3𝜇ா௉,௜ = 𝜇௔௣௣,௜ − 𝜇ாைி = ௅ವ௧೔∙ா −
௅ವ
௧ಶೀಷ∙ா =
௅ವ
ா ቀ
ଵ
௧೔ −
ଵ
௧ಶೀಷቁ (S1)
where μapp is the net mobility of component i [cm2 (Vs)-1], μEOF is the mobility of the electroosmotic
flow [cm2/Vs], LD is the effective separation length [cm], ti is the migration time of component i [s],
tEOF is the migration time of the EOF marker, coumarin [s], and E is the electric field strength [V cm-1].
The μEP:s of the five peptide standards used were determined by injecting them in the BGE (30 mM
ammonium acetate with 30% methanol) or in 2% ampholyte solution (pH range 3-10) including 0.33%
N, N, N´, N´-tetramethylethylenediamine (TEMED) (Table S1). The running buffer was the same in
both cases (i.e., the BGE, 30 mM ammonium acetate with 30% methanol).
Table S1. The electrophoretic mobilities (μEP) of the five model peptides used in the study as
determined by conventional CE-UV instrument.
Peptide
pI* μEP in BGE [cm2
(Vs)-1]
μEP in ampholyte
[cm2 (Vs)-1]
Bradykinin 1-5 10.55 5.27×10-5 6.19×10-5
Angiotensin III 9.35 4.27×10-5 6.76×10-5
Substance P 6-11 7.81 3.53×10-5 4.21×10-5
Angiotensin I 7.70 1.98×10-5 -6.16×10-6
Angiotensin II 7.54 4.15×10-6 -1.24×10-5
*derived from GenScript Peptide Property Calculator (https://www.genscript.com/ssl-
bin/site2/peptide_calculation.cgi)
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a b s t r a c t
Monolithically integrated, polymer (SU-8) microchips comprising an electrophoretic separation unit, a
sheath ﬂow interface, and an electrospray ionization (ESI) emitter were developed to improve the speed
and throughput of metabolism research. Validation of the microchip method was performed using bufu-
ralol 1-hydroxylation via CYP450 enzymes as the model reaction. The metabolite, 1-hydroxybufuralol,
was easily separated from the substrate (Rs = 0.5) with very good detection sensitivity (LOD=9.3nM),
linearity (range: 50–500nM, r2 = 0.9997), and repeatability (RSDArea = 10.3%, RSDMigration time = 2.5% at
80nM concentration without internal standard). The kinetic parameters of bufuralol 1-hydroxylation
determined by the microchip capillary electrophoresis (CE)-ESI/mass spectrometry (MS) method, were
comparable to the values presented in literature as well as to the values determined by in-house liquid
chromatography (LC)-UV. In addition to enzyme kinetics, metabolic proﬁling was demonstrated using
authentic urine samples from healthy volunteers after intake of either tramadol or paracetamol. As a
result, six metabolites of tramadol and four metabolites of paracetamol, including both phase I oxida-
tion products and phase II conjugation products, were detected and separated from each other within
30–35 s. Before analysis, the urine samples were pre-treated with on-chip, on-line liquid-phase microex-
traction (LPME) and the results were compared to those obtained from urine samples pre-treated with
conventional C18 solid-phase extraction (SPE, off-chip cartridges). On the basis of our results, the SU-8
CE-ESI/MS microchips incorporating on-chip sample pre-treatment, injection, separation, and ESI/MS
detection were proven as efﬁcient and versatile tools for drug metabolism research.
© 2010 Elsevier B.V. All rights reserved.
1. Introduction
Oneof themajor reasons for the terminationof thedevelopment
of potential drug candidates is their poor adsorption, distribution,
metabolism, and excretion (ADME) properties. To prevent expen-
sive terminations in late clinical stages, much effort needs to be
expended to investigate the ADME characteristics as early in the
drug discovery process as possible [1]. Metabolic proﬁling of new
drug candidates is particularly important and includes not only
identiﬁcation of metabolites, but also screening of their proper-
ties, such as stability and toxicity [2]. Also screening of drug–drug
interactions and determining the kinetic parameters of the drug
metabolism are equally important [2]. In these types of analy-
ses, the key issue is high throughput and therefore the analytical
∗ Corresponding author. Tel.: +358 9 19159169; fax: +358 9 19159556.
E-mail address: tiina.sikanen@helsinki.ﬁ (T. Sikanen).
method should be as fast as possible. Sometimes the amounts of
the metabolites are extremely low and thus, highly speciﬁc and
sensitive analytical methods are also required.
Presently, most metabolism assays are performed by gas (GC)
– or liquid (LC) chromatography combined with mass spectrom-
etry (MS) or by nuclear magnetic resonance (NMR) spectroscopy
[3,4]. Since a vast majority of metabolites are polar and ionic, capil-
lary electrophoresis (CE) is another approach for the separation of
metabolites, in addition to LC analysis. Microchip CE in particular
provides signiﬁcant improvement in terms of fast analysis times
and enables direct coupling to electrospray ionization (ESI)/MS
which eventually results in high sensitivity and good selectivity.
Although microchip CE with electrochemical [5,6] or optical [7–9]
detection has occasionally been applied to metabolism research,
the use of MS detection is still rare. Even though most microchip
methodsprovide considerable increase regarding speedof analysis,
the time-consuming (off-chip) sample pre-treatment often pro-
longs the total analysis time. Typically, complexbiologicalmatrices,
0021-9673/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
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Fig. 1. Schematic illustration of the on-chip droplet-membrane-droplet LPME sys-
tem on top of an SU-8 CE-ESI/MS microchip. The sample solution was alkaline
(30mMNaOH, pH11.4) urine. The acidic (0.1% formic acid, pH 2.7) acceptor solution
contained 100M verapamil as an internal qualiﬁer. SI = sample inlet.
such as urine, require extensive and laborious clean-up before
analysis. Thus, integration of sample pretreatment with injection,
separation and detection on a single microchip increases sample
throughput and approaches the TAS (micro total analysis sys-
tems) concept [10].
Today, modern lithographic and adhesive bonding techniques
enable mass production of very complex and accurately deﬁned
microstructures on highly integrated devices [11]. Recently, the
epoxy-based negative photoresist SU-8 has shown to be a very
suitable material for microchip production [12–15]. It is easily
patterned by standard photolithography, it has excellent ther-
mal and mechanical properties, and it is also stable against many
acids, bases and solvents. In this work, highly integrated CE-ESI/MS
microchips were fabricated from SU-8 polymer so that all criti-
cal structureswere simultaneously patterned by photolithography.
SU-8 microfabrication technology relies on photolithography and
wafer-level bonding, an approach that enables production of
tens of identical chips on one wafer [12,16]. Also reproducibil-
ity from wafer-to-wafer and batch-to-batch is very good [17].
Here, the applicability of the microchips to metabolism research
was ﬁrst demonstrated by determining the kinetic parameters of
the cytochrome P450 (CYP) mediated bufuralol 1-hydroxylation
by microchip CE-ESI/tandem MS (MS/MS). In addition, authen-
tic urine samples were screened for metabolites of tramadol and
paracetamol by microchip CE-ESI/MS after on-chip liquid-phase
microextraction (LPME). To the best of our knowledge, CE-ESI/MS
microchips have not been previously used in drug metabolism
research, which is highly demanding because of the need for
very low detection limits and highly reproducible and quantita-
tive determination of the produced metabolites. Instead, most of
Fig. 2. (A) Schematic view of the ﬂuidic design of the SU-8 CE-ESI/MS microchip
(dimensions not to scale) and (B) photograph of the SU-8microchip. BI = buffer inlet,
SI = sample inlet, SW=sample waste, SLI = sheath liquid inlet.
Fig. 3. Michaelis–Menten kinetics of the CYP450 mediated bufuralol metabolism
to 1-hydroxybufuralol in HLM determined by microchip CE-ESI/MS in SRM mode.
The separation was performed under electric ﬁeld strength of 750V/cm in 30mM
ammonium acetate with 50% methanol as BGE and 80% methanol–20% water with
1% acetic acid as sheath liquid. The substrate concentration ranged from 12.5 to
400M and all incubations were done in duplicate at each substrate concentration.
the previous work has gone into development of microchips for
qualitative protein analysis [18–20].
2. Materials and methods
2.1. Chemicals
Bufuralol was obtained from Roche (Basel, Switzerland),
1-hydroxy bufuralol was from Ultraﬁne Chemicals (Manch-
ester, England), paracetamol was from Orion Pharma (Espoo,
Finland), paracetamol glucuronide and verapamil hydrochloride
were from Sigma–Aldrich (Steinheim, Germany), and tramadol
as well as the metabolites O-desmethyltramadol (M1), N,O-
didesmethyltramadol (M5) were kindly donated by the Depart-
ment of Forensic Medicine, University of Helsinki, Finland. Human
liver microsomes (HLM) were purchased from BD GentestTM
(Erembodegem, Belgium) and nicotinamide adenine dinucleotide
phosphate-oxidase (NADPH) was from Sigma–Aldrich. Acetic acid,
formic acid, ammonium formate and 1-methoxy-2-propyl acetate
(PMA) were all purchased from Sigma–Aldrich, sodium hydroxide
andmethanolwere from J.T. Baker (Deventer, Holland), acetonitrile
was from VWR (Espoo, Finland), hydrochloride and sodium phos-
phate from Riedel de Haen (Seelze, Germany), and 1-octanol and
ammonium acetate were from Fluka (Buchs, Switzerland). Water
was puriﬁed with a Milli-Q water puriﬁcation system (Millipore,
Molsheim, France).
2.2. Enzyme incubations
The kinetic parameters of the bufuralol 1-hydroxylation in HLM
were determined by monitoring the CYP mediated reaction dur-
ing incubation at 37 ◦C for 60min. The incubation conditions were
optimized in-house (data not shown) and six different substrate
concentrations were used, i.e., 12.5, 25, 50, 100, 200 and 400M
(two replicates of each). The incubationmixture (100L) contained
bufuralol (12.5–400M), 50mMsodiumphosphatebuffer (pH7.4),
HLM (0.8mg/mL) and NADPH (1mM), and the reaction was ter-
minated by the addition of 100L of ice-cold acetonitrile. After
removal of the proteins by centrifugation (5min, 13,000 rpm), the
supernatant was analyzed without further treatment. Blank sam-
ples were prepared without NADPH, HLM or substrate as well as
with zero incubation time. GraphPad Prism 5.01 was used for data
processing.
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Fig. 4. Extracted ion electropherograms (EIE) of tramadol and its metabolites detected from a human urine sample and separated by microchip CE-ESI/MS after SPE (5-fold
preconcentration). The BGE was 30mM ammonium acetate with 50% methanol and the sheath liquid was 80% methanol–20% water with 1% acetic acid. The electric ﬁeld
strengths during injection (20 s) and separation were 1000 and 800V/cm, respectively.
2.3. Urine samples
Urine samples were collected from two healthy volunteers 4h
after paracetamol (500mg) intake or 12h after tramadol (50mg)
intake. Urine samples were stored frozen at −20 ◦C until use and
pretreated either by off-chip solid-phase extraction (SPE) or by on-
chip LPME before analysis.
2.4. Off-chip solid phase extraction
Two different SPE extraction sorbents were used for the urine
samples containing paracetamol or tramadol metabolites. For
paracetamol samples, an Isolute MF C18, 100mg reversed phase
cartridge (International Sorbent Technology Ltd., Mid Glamorgan,
U.K.) was conditioned with 1mL methanol and balanced with 1mL
of 50mM HCl in 2% methanol. One milliliter of paracetamol urine
was acidiﬁed with 50L of 1M HCl and slowly loaded onto the
cartridge and washed with 1mL 10mM HCl. The analytes were
eluted with 1.5mL of methanol. For tramadol urine samples an
Oasis HBL, 30mg cartridge (Waters, Milford, MA, USA) was con-
ditioned with 1mL of methanol and 1mL of water. The tramadol
urine sample (1mL) was slowly loaded onto the cartridge and
washed with 1mL of water. Elution was performed with 1mL of
methanol. The extracts of both the tramadol and paracetamol urine
were evaporated to dryness under nitrogen and the residues were
reconstituted in 200L of 10mM ammonium acetate containing
50% methanol (5-fold concentration).
2.5. On-chip liquid-phase-microextraction
On-chip LPME was performed as previously described [21] and
as illustrated in Fig. 1. An aliquot of 2L of 0.1% formic acid (pH
2.7) with 100M verapamil as an internal qualiﬁer (acceptor solu-
tion) was applied to the sample inlet (SI) of the SU-8 CE-ESI/MS
microchip (Fig. 2). A 5mm×5mm piece of a Celgard 2500 micro-
porous polypropylene membrane (Celgard, Charlotte, NC, USA)
with a25mthickness, 55%porosity, and0.21m×0.05mpores
was wetted with 1-octanol and placed on top of the acceptor solu-
tion. Finally, 4L of alkaline tramadol urine sample (30mMsodium
hydroxide, pH 11.4, donor solution) was applied on top of the
membrane to initiate extraction. After 5min, the polypropylene
membrane was removed and a platinum electrode was placed in
the acceptor solution in the SI. The injection voltages were imme-
diately applied and the injection was performed in pinched mode
for 60 s before application of the CE separation voltages.
2.6. Microchip capillary electrophoresis
The microchips comprising a monolithically integrated injec-
tion and separation unit, a sheath ﬂow interface and an ESI emitter
were fabricated entirely of epoxy photoresist SU-8 using pho-
tolithography and adhesive bonding techniques as reported earlier
[12,13]. The effective separation length of the CE chip was 2 cm.
Other microchannel dimensions are given in Fig. 2. Before use,
poly(dimethylsiloxane) (PDMS) sheets with 2mm inlet holes were
attached on top of the SU-8 chips to increase the inlet volumes. On
the microchips that were used for the LPME experiments, the SI
(Fig. 2) was left uncovered.
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Fig. 5. Extracted ion electropherograms (EIE) of paracetamol and its metabolites detected from a human urine sample and separated by microchip CE-ESI/MS after SPE
(5-fold preconcentration). The BGE was 30mM ammonium acetate with 50% methanol and the sheath liquid was 80% methanol–20% water with 1% acetic acid. The electric
ﬁeld strengths during injection (20 s) and separation were 1000 and 500V/cm, respectively.
Fig. 6. Extracted ion electropherograms (EIE, M9, M1 and tramadol) and selected reaction monitoring (SRM) electropherogram (M5) of tramadol and its metabolites detected
from a human urine sample and separated by microchip CE-ESI/MS or MS/MS after on-chip LPME (2-fold preconcentration). The LPME was performed from alkaline urine
(NaOH 30mM, pH 11.4) into acidic acceptor solution (0.1% formic acid, pH 2.7) for 5min followed by injection (60 s, 1000V/cm) and separation (750V/cm) in 30mM
ammonium formate with 50% methanol. The sheath liquid consisted of 80% methanol–20% water with 1% formic acid. LogD and pKa values were derived from the online
MarvinSketch chemical editor at www.chemaxon.com.
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The samples were injected electrokinetically (20–60 s) in
pinched injectionmodewith an electric ﬁeld strength of 1000V/cm
applied between the SI and the sample waste (SW). Simultane-
ously, a small focusing potential was applied to the buffer inlet
(BI) to avoid sample leakage into the separation channel (Fig. 2).
The sheath liquid inlet (SLI) was left ﬂoating during injection so
that no spray was produced. The CE separations were performed
in cathodic mode using electric ﬁeld strengths of 500–800V/cm
between the BI and SLI. In addition, small push-back voltages
were applied to the SI and SW. The background electrolyte (BGE)
consisted of 30mM ammonium acetate (pH 7.0) or ammonium
formate (pH 6.4) with 50% methanol, while the sheath liquid was
methanol:water 80:20 (v/v) with 1% acetic or formic acid, respec-
tively.
2.7. Mass spectrometry
The microchips were placed on an xyz-aligning stage in front
of an API3000 or an API365 triple–quadrupole MS (Perkin-Elmer
Sciex, Concord, ON, Canada). An external power supply (Micralyne
Inc., Edmonton, Canada) was used for application of the injection,
separation and electrospray (ES) voltages through platinum wires
placed in the liquidﬁlled inlets. TheMSwas operated inpositive ion
mode with an ES voltage of 3.6 kV (relative to MS) applied through
the SLI. This voltage also served as the counter voltage for the CE
separation. The separation current was divided at the sheath ﬂow
intersection into the ES and the auxiliary channel from where the
excess current was led to ground through a 50M resistor coupled
in parallel with the ES voltage power supply. Data were recorded
in full-scan MS mode (metabolic proﬁling) with a dwell time of
300ms per scan and a mass range of m/z 50–500 or in selected
reaction monitoring (SRM) mode (enzyme kinetics) with a dwell
time of 50ms per selected precursor/product ion pair. Analyst 1.4
software was used for data acquisition and processing.
2.8. High performance liquid chromatography (a reference
method)
In addition to microchip CE-ESI/MS, the kinetic parameters of
the bufuralol 1-hydroxylation were determined based on con-
ventional high performance liquid chromatography (HPLC)-UV
analysis. The HPLC instrument was an Agilent 1100 (Agilent Tech-
nologies, Palo Alto, CA, USA) equipped with an autosampler and a
UV multiple wavelength detector. The HPLC separation was per-
formed by reversed phase chromatography using a Zorbax Eclipse
Plus C18 column (5m, 150mm×4.6mm, Agilent Technologies,
Palo Alto, CA, USA). The injection volume was 20L and the eluent
consisted of 0.1% formic acid (A) and methanol (B) with a gradient
proﬁle from 20% to 90% B in 6min followed by 90% B for 5min.
The ﬂow rate was 1mL/min and the UV detection wavelength was
250nm.
3. Results and discussion
The performance of the SU-8 microchips in quantitative CE-
ESI/MS analysis was validated using 1-hydroxy bufuralol as a
standard. The limit of detection (LOD, S/N=3) and limit of quan-
titation (LOQ, S/N=10), as per the ICH guidelines, were 9.3 and
31.2nM, respectively. This corresponds to sample amounts of only
0.42 and 1.4 attomol for LOD and LOQ, respectively, as per injection
volume of 45pL (determined by the volume of the intersection of
the separation and the injection channels). The regression coef-
ﬁcient (r2) in the concentration range 50–500nM was 0.9997
indicating good linearity. At best, the relative standard devia-
tions (RSD, at 80nM, n=5) of the peak area and the migration
time were 10.3% and 2.5%, respectively, which indicated relatively
good quantitative performance of the microchip-based system
even without the use of an internal standard. All values were
determined using SRM mode with the selected precursor (proto-
nated 1-hydroxybufuralol)/product ion pairs of m/z 278.1→242.0
([M+H-2H2O]+) and 278.1→186.1 ([M+H-2H2O-C(CH3)3]+).
3.1. Enzyme kinetics
Bufuralol is a fairly speciﬁc substrate of the CYP2D6 enzyme and
thus bufuralol 1-hydroxylation is often used as a model reaction
to determine the activity of this CYP isoenzyme [22,23]. How-
ever, few other CYP enzymes, of which the two most important
are CYP1A2 [24] and CYP2C19 [25], also exhibit minor bufuralol
1-hydroxylase activity in addition to CYP2D6. In this study, we
determined the kinetic parameters (Km and Vmax) of bufuralol
1-hydroxylation in HLM in order to demonstrate the applica-
bility of the SU-8 microchips to enzyme kinetics studies. The
kinetic parameters of the bufuralol 1-hydroxylation in HLM were
determined by the developed microchip CE-ESI/MS/MS method.
As a result, the CYP mediated metabolism was shown to follow
Michaelis–Menten kinetics with Km and Vmax values of 55M
and 147pmol/min/mg protein, respectively (Fig. 3). These kinetic
parameters compare very well with the values determined by
in-house HPLC-UV (Km =31M, Vmax =185pmol/min/mg protein)
and also with the literature values for Km of 50–250M [24]
and for Vmax of 60–240pmol/min/mg protein [25]. In contrast to
conventional HPLC analysis, the SU-8 CE-ESI/MS microchips offer
signiﬁcantly improved speed of analysis and lower sample con-
sumption. Here, the migration time of 1-hydroxybufuralol and
bufuralol were only 20.6 s and 22.5 s, respectively, while the cor-
responding retention times with the in-house HPLC-UV method
were 5.0min and 6.5min. In addition, the microchip CE-ESI/MS
consumes only few tens of picoliters of sample (here approxi-
mately 45pL) while a typical injected volume in HPLC is tens of
L (here 20L). Instead, the actual volumes of sample needed for
the microchip CE-ESI/MS analysis (here 3L applied to the sample
inlet) and the HPLC-UV analysis (here 30–40L in the sample vial)
largely depend on the injector geometry and typically differ from
each other by an order of magnitude.
3.2. Analysis of urine samples
In addition to enzyme kinetics, microchip CE-ESI/MS was used
in the screening of metabolites of tramadol and paracetamol from
human urine samples. The metabolic proﬁles of these two pharma-
ceuticals are very different and their broad spectrum of potential
metabolites with variable chemical and physical properties make
them particularly suitable reference compounds for validating the
microchip CE-ESI/MS method for metabolic proﬁling. Namely, the
main urinary metabolites of paracetamol are the phase II conjuga-
tion products, e.g., glucuronides [26] while tramadol is extensively
converted to several phase I metabolites (oxidation products) by
CYP enzymes. The main urinary metabolites of tramadol are O-
desmethyl-tramadol (metabolite M1) and N-desmethyl-tramadol
(metabolite M2) [27]. In addition, traces of several other metabo-
lites, both phase I and phase II (conjugation products) are possible
[28].
Before analysis, the urine samples were pre-treated either by
off-chip SPE (5-fold concentration) or by on-chip LPME (2-fold con-
centration). SPE is extensively used in metabolic proﬁling because
of its versatility and the possibility of extracting a broad range of
metabolites from urine samples, for example. In this study, six tra-
madol metabolites, including both phase I and phase II products, as
well as tramadol itselfweredetectedandseparated fromeachother
by the microchip-based analysis following off-chip SPE (Fig. 4). In
case of paracetamol, mainly phase II conjugation products (glu-
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curonide, glutathione and cystein) were detected in addition to
paracetamol itself which was detected as a very intense, slightly
tailing peak in the electropherogram (Fig. 5). The biotransforma-
tion of xenobiotics is a very complex process and can greatly vary
between individuals. Here, the content of unmetabolized parac-
etamol in urine was seemingly much higher than those of the
metabolites. Taking into account the relatively high dose of parac-
etamol (500mg), it is likely that thiswas the reason for theobserved
tailing of the paracetamol peak in Fig. 5. All tramadol and parac-
etamol metabolites migrated within approximately 30–35 s. These
metabolite ﬁndings are in good accordance with the previously
published reports [29,30].
In addition to SPE, the urine samples containing metabolites of
tramadol were pre-treated using on-line LPME prior to microchip
CE-ESI/MS. LPMEoffers selectivity in the analysis of less polar phase
I metabolites, which may be hard to detect if the SPE conditions
are optimized for the extraction of very polar phase II metabo-
lites. In LPME, target analytes are extracted from the biological
matrix, through a hollow ﬁber wetted with an organic solvent,
into a suitable acceptor solution [31]. The acceptor solution is then
injected into a chromatographic or electrophoretic separation sys-
tem. LPME is easily downscaled to low L volumes by replacing
the hollow ﬁber with a ﬂat polypropylene membrane, which also
facilitates its implementation to lab-on-a-chip systems [21]. The
experimental set-upused in this study is shown in Fig. 1. For extrac-
tion of the tramadol metabolites, the urine pH was adjusted to
11.4 with NaOH (30mM) in order to convert tramadol as well as
the expected basic metabolites into their neutral form (Fig. 6).
In the acceptor droplet, the pH was adjusted to 2.7 with formic
acid (0.1%) to ensure full protonation. In brief, the analytes in
their neutral form were extracted from 4L of alkaline donor
solution into the organic phase (octanol wetted polypropylene
membrane) from which they were distributed and concentrated
(2-fold) into 2L of acidic acceptor solution in their protonated
form. The pH gradient between the donor and acceptor solution
served as the only driving force for extraction, since no stirring
was applied to promote mass transfer in the system. Fig. 6 lists
the metabolites of tramadol detected using the LPME set-up. All
compounds except the metabolite M5 could be easily detected
even in full scan MS mode. For reference, the estimated detec-
tion limits (S/N=3) of the tramadol M1 metabolite, for example,
were 2M and 4nM in full-scan and SRM modes, respectively.
The metabolite M5 was only observed by using the more speciﬁc
and sensitive detection in SRM mode, which was likely because
of its poorer extraction efﬁciency (i.e., zwitterionic nature and
relatively low logD value at pH 11, which lower its theoretical
mass transfer from the donor solution into the octanol wetted
membrane).
A closer examination of the SPE and LPME treated samples
clearly shows the differences between the two methods. The phase
I metabolites M1 and M5 as well as tramadol itself were detected
by both SPE (Fig. 4) and LPME (Fig. 6). As expected, the phase II
metabolites were detected by SPE only, whereas LPME provided
increased selectivity with respect to the less polar phase I metabo-
lites so that one additional metabolite, M9, was detected by LPME
only. A further advantage of the LPME set-up is the possibility of
performing on-line sample clean-up and preconcentration prior to
analysis. In thiswork apreconcentration factor of twowasused, but
dependingon the applied chipmaterial and fabricationmethod, the
depth of the sample inlet (i.e., acceptor side) can be reduced to only
a few tens of micrometers which correspond to acceptor volumes
in the nL range. Thereby, multi-fold sample preconcentration can
easily be achieved with on-chip LPME in the same way as with off-
chip SPE. In addition, on-chip LPME offers advantages in terms of
speed of analysis. For example the time for sample preparation by
LPME is only a fewminutes (here a 5min extraction timewas used),
while the time for sample preparation by conventional off-chip SPE
columns is tens of minutes.
4. Conclusions
Sensitive and efﬁcient analysis of drug metabolism products
was demonstrated by using the SU-8 CE-ESI/MS microchips. The
microchip method including rapid CE separation of parent drugs
and their metabolites followed by MS detection in full-scan
MS or SRM mode was validated by using 1-hydroxybufuralol, a
CYP metabolism product of bufuralol, as the model compound.
The enzyme kinetic parameters determined for the bufuralol 1-
hydroxylation compared very well between the microchip method
and a standardHPLC-UVmethod. Themicrochipswere also applied
to the analysis of authentic urine samples from which metabolites
of tramadol or paracetamol were detected. Before microchip CE-
ESI/MS analysis, the urine samples were pre-treated with either
off-chip SPE or on-chip LPME. Comparison of these sample pre-
treatment methods evidenced that LPME increases selectivity for
the less polar phase I metabolites, while SPE is capable of extract-
ing a broad range of phase II metabolites. However, the small
sample volumes required in LPME together with the possibil-
ity of very simple on-line coupling to the separation microchips
offer advantages in terms of speed of analysis and performing on-
line sample concentration prior to analysis. Most importantly, the
highly reproducible, low cost fabrication of SU-8 microchips by
photolithography and wafer-level adhesive bonding enables mass
production of microchips with accurately deﬁned microstructures
and identical features from chip to chip. In addition to the very fast
analysis times and the reported high sensitivity, this is the main
advantage of the fully integrated SU-8 CE-ESI/MS microchips over
other thus far published CE-ESI/MS microchips.
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Short Communication
Shape-anchored porous polymer monoliths
for integrated online solid-phase extraction-
microchip electrophoresis-electrospray
ionization mass spectrometry
We report a simple protocol for fabrication of shape-anchored porous polymer monoliths
(PPMs) for on-chip SPE prior to online microchip electrophoresis (ME) separation and
on-chip (ESI/MS). The chip design comprises a standard ME separation channel with
simple cross injector and a fully integrated ESI emitter featuring coaxial sheath liquid
channel. The monolith zone was prepared in situ at the injection cross by laser-initiated
photopolymerization through the microchip cover layer. The use of high-power laser
allowed not only maskless patterning of a precisely deﬁned monolith zone, but also faster
exposure time (here, 7 min) compared with ﬂood exposure UV lamps. The size of the
monolith pattern was deﬁned by the diameter of the laser output (500 m) and the
porosity was geared toward high through-ﬂow to allow electrokinetic actuation and thus
avoid coupling to external pumps. Placing the monolith at the injection cross enabled ﬁrm
anchoring based on its cross-shape so that no surface premodiﬁcation with anchoring
linkers was needed. In addition, sample loading and subsequent injection (elution) to the
separation channel could be performed similar to standard ME setup. As a result, 15- to
23-fold enrichment factors were obtained already at loading (preconcentration) times as
short as 25 s without sacriﬁcing the throughput of ME analysis. The performance of the
SPE-ME-ESI/MS chip was repeatable within 3.1% and 11.5% RSD (n = 3) in terms of
migration time and peak height, respectively, and linear correlation was observed between
the loading time and peak area.
Keywords:
Electrospray ionization / Mass spectrometry / Microchip electrophoresis / Porous
polymer monoliths / Solid-phase extraction DOI 10.1002/elps.201400278
 Additional supporting information may be found in the online version of thisarticle at the publisher’s web-site
Integration of multiple analytical operations on a single
microﬂuidic chip via miniaturization is one of the fore-
front technologies for modern bioanalysis. The combination
of microchip (capillary) electrophoresis (ME) with on-chip
(ESI/MS) is a particularly powerful tool because of its high
separation efﬁciency and selectivity of ME and MS, respec-
tively [1–4]. As a result of miniaturization, multiple repeated
analyses can be performed out of a fewmicroliters sample vol-
Correspondence: Dr. Tiina Sikanen, Division of Pharmaceutical
Chemistry and Technology, Faculty of Pharmacy, University of
Helsinki, Viikinkaari 5E, FI-00014, Helsinki, Finland
E-mail: tiina.sikanen@helsinki.ﬁ
Fax: +358-2941-59556
Abbreviations: ME, microchip (capillary) electrophoresis;
PPM, porous polymer monolith
ume, since only a few tens of picoliter is effectively used (in-
jected) for a single analysis. At best, detection limits reaching
low attomole amounts per injected volume (typically submi-
cromolar concentration limits) have been shown [5–7]. How-
ever, there is a need for coupling online sample pretreatment
as an integral part of the separation chips in order to im-
prove the efﬁciency of sample consumption (injected vs. total
sample volume required) and to reach better concentration
sensitivity [8].
Although electrokinetic sample stacking [8] and liquid–
liquid extraction [7, 9, 10] have efﬁciently been implemented
on chip, SPE typically allows for improved selectivity and
enrichment factors in bioanalysis. To accomplish SPE on a
microchip, solid support structures have to be incorporated
Colour Online: See the article to view online Fig. 2 in colour.
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Figure 1. Schematic views of the SU-
8-based ME-ESI chip with a UV-cured
PPM pattern at the injection cross
(top left, dimensions not to scale)
and of the UV curing setup used
for crosslinking of the cross-shaped
monolith zone at the injection cross
(right) accompanied by an SEM im-
age and a photograph (topview) of
the microchannel cross section ﬁlled
with cross-linked porous methacry-
late monolith (bottom left, porogen
PEG10k, exposure time 15 min). BI =
buffer inlet, SI = sample inlet, SW =
sample waste, SLI = sheath liquid in-
let, MS = mass spectrometer.
into the microchannel [11, 12], which has been achieved in
several different ways, for example, coating of the channel
wall with octadecyltrimethylsilane [13] or using magnetic or
mechanical trapping of C-18 beads [14–19]. Precisely ordered
microfabricated silicon pillar arrays have also been used as
alternatives to packed beads [20, 21], but their selectivity is
often limited and postmodiﬁcation has to be performed in
order to add stationary phase material onto the silicon pillars.
Porous polymermonoliths (PPMs) offer several attractive
features formicrochannel packing for on-chip SPE, including
fritless polymerization in situ by heat or UV light, and easy
tuning of the porosity and the surface chemistry by simply
changing the polymerization time and/ormonomer/porogen
composition [22]. In addition, cross-linked polymer mono-
liths avoid the risk of individual beads leaking out of the mi-
crochannel, which is particularly important when coupling to
an MS instrument is desired. However, surface prefunction-
alization of the channel walls with suitable linker molecules
is often required in order to permanently ﬁx the cross-linked
monolith zones into a microchannel.
In this work, we report a simple and fast approach for
implementing a PPM-based SPE unit as an integral part of
a standard ME separation chip made of SU-8 polymer [23]
and featuring an on-chip ESI emitter with a coaxial sheath
liquid channel for coupling to MS (Fig. 1). The novel ap-
proach herein arise from the use of high-power UV laser for
maskless photopolymerization of a precisely deﬁned, cross-
shaped PPM zone in situ at the injection cross of the SU-8
separation chip (Fig. 1). The high intensity of the laser beam
(15 J at 1 kHz, 355 nm) enables very fast curing (here, best
performance at 7 min) and initiation of the photopolymeriza-
tion reaction even through a 70-m-thick SU-8 cover layer,
which itself absorbs the near UV light to some degree [24]. To
our knowledge, most previous work have made use of lower
power ﬂood exposure lamps, which entails the use of photo-
exposure masks and UV transparent substrates only, and
also requires relatively long exposure times (typically 20–
40 min [25,26]). Therefore, our approach provides signiﬁcant
simplicity for fabrication of PPMs inside a microchannel.
Most importantly, the placing of the cross-linked monolith at
the intersection of the injection and separation channels (Fig.
1) allowed us to ﬁrmly anchor themonolith based on its shape
with noneed for prefunctionalization of the SU-8 surfacewith
molecular linkers. Since the UV laser was coupled to an (up-
right) epiﬂuorescence microscope, the size of the exposure
beam, and thus the size of the cross-linked monolith pattern,
could be adjusted by simply changing the microscopic mag-
nitude. In this work, a 20× magniﬁcation was used in order
to deﬁne a 500-m-diameter exposure area. Before exposure,
the microchannel was ﬁlled with a methacrylate monomer
mixture containing appropriate crosslinkers and porogens,
according to a previously published recipe [27] (see Support-
ing Information). Distinct from the previous work, we used
a ﬂuorescent-labeled porogen (PEG 5k) for monitoring and
ensuring complete removal of PEG residues (after crosslink-
ing), which is crucial regarding the MS coupling as PEG
residues causemajor background disturbance inMS analysis
(see Supporting Information). Finally, the morphologies and
the performance of themonoliths were characterized by SEM
(Fig. 1) as well as ﬂuorescence microscopy and ME-ESI/MS
experiments (see Supporting Information).
Regardless of themicrochannel packing technique, most
chip-based SPE devices thus far reported have been cou-
pled to external pumps in order to allow for operation by
pressure-driven ﬂow. Obviously, the use of pressure ﬂow
makes the system much more complex as interfacing be-
tween microchips and external pumps often requires imple-
mentation of pressure-tight capillary couplings and mechan-
ical valves and thus makes the system prone to dead volume
(time lag). In this work, with a view to performing rapid on-
line preconcentration, the porosity of the monolith was com-
promised with relatively high through-ﬂow (i.e., large pores
for low back pressure) over ﬂawless retention in order to al-
low for fully electrokinetic actuation and thus avoid the need
for coupling to external pumps. In this respect, the PPMs ap-
peared as amore convenient technology over particle packing
because of the possibility to tune the porosity of the monolith
by simply changing the amount and size of porogens and
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
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Figure 2. The operation principle of the SPE-ME-ESI microchip is illustrated with squares (black) and circles (red) representing hydrophilic
and hydrophobic sample components, respectively. EIE of the [M+H]+ ions of cotinine (black line, 50 M) and verapamil (red line,
20 M) show that the hydrophilic, unretained cotinine is washed away in step 2, whereas hydrophobic verapamil is selectively retained
(steps 1–2), released (step 3), and eluted to MS (step 4). The electric ﬁeld strength during separation was 800 V/cm and other operating
voltages (steps 1–4) were according to the schematic view. The blank injection (4.5–5 min) and elution (5–6.5 min) in the end of the
electropherogram show no memory effect, that is, all sample components are efﬁciently released from the monolith in steps 3–4. The
sample components were loaded in 2% ammonium hydroxide solution (pH 12) and the BGE was 30 mM ammonium acetate with 50%
methanol.
the exposure time. The operation principle of our fully inte-
grated SPE-ME-ESI chip is presented in Fig. 2 and illustrated
with a four-step protocol: (1) sample loading, (2) rinsing (of
unretained, hydrophilic impurities), (3) injection (release of
retained hydrophobic analytes), and (4) elution followed by
simultaneous ME separation (of released hydrophobic ana-
lytes) prior to online ESI/MS detection. Detailed description
of the ME voltages and MS parameters is given in the Sup-
porting Information.
In order to visualize the rinsing step, a hydrophilic com-
pound, cotinine (logP = 0.21), was added to the sample so-
lution containing verapamil (logP = 5.04) in 2% ammonium
hydroxide solution (pH 12) (step 2, Fig. 2). As a result, the hy-
drophilic cotinine was not adsorbed on the porous monolith
during sample loading (step 1), but rather spread throughout
themonolith and gave a broad and tailing peakwhen rinsed to
theMS (step 2). Instead, themore hydrophobic verapamil was
concentrated at themonolith border (step 1) and released only
after elution with organic solvent (50%methanol with 30mM
ammonium acetate, steps 3 and 4). Despite the relatively long
loading time of 30 s, verapamil gave a narrow and symmetric
peak (w1/23 s) at theMSdetector (step 4) evidencing efﬁcient
retention and selective elution during loading and injection-
separation steps, respectively. Most importantly, there was no
memory effect of either cotinine or verapamil in the subse-
quent blank injection (SI → SO) and separation (BI → MS)
steps performed immediately after analysis (Fig. 2). Also,
the good repeatabilities for both the migration time (RSD =
3.1%, n = 3) and the peak height (RSD = 11.5%, n = 3) of
the preconcentrated verapamil suggest robust performance
from run to run. These values are comparable to those previ-
ously reported for similar ME-ESI/MS analyses, but without
SPE concentration, by our group [7, 23] and others [15, 28],
which clearly indicates that addition of on-chip SPE did not
signiﬁcantly interfere with the ME separation. Furthermore,
correlation was established between the loading time (10–
25 s) and the peak area obtained using two test compounds
with somewhat similar hydrophobicity, namely tramadolwith
logP = 2.45 (R2 = 0.950) and propranolol with logP = 2.58
(R2 = 0.999) (Fig. 3A). The estimated enrichment factors
were approximately 15-fold (tramadol) and 23-fold (propra-
nolol) already at a loading time of 25 s. The possibility to
use such short loading times (which are comparable to ME
injection times) emphasizes the fact that our chip design
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
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Figure 3. (A) Effect of the sample loading time
(step 1) on the area of the released peaks (step
3) as illustrated with tramadol (logP = 2.45) and
propranolol (logP = 2.58). (B) Separation of pre-
concentrated bufuralol (logP = 2.99; black line)
and verapamil (logP = 5.04; grey line) after si-
multaneous loading into the monolith (step 1, 15
s), release (step 3), and separation byME (step 4).
Sample loading (each 25 M) and rinsing (steps
1–3) was according to Fig. 2, but the electric ﬁeld
strength during separation (step 4)was 900V/cm.
enables efﬁcient SPE without compromising the inherent
high speed of ME separations as illustrated with rapid SPE-
ME-ESI/MS analysis of preconcentrated pharmaceuticals in
Fig. 3B.
In conclusion, we report a simple and rapid fabrication
protocol for implementation of on-chip SPE based on mask-
less laser-initiated photopolymerization of PPMs in situ at
the injection cross of an ME-ESI chip (made of SU-8). In this
work, conventional RP chemistry (of metacrylate monoliths)
was exploited to SPE, but the selectivity of the monolith can
easily be altered by simply changing the monomer composi-
tion. The porosity of the monolith zone was geared toward
relatively high through-ﬂow in order to reduce the back pres-
sure, and thus allow actuation based on electrokinetic ﬂow
alone. Thiswas considered advantageous for precise ﬂow con-
trol and easy valving with negligible dead volume (time lag)
as compared to pressure-driven ﬂow. Anchoring of themono-
lith based on its shape eliminated the need for surface pre-
functionalization with anchoring linkers and this made the
fabrication process particularly straightforward. The use of
shape-anchored PPMs was also preferred over packed beads
in order to avoid the risk of individual beads leaking to the sep-
aration channel, which could cause problems in the MS mea-
surements. Apart from this work, only a few prior examples
of similar electrokinetically operated on-chip SPE with subse-
quent online ME have been reported [25,26,29,30]. However,
in most of these devices, the loading/preconcentration time
required for SPE has been rather long (5–20 min) compared
to our design and coupling to MS detection has been rare.
In our chip design, all analytical operations including online
coupling to MS via a fully integrated, dead-volume-free ESI
emitter – are combined on a single ME-ESI chip featuring
relatively simple ﬂuidic layout so that the microchips can be
mass produced in a reproducible manner based on standard
parallel microfabrication processes (lithography and wafer-
scale adhesive bonding). The PPM, in turn, can be prepared
on demand whenever sample pretreatment by SPE is con-
sidered necessary prior to ME-ESI/MS analysis. Most impor-
tantly, the chip conﬁguration used in this study allows for
online SPE with the standard ME chip geometry and with
only four individual high voltage (HV) supplies so that the
complexity of the system is not increased at the cost of inte-
grated sample preparation. To our knowledge, this is the ﬁrst
fully electrokinetically actuated online SPE-electrophoresis
microchip coupled to on-chip ESI/MS. For future work, 2D
separations are envisioned through selective retention and
release of sample components from the monolith (ﬁrst di-
mension) followed by subsequent electrophoretic separation
during the elution step (second dimension).
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2Materials and Reagents
Verapamil hydrochloride, propranolol hydrochloride, cotinine, ammonium acetate, 2,3-
epoxypropyl methacrylate (GMA), 2-methoxyethanol (2ME), benzoin methyl ether (BME), 1-
methyl 2-pyrrolidone  (NMP), trimethylolpropane trimethacrylate (TRIM), and triethylene glycol
dimethacrylate (TEGDMA) were purchased from Sigma-Aldrich (Steinheim, Germany).
Polyethyleneglycol 6000 (PEG (6k)) was from Applichem (Darmstadt, Germany) and
fluorescein polyethyleneglycol succinimidyl ester 5000 (fluorescein-PEG-NHS- 5k) was from
Creative PEGWorks (Winston Salem, NC). Methanol, acetic acid, and ammonium hydroxide
were from Mallinckrodt Baker B.V. (Deventer, The Netherlands). Tramadol was kindly donated
by the Department of Forensic Medicine, University of Helsinki, Finland. Water was purified
with a Milli-Q water purification system (Millipore, Molsheim, France). All solutions were
sonicated for 15 min before use.
Negative photoresist SU-8 50 (Microchem, Newton, MA, USA) was from Microresist
Technologies GmbH (Berlin, Germany) and poly(dimethylsiloxane) (PDMS) (Sylgard 184, Dow
Corning, Midland, MI, USA) from VWR International Oy (Espoo, Finland).
Microchip design
The microchips used in this study comprised a 25-mm-long (20 mm effective length) separation
channel (50×50 μm, w×h) intersected by a 10-mm-long simple cross injection channel (30×50
μm, w×h), an auxiliary channel (100×50 μm, w×h) for sheath liquid, and an ESI emitter (Fig. 1).
The microchips were fabricated of epoxy photoresist SU-8 using photolithography and adhesive
bonding techniques as reported earlier [1, 2]. Prior to use, thin sheets of PDMS with Ø2 mm inlet
holes were attached on top of the microchip to avoid liquid spreading on SU-8 surface.
3Monolith Preparation
The methacrylate monolith was prepared according to a protocol slightly modified from that
previously published [3, 4]. Briefly, the monomer mixture was prepared by mixing the main
monomer  GMA  with  the  crosslinkers  TRIM  and  TEGDMA  in  a  mass  ratio  of  1:1
(TRIM:TEGDMA ratio 1:5, w/w). Next, the main porogen PEG dissolved in 2ME (1:5, w/w)
and the co-porogen NMP was added to the monomer mixture. The main porogen used during the
method development was fluorescein-labeled PEG (5k) which allowed us to monitor the
efficiency of washing based on the fainting fluorescence. However, for the final monolith
preparation, non-fluoresent PEG (6k) was used. The final ratio of the components in the mixture
was 30% monomers and cross-linkers, 60% main porogen, and 10% co-porogen. Last, the
photoinitiator BME was added to the polymer solution to a final concentration of 1% (w/w). The
mixture was vortexed and sonicated for 10 minutes after which the microchip was filled with the
solution. Polymerization was done by exposing the injection cross area through the SU-8 cover
layer (thickness 70 μm) with a UV laser (355 nm, 15 μJ at 1 kHz, PowerChip, Teem Photonics)
for  7  minutes  (Figure  1).  The  UV  laser  was  coupled  to  a  Zeiss  Axioscope  A1  upright
epifluorescence microscope (Carl Zeiss Oy, Espoo, Finland) through a Plan-Neofluar 20×/0.30
objective so that the exposed area was roughly 500 μm in diameter. After exposure, the
microchip was filled with and immersed in a water:methanol (1:1) solution at 60°C for 1 h to
dissolve the unpolymerized methacrylate monomers. In addition, the microchannel was rinsed by
vacuum suction for 10 minutes before and after immersion in the warm water:methanol solution
in order to efficiently remove the dissolved porogens from the microchannel. The morphology of
the monolith was characterized by scanning electron microscope (SEM) photographs (Figure 1,
see manuscript).
4Microchip electrophoresis and Mass Spectrometry
Schematic illustration of the operation principle of the integrated on-chip SPE-MCE-ESI/MS is
presented in Figure 2 (see manuscript). The SPE-ME-ESI/MS chip was placed on an xyz-aligning
stage in front of an API3000 or API365 triple-quadrupole MS (Perkin-Elmer Sciex, Concord,
ON, Canada). An external power supply (Micralyne Inc., Edmonton, Canada) was used for
application of the loading/injection, rinsing/separation and ESI voltages through platinum wires
placed in the microchip inlets. The MS was operated in positive ion mode with an ESI voltage of
3.5 kV applied to the sheath liquid inlet (SLI). The ESI voltage also served as the counter voltage
for the ME separation. Before analysis, the monolith was equilibrated with the background
electrolyte (BGE) which consisted of 30 mM ammonium acetate with 50% methanol (v/v).
Sample loading (in 2% ammoniumhydroxide, pH 12) and injection (in BGE) were performed in
pinched mode with the following voltages: 1.0 kV (sample inlet (SI)), ground (sample waste
(SW)), and 0.8 kV (buffer inlet (BI)) (Figure 1). The ME separations were performed in cathodic
mode using a separation voltage of 5.5 kV applied to the BI (800 V/cm between the BI and the
SLI) and antileakage voltages of 5.3 kV applied to the SI and SW, while an ESI voltage of 3.5
kV was  applied  to  the  SLI.  The  sheath  liquid  used  for  all  analyses  was  methanol:water  80:20
(v/v) with 1% acetic acid. The excess separation current was grounded through a 50 M resistor
coupled in parallel with the ESI voltage supply in a configuration similar to earlier work [5].
Data were recorded in full-scan MS mode at a speed of 300 ms per scan over a mass range of m/z
50-500. Analyst 1.4 software was used for data acquisition and processing.
5Characterization of the Monoliths
Rinsing of the porogens and unpolymerized methacrylate monomers from the monolith was
found to be crucial in order to minimize background disturbances and suppression of ionization
in ESI/MS. Therefore, the washing procedure was optimized by using fluorescent labeled
porogens (fluorescein-PEG5k) so that the washing efficiency could be monitored based on the
fainting fluorescence of the monolith pattern, in addition to monitoring the quality of the mass
spectra (Fig. S1). Here, a one-hour water-methanol 1:1 bath at +60°C with additional rinsing by
vacuum suction for 10 minutes before and after the bath was found adequate in order to assure
high quality MS analysis (Fig. S1).  Namely, abundant PEG residues were observed unless the
washing procedure was carefully optimized with help of fluorescent-labeled PEG.
Figure S1. ESI/MS spectra of a BGE run obtained by using an SU-8 ME-ESI/MS chip with
porous methacrylate pattern at the injection cross: (A) after inadequate washing showing the
characteristic PEG patterns and (B) after a one-hour water-methanol 1:1 bath (60°C) and
additional rinsing by vacuum suction for 10 min showing negligible number of different
background ions.
6In addition to monolith washing, fluorescence microscopy was exploited to examining the
retention capacity of the monolith. A fluorescent dye of similar lipophilicity than the test
compounds (i.e., rhodamine, logP=2.85) was used for illustration of the analyte adsorption onto
the  monolith  (Fig.  S2).  It  was  observed  that  the  fluorescent  dye  was  firmly  retained  to  the
metacrylate monolith during sample loading (Step 1) and did not elute when rinsing the monolith
with aqueous buffer (Step 2), but until organic solvent was added to the run buffer for sample
injection/release (Steps 3-4, data not shown).
Figure S2. (a)  A  micrograph  (topview)  of  a  microchannel  filled  with  monolith  and
(b) adsorption of a fluorescent dye (10 μM rhodamine 123) onto the monolith during sample
loading in 100 mM Tris (pH 9).
Although the metacrylate monoliths as such showed reversed phase chemistry, it was obvious
that some sample leakage may occur between the monolith pattern and the microchannel wall
since the monolith patterns were not cross-linked to the microchannel surface but rather
anchored based on their shape. In order to examine the effect of sample leakage (during loading)
on the quantitativity of sample enrichment, a series of SPE-ME-ESI/MS runs was performed
with  varying  sample  loading  times.  It  was  observed  that,  if  there  were  void  volumes  in  the
7monolith (e.g., at microchannel corners or near microchannel walls), minor sample leakage took
place during loading so that traces of the test compounds were eluted to the MS already during
the rinsing step. However, the amounts (peak areas) of leaking sample components hardly
exceeded 10% of those obtained after controlled release (injection and elution) of the same
sample components from the monolith (Fig. S3). Nevertheless, the SPE chip showed quantitative
performance and linear regression between the loading time and the enrichment factor was
obtained despite of the minor sample leakage. Since the emphasis here was put on developing
prominently rapid sample preparation protocols, and not high performance separations, the minor
leakage during sample loading did not play a crucial role with respect to the chip performance.
Instead, the possibility to use electrokinetic flow instead of pressure driven flow was highly
beneficial in terms of minimizing the time required for SPE as no capillary couplings to external
pumps (with inherent dead volume/time lag) were needed. Thus, relatively loose monoliths with
high degree of porosity are likely the best compromise in order to reduce the back pressure
(macro pores), but still maintain sufficient retention capacity (micro pores).
8Figure S3. Comparison of the peak areas observed for (a) propranolol and (b) tramadol signals
originating from sample leaking during loading (i.e., Step 2, rinsing) and from controlled sample
release (i.e., Step 4, elution).
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